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Allergic Rhinitis is a common condition associated with the inflammation of the nasal 
airways mediated through mechanisms involving the production of immunoglobulin E (IgE) 
which binds to the basophils/mast cells with histamine. Most studies on rhinitis focus 
primarily on ‗hay fever‘ caused by seasonal allergens such as grass pollen and pollen from 
plants (commonly referred to as pollinosis). These studies were performed primarily in the 
European and the American populations where allergy is more seasonal than perennial. 
However in South East Asia, and especially here in Singapore the problem of allergens is 
more perennial in nature. The house dust mites are the major allergens in Singapore with a 
large proportion of close 90% of allergic individuals reacting to a house dust time species if 
tested for sensitization. The prevalence of house dust mite sensitization in Singapore is quite 
high as presented in Chapter 2. This is quite unique to this region where although the allergic 
sensitization prevalence is high, the prevalence of allergic phenotypes are comparable to 
trends seen in other parts of the world. Hence the need for more focused studies on Singapore 
using the perennial model of allergic rhinitis. 
 
In addition, most genetic studies on allergic phenotypes such as asthma, allergic rhinitis and 
atopic dermatitis are primarily performed in cohorts of European descent and in some instants 
American descent. Only a small proportion of genetic studies including the most recent 
GWAS have been studying Asian populations and to a much lesser extent populations from 
South East Asia such as Singapore, Malaysia, Thailand, Indonesia, Vietnam, etc. A quick 
review of genetic studies would indicate the issues of population based differences when 
considering association of polymorphisms in genes to disease and/or phenotypes. There has 
been more literature in the recent past emphasizing the need to find association in specific 
xv 
 
populations before pursuing the functional characterization of such candidates to understand 
disease pathogenesis.  
 
Allergic rhinitis and asthma are complex diseases resulting from an interaction between 
genetic and environmental factors. Decades of research on the genetic variants associated 
with these diseases have suggested that possibly there is a large group genetic variant 
involved in genetic predisposition, many of these could be specific to different populations 
and others controlling the biology of the genes relevant across populations. Also these genetic 
variants have epistatic interactions with other candidates (gene gene interactions) and also 
with environmental conditions (gene environment interactions) controlling disease risk. 
Taken together these information suggest that genetic studies in allergic diseases need (i) a 
large well characterized population cohort preferably of a single ethnicity stratified by age, 
gender and environment (ii) an unbiased interrogation to identify genetic variants associated 
with disease predisposition (iii) considering epistatic interactions among candidate genes to 
understand synergistic and antagonistic mechanisms for disease (iv) possible functional 
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1. INTRODUCTIONS AND LITERATURE REVIEW 
 
1.1 What is Rhinitis? 
Rhinitis is an inflammatory disorder of the lining of nasal mucosa characterized by symptoms 
such as rhinorrhea, sneezing, pruritus, nasal blockage, post nasal drainage and occasionally 
associated with lacrimation of eyes and loss of taste and smell [1,2]. Allergic rhinitis is 
caused mainly by allergen-driven inflammation of the mucosal membrane lining and involves 
a variety of inflammatory mediators such as cytokines and neurotransmitters that results in 
activation of sensory nerves, plasma leakage and venous sinusoidal congestion [3].  AR is 
mediated by hypersensitivity responses to indoor and outdoor allergens [4]. The immediate or 
early phase response results in the vasodialation, oedema and characteristic AR symptoms 
such as sneezing, itching and nasal congestion. However the late phase response generally 
observed after 4-24 hours after allergen exposure is consists of cytokine production (mainly 
Th2 cytokines) and tissue eosinophilia. AR is generally considered to be a seasonal 
disturbance, could also result in minimal persistent inflammation of the nasal musosa which 
could result in viral colds if the inflammation synergizes with infection [5,6]. In children 
especially this interaction of virus infection with allergen sensitization have resulted an 
increased severity of asthma thus resulting in more hospital admissions for emergency care 
[7].   
  
1.2 Types of Allergic Rhinitis  
AR can be classified as either seasonal or perennial based on the type of allergen mediating 
the disease. Seasonal AR (SAR) is characterized by an IgE-mediated response to seasonal 
aeroallergens, specifically during certain parts of the year such as spring or fall. Pollen is a 
major aeroallergen and hence SAR is also sometimes referred to as pollen allergy that might 
also refer to allergy to trees, weeds and grasses. In some cases molds might also serve to 
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cause SAR. Duration of allergen exposure varies based on location. Perennial AR (PAR) in 
similar to SAR as it is also IgE-mediated, but contrasts in that the allergens are present in the 
environment throughout most of the year. Some of the perennial allergens include house dust 
mites (HDM), animal allergens and in some cases pollen and molds if they are present 
perennially in certain parts of the world.  
 
1.3 Symptomology 
Allergic rhinitis is usually consistent with the presence of the following four common 
symptoms in the absence of a viral infection or cold or flu infection [8, 20]: 
 
1) Watery anterior rhinorrhea or runny nose 
2) Sneezing usually paroxysmal  
3) Nasal Obstruction or blockage 
4) Nasal itching or pruritis 
 
In some cases itchy and/or watery eyes the condition usually referred to as conjunctivitis 
might accompany these symptoms. In other instances troublesome symptoms of the ear and 
throat might also be reported in patients with allergic rhinitis.   
 
1.4 Classification based on Severity  
Allergic Rhinitis can be classified into mild, moderate and severe based on the duration of the 
symptoms associated with the disease and also their severity. AR is referred to as ―mild‖, if 
the symptoms are indeed present, but however don‘t cause disturbance to the individual. This 
also implies that probably the quality of life of the individual is not affected and they are able 
to perform their daily activities normally, and also especially have no sleep disturbances. In 
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contrast if the individual does feel uncomfortable and suffers a loss to quality of life, by 
missing school or work; or unable to perform exercise of be involved in sports, leisure then 
the individual is classified as having ―moderate to severe‖ AR. Usually such individuals also 
have sleep disturbances and occasionally slight loss of performance of the other senses such 
as smell and taste. 
 AR can also be referred to as ―intermittent‖ or ―persistent‖ depending on the duration 
of symptoms. If the symptoms persist for 4 or more days in a week, and also continues to 
persist for more 4 weeks, then it is categorized as ―persistent‖. If the AR symptoms persist for 
less than 4 days a week or continuously less than 4 weeks, it is categorized as ―intermittent‖. 
 
1.5 Epidemiology 
AR affects over 500 million people worldwide. The prevalence of AR has been on the rise in 
the recent decades in most of the countries, especially in those regions of the world where the 
reported prevalence previously was low to moderate. In adolescents especially the prevalence 
is very high, with some countries having 50% of the adolescents experiencing symptoms of 
AR [8]. But it most be noted that in some countries this increasing trend is not observed as 
recorded in the ARIA 2008 update. The onset of the disease is usually in the adolescent age 
with close to 80% of individuals diagnosed with AR have experienced symptoms before 20 
years of age [9]. However this increase in prevalence over the recent years has not been fully 
understood.  The International Study of Asthma and Allergies in Childhood (ISAAC) have 
used standardized questionnaires and video interviews to understand and explain the 
prevalence and severity of allergic disease such as asthma, AR and allergic dermatitis in 
children worldwide.  This study was carried out in 3 phases during the late nineties and early 
2000 and the children were classified into two groups based on age: (i) 6-7 years of age and 
(ii) 13-14 years of age. The comprehensive evaluation of AR prevalence identified that 
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although there was a variations in trends among countries a large proportion of the countries 
reported a higher prevalence or an increasing trend over the recent years in comparison to 
those countries that had a stable or decreasing trend for prevalence of AR [1].  
 
1.6 Quality of Life 
Allergic Rhinitis is usually considered to be a nuisance rather than a disease or disorder 
mainly because it is manageable/bearable [12]. However recent studies have clearly 
demonstrated the impact it has on daily living and its effect on the well being of the affected 
individual. A study performed by Leynaert et al., reflected the impact that AR and asthma 
had on quality of life or as to how QoL was impaired. They had used the SF-36 questionnaire 
to study a population of young adults in two centers in France [13]. Individuals with asthma 
and/or allergic rhinitis reported more issues with social activities and impairment of daily 
activities that influenced their emotional behavior and resulted also in a poor mental state. 
Problems associated with physical well being were more prevalent in individuals who had 
both AR and asthma in comparison with those who had either. Similar studies by other 
research groups have also highlighted the impairment to QoL caused by AR [14,15,16]. 
 Children in specific suffer a large extent due to AR, as demonstrated by Arrighi et al 
., in USA, a total of 2 million school days are lost by children suffering from AR. Emotional 
disturbances have also been reported in these kids due to their inability to participate in 
family, social and cultural events due to their illness. A study in the UK has highlighted that 
performance in examination is reduced due to the use of antihistamine-based drugs for 
treating AR, which in turn cause sedation. About one-fifth of individuals with AR could 
develop severe chronic upper-airway disease if the rhinitis is insufficiently kept under 




1.7 Co morbidities 
Allergic rhinitis has commonly been observed in patients with asthma, however AR is also 
linked to other inflammatory conditions such as rhinosinusitis, allergic conjunctivitis, otitis 
media, anosmia, nasal polyps and lower airway infection [8,17,18,19]. Many studies have 
focused on the co-occurrence of asthma and AR [8,20,21]. Nearly 25% of individuals with 
AR have asthma; while close to 60% of individuals with asthma have co-existing AR. In 
children especially those who develop within their first year have two times greater risk of 
developing asthma considering those who don‘t have AR. Nasal symptoms in asthmatic 
children also worsen their bronchial symptoms and results in exacerbation of asthma, 
especially in individuals with perennial AR [22,23]. Severity of AR also is affected when 
present with asthma, as shown by Hellgren et al ., who performed baseline acoustic 
rhinometry in subjects with rhinitis co-existing with asthma and those without [24,25]. The 
subjects with rhinitis co-existing with asthma had a lower cross-sectional and significantly 
reduced nasal volume in comparison to the subjects with rhinitis alone [25]. Another similar 
study demonstrated that the patients with rhinitis and asthma had a more exaggerated 
response to nasal cold and provocation with dry air in comparison with other patients who 
only had rhinitis [26].  
 
1.8 Allergic rhinitis and asthma 
Allergic rhinitis and asthma often co-exist with AR considered as a risk factor for developing 
asthma. There has also been a ―one airway, one disease‖ unified theory which suggests that 
the symptoms of asthma and AR are indeed manifestations of the same inflammatory 
response and thus proposing that the treatment of the two diseases together [20, 92]. This is 
important to note as in patients suffering from asthma, the AR symptoms have been shown to 
be difficult to control. In addition, the onset AR is observed to precede the manifestation of 
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asthma symptoms such as airway obstruction and bronchial hyper-responsiveness [93]. And 
also the symptoms of AR are less severe in the absence of asthma as co-morbidity [91]. 
Treatment of asthma has also been more effective when treating the AR symptoms in 
addition. This led to the Allergic Rhinitis Impact on Asthma hence providing guidelines for 
diagnosis, evaluation and treatment of both diseases when symptoms of either of the diseases 
are observed by clinicians to improve patient care [8]. Although asthma and AR share some 
common pathways and etiologies, certainly there are different symptoms manifested and thus 
the risk factors for the two diseases should be different.  
 
1.9 Pathophysiology of Allergic Rhinitis 
This allergic disease is characterized two main phases in response to an allergen that results 
in eventual manifestation of nasal symptoms such as itchy nose, sneezing, runny nose and 
nose blockage. 
 
1.9.1 Early phase inflammatory response (Sensitization) 
The upper airway in human nasal mucosa contains the antigen presenting cells (APCs): 
dendritic cells (DCs) and macrophages/monocytes. DCs are located in the channels 
surrounding the basal epithelial cells and are highly efficient in moderating the primary 
immune response regulation [55, 56].  Sensitization occurs during the early phase of the 
allergic response to an allergen immediately within a few minutes of allergen exposure, 
which results in a variety of mediators released by the mast cells. The APCs on encountering 
an allergen recognize, uptake and process this foreign body (antigen) into shorter peptides 
that interact with the major histocompatibility complex molecules (MHC class II). The 
primary mediator of this response is histamine and in addition tryptase, cytokines such as 
interleukins (IL-4, IL-5, IL-6, etc), tumour necrosis factor alpha (TNF alpha), enzymes and 
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chemotactic factors are also released [57]. This environment facilitates the APCs to transform 
naïve T cells to Th2 (T helper type 2) cells that proliferate production of interleukins such as 
IL4 and IL13 [58]. This proliferation of cytokines promote B cells to produce antigen-
specific IgE through a complex mechanism of ‗isotype class switching‘ in which certain 
subsets of B cells transform into plasma cells which switch the production of IgM to IgE 
[59]. On a second encounter with the same antigen, the memory B cells are re-stimulated and 
quickly respond by proliferating and differentiating into plasma cells that secrete high affinity 
antibodies [56]. Mast cells characteristically express a high affinity Fc receptor (FCER1) and 
thus the binding of IgE occurs as an irreversible process. As these IgE molecules are specific 
to a single antigenic molecule, re-exposure to the same antigen results in binding of the 
variable region of the IgE molecule bound on the surface of the mast cells [56]. As the 
number of IgE molecules increase, cross-linking occurs between these IgE on the mast cells 
which results in a series of complex events which results in the degranulation of mast cells 
which produces more inflammatory mediators which are the primary cause of the observed 
early symptoms of allergic rhinitis such as itching of the nasal mucosa, sneezing and 
rhinorrhea and also airway obstruction as observed in asthma [57, 60]. Localized 
inflammation of the nasal mucosa results from the production of circulating leukocytes, their 
adhesion and infiltration, in particular the eosinophils and the preformed mediators such as 
histamine and tryptase released from the degranulating mast cells [56, 57]. 
 
1.9.2 Late phase inflammatory response 
The late phase inflammatory response typically occurs after 2-4 hours of allergen exposure 
and is described as more of a cellular event, characterized by clear increase lymphocytes of 
Th2 lineage along with increased eosinophils, basophils and neutrophils and elevated 
cytokine levels with increase secretion of pro-inflammatory mediators. Eosinophils are key 
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mediators of the late phase allergic response as they produce superoxide anion and hydrogen 
peroxide that are free radicals that damage the epithelium and also create hyper-inflammatory 
environment [56]. The net effect is local edema and tissue damage and promotes a prolonged 
inflammatory allergic cascade.  Such an intense inflammatory cascade results in 
manifestation of symptoms such as nasal congestion and nasal obstruction which are 
characteristic of the late phase response contrary to sneezing and rhinorrhea in the early phase 
response to the allergen [57, 58, 60].  
 
1.10 Chemoattractants and allergic rhinitis 
Eosinophils induce key chemoattractant molecules such as eotaxin (both major basic protein 
and the eotaxin cationic protein (ECP)), IL-5 and also the eosinophil derived neurotoxin that 
influence significantly the induction of nasal hyper-reactivity. The main effect of these 
molecules is seen in their ability to cause severe airway epithelial damage which result in the 
exposure of the local nerve fibers. Another effect resulting from this process might be 
disrupted endopeptidase production and regulation which produce an environment where the 
neuropeptides secreted are not degraded thereby resulting in the sustained and prolonged 
inflammatory response [56]. Cysteinyl leukotrienes (CysLTs) also serve as chemoattractants 
for eosinophils in particular which facilitate infiltration to the nasal tissue thereby getting 
activated and secreting more inflammatory mediators, which include more CysLTs 
themselves. This results in augmented inflammation and nasal congestion [63, 64]. The 
CysLTs have been reported to increase the resistance in the nasal airway, along with airway 
obstruction in some cases. They have also been associated with increased vascular 





1.11 Prostaglandins and allergic rhinitis 
On nasal challenge, the nasal lavage obtained from patients with allergic rhinitis indicated the 
local release of prostaglandin D2 (PGD2) along with other key mediators such as histamine 
and tryptase. Increase in the levels of PGD2 was also rapid considering it occurred just after 
10-15 min allergen exposure [69]. PGD2 along with tryptase are considered as indicative of a 
mast-cell source and also believed to be consistent with the degranulation of mast cells [69]. 
Other reports have shown that PGD2 enhances Th2 type inflammation and also causes nasal 
congestion and also rhinorrhea [67, 68]. PGD2 is synthesized through enzyme-mediated 
reactions controlled primarily by cyclooxygenase (COX) and PGD synthase (PGDS) [70]. 
COX is important in the context of PGD2 synthesis especially in the context of chronic 
rhinitis where increased PGD2 levels might be due to the selective activation of   COX-1 
expressing mast cells by triggers that are airborne, as COX-1 immunoexpression was seen to 
be increased in the epithelium of patients with allergic rhinitis both seasonal and perennial 
[71]. Also, Okano et al., [71] observed that in patients with allergic rhinitis, the nasal mucosa 
had higher expression of a specific isoform of PGDS called hematopoietic PGDS (H-PGDS) 
while the other isoform lipocalin-type PGDS (L-PGDS) was detected in scarce amounts. 
Possibly, the enhanced expression of COX-1 in the epithelia might lead to the increased 
synthesis of Prostaglandin E2 (PGE2) synthesis that has been observed to be having anti-
inflammatory functions and also protecting against exaggerated allergic responses by 
reducing the airway influences [72]. Taken together, it is evident that the prostanoid pathway 
including the prostaglandins and cycloxygenases might be important in understanding the 
pathophysiology of allergic rhinitis and provide possible points of therapeutic intervention to 





1.12 Nervous system and allergic rhinitis 
The nervous system and the immune system have been shown to be more functionally related 
in the recent decades [73] and especially in a disease like allergic rhinitis which involves a 
neuronal reflex for inducing symptomologies like itching [76] and sneezing, the interaction 
between these two systems needs to be elucidated. The observation by clinicians that 
psychological stress increased allergic symptoms both nasal and skin allergies as in the case 
of atopic dermatitis [74, 75]. This suggested that psychological influences modulate the 
allergic response cascade. 
  Nasal inflammation in allergic rhinitis patients has clear release of the 
neurotransmitter substance P (SP) which is a tachykinin by the C-fibres. C-fibres of the nasal 
mucosa are non-myelinated and responsible for transmitting signals that generate sensations 
such as itching and motor reflexes such as sneezing [77,78]. SP is shown to be highly 
upregulated in patients with allergic rhinitis in contrast to health volunteers that might reflect 
that there is a prolonged stimulation of the sensory system. And when administered 
exogenously SP increases the production of pro-inflammatory mediators after nasal challenge 
[79, 80]. Substance P works through the neurokinin 1 (NK-1) receptors, which are expression 
on the nasal glands, the mast cells and the epithelia in humans [81]. Binding of SP to NK-1 
receptors has been shown to be involved in transmission of signals for stress, pain, smooth 
muscle contraction and also inflammation [82]. NK-1 receptors have also been associated 
with increased secretion of mucous and also resulting chial obstruction in the airways [83]. 
Inflammation in allergic responses was shown to have increased neuopeptide production by 
the sensory nerves in a guinea pig model [85]. Similar evidence was also seen in human 
studies where neuropeptides such as calcitonin gene-related peptide (CGRP), neuropeptide Y 
(NPY) and vasoactive intestinal peptide (VIP) have also been observed to be elevated in the 
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nasal lavage of the allergic rhinitis patients in contrast to healthy subjects [84] in addition to 
SP.  
A key characteristic of allergic rhinitis is sensorineural hyper-responsiveness induced by the 
allergic response products such as eicanosoids, interleukins and other cytokine molecules, but 
more recently and interestingly neurotrophins such as nerve growth factor (NGF) and brain 
derived neurotrophic factor (BDNF) [86]. Neurotrophins such as NGF and BDNF that were 
primarily thought to be expressed in the brain have now shown to be present in the glandular 
and nasal epithelium in the nasal mucosa by the peripheral nerves [87, 88]. Raap et al., also 
showed that on nasal provocation with allergen there was increased levels of both NGF and 
BDNF in allergic patients [88]. And also significantly, the increased levels of BDNF 
correlated with the total symptom score for allergic rhinitis. Eosinophils have been identified 
to express these neurotrophins and are believed to modulate the function and activity of the 
granulocytes of eosinophils especially in allergic rhinitis [89, 90]. Hence these neurotrophins 
are indeed crucial for the complex interaction of the nerves with the immune cells that in turn 
regulate the neuroimmune interaction. 
 
1.13 Diagnosis 
Allergic rhinitis is diagnosed by the presence of symptoms (sneezing, pruritis, nasal 
congestion, rhinorrhea and occasionally blocked nose and nasal bleeding) and test for 
reactivity towards common allergens in that particular geographic location. Atopy is a 
condition that signifies a positive reactivity to any of the allergens test. The tests usually 
employed to determine atopy are Skin Prick Test (SPT) and screening for allergen specific 
IgE antibody test. In some cases, if the physician recommends, a nasal provocation and/or 
nasal cytology is performed to better evaluate the individuals AR condition [10].  An 
alternative to skin testing is radioallergosorbent test (RAST) in situations where SPT is 
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unavailable or not dependable as the patient is on medications such as antihistamines. In 
patients with severe eczema SPT is not favorable and hence RAST could be considered.  
However RAST is not as sensitive as the skin testing procedure and usually costs more as 
well [11].  
 
1.14 Risk Factors 
AR results from a complex interaction between multiple genetic and environmental factors. 
Many factors have been suggested to play a role in development and expression of atopic 
diseases such as higher load of irritants and allergen exposure, change in lifestyle, pollution, 
diet changes with diminished nutritive value and also stress [30, 31, 32, 33].  
 
1.15 Genetics of Allergic rhinitis 
Atopy is defined as the tendency of an individual to produce responses by developing specific 
IgE antibodies against common allergens in the environment that are otherwise not harmful. 
Atopy is vital in the development of allergic diseases through an IgE-mediated mechanism. It 
is a genetic predisposition usually starting in childhood or adolescence, when individuals are 
sensitized and produce IgE antibodies in response to common allergens [29]. This atopy or 
the tendency has been observed to be hereditary as linkage to atopy has been found on several 
chromosomal regions along the entire genome [9,27,28]. Atopy is vital in the development of 
allergic diseases through an IgE-mediated mechanism, the mechanism of inheritance, as to 
how a genetic predisposition leads to allergic symptoms, is still unclear. 
 The strongest risk factor for the development of allergic symptoms has been a strong 
family history of allergic disease irrespective of the varying prevalence and environmental 
risk factors across populations and societies [31,34]. Various reports support the genetic basis 
of atopy and allergic disease [35,36,37,38,39]. Twin studies provide key evidence for a 
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genetic effect as there was a greater concordance of allergic manifestations observed in 
monozygotic compared to dizygotic twins [40,41,42,43] and the heritability for atopy is 
estimated to be ranging between 50–84%. Many candidate genes have been suggested for 
atopy and allergic diseases [44,45,46,47,48,49,50]. To date, a number of genome wide 
association (GWA) studies performed to identify loci contributing to the development of 
asthma and related phenotypes [51-54] however, no GWA study has been performed 
specifically for allergic rhinitis.  
 
1.16 Interactions 
The advancement of genotyping platforms facilitated the design and execution of large-scale 
genetic association studies. However, last decade of genetic association studies as mentioned 
previously have been failing to replicate original reports of association in follow-up/ 
replication studies by other research groups in some cases within the same ethnic groups. Our 
understanding has been clarified that neither the genes in isolation or an environment by itself 
cannot lead to the development of complex disease not only allergic but ‗complex‘ diseases 
in general. Hence the failure of the above mentioned studies to replicate earlier original 
reports of associations primarily might be due to interactions, which inherently play a role in 
the manifestation of the disease. These could be either gene- gene interactions or gene-
environment. Given a scenario that the genetic predisposition to a disease confers risk for a 
disease through interaction with other genes and also under a particular environmental 
influence; looking for association in a conventional genetic association study or even the 
genome-wide association studies (GWAS) where the gene is in isolation would yield negative 
results i.e., the genetic variation is undetected [95, 96]. Hence for the genetic variant to show 
up in an association study there needs to be a study design which incorporates the need for 
gene and environmental interactions. 
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1.16.1 Gene –gene interactions 
Gene-gene interactions are conventionally termed as ‗epistatic interactions‘. The English 
geneticist William Bateson defined the term ‗epistasis‘ in 1907 to describe the masking of the 
expression of a gene at a specific position on the chromosome by one or more genes at other 
positions in the genome [94]. However gene-gene interactions can either be functional or 
statistical. A functional interaction among genes refers to the molecular interaction that 
occurs between genetic elements and protein molecules involved in a similar pathway or in 
forming complexes where there exists a direct interaction.  A statistical epistasis refers to a 
quantitative difference in the allele specific effects i.e., when a particular outcome or effect or 
disease risk is modified when a particular set of alleles from different loci are considered 
together than when they are studied individually [94, 95, 97]. The net effect arising from the 
epistasis can be quantitatively measured as the departure or difference in the risk or outcome 
when considered together from when considered in isolation. This net effect could either be 
additive (effect of the each of the individual loci added together i.e., sum) or multiplicative 
(effect of the each of the individual loci multiplied together i.e., product) [97].   
 Gene-gene interactions for allergic rhinitis have been attempted, but these studies are 
few and far between. However there has been evidence for such interactions as reported by 
Huebner et al., where GATA3 and IL13 polymorphisms have been shown to interact to 
influence risk to childhood rhinitis and atopy [98]. In another report in 2008 demonstrated 
both biological and genetic interaction between tenascin C (TSC) and neuropeptide S 
receptor 1 (NPSR1) influencing risk to both asthma and also rhinoconjunctivitis. Up 
regulation of TNC mRNA was observed to be influenced by certain genotypes of the NPSR1 
polymorphisms [99]. More recently polymorphisms in genes involved in the development of 
T regulatory cells such as IL2RA, TLR2, TGFBR2, and FOXP3 were shown to be interacting 
to modify the risk of developing atopy and asthma [100]. However more comprehensive well 
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defined gene-gene interaction studied with sufficient sample sizes are still needed to evaluate 
the effect of epistasis on AR disease predisposition and severity. 
 
1.16.2 Gene-environment interactions 
Similar to gene-gene interactions, gene-environment interactions refers to the net effect 
observed in considering a particular gene along with a particular environment rather than 
considering the gene without factoring the environment in. This potential quantitative 
difference could either be additive or multiplicative [102]. Complex traits would be primarily 
influenced by different environment albeit for the same genetic makeup; as demonstrated by 
the differences observed in mice and other laboratory animals which are identical genetically 
but exhibit different phenotypes under different environments [104]. Gene-environment 
interactions might be essential in understanding the potential of a risk variant or allele of a 
particular candidate gene to result in a disease or phenotype based on the environment [103]. 
For allergic disorders considering the environment and age during the first encounter with an 
allergen and possibly its subsequent encounters would be crucial in understanding why 
certain individuals express disease symptoms and have certain phenotypes while others with 
similar genetic makeup don‘t. Varying risk estimates for allergic rhinitis while considering 
different societies and ethnicities and age might be due to difference in their environments 
[101].  The innate immunity genes, in particular CD14, toll-like receptor 4 (TLR4) and TLR2 
have been demonstrated to have a potential role in the interactions involving microbial load 
and the immune regulation thereby influencing risk to asthma and allergic diseases [105, 
106].  The most studied environmental effect for allergic disorders is the effect of farming or 
its related exposures. Genetic variants were found to be associated in certain populations, 
which were exposed to farm exposure while these variants were negative for association 
otherwise. For examples, polymorphisms in TLR2 were found to be associated with 
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predispose to asthma only when children were living in farms while the other children not 
living in farms showed no association [107]. Similarly CD14 polymorphisms have found to 
be associated with atopy and asthma only in young Danish farmers who were exposed to 
farm environments [108]. A review by Martizez in 2007 clearly describes how the 
polymorphisms in CD14 which were producing negative results for association in single gene 
association studies eventually proved to be confounded by the difference in environments 
between the different populations studied [109]. These studies at least in part account for the 
inconsistency in replicating genetic association studies by multiple research groups 
independently evaluating the candidate genes for association to allergic phenotypes, which 
might not be restricted essentially to allergy but can also be extended in principle to other 
complex diseases [106]. However from an Asian context, there has not been a large extent of 
studies evaluating the effect of environment on genetic association studies for allergic 
phenotypes. Hence careful well-designed and well-powered studies are needed to evaluate the 
discrepancy in reported prevalence of allergic disorders in Asia. 
 
1.17 Objectives 
The objectives of the current study is to elucidate the genetic basis of atopy and allergic 
rhinitis with careful consideration of the confounders such as environmental factors and also 
evaluating the role of interactions both gene-gene and gene-environmental in our Singapore 
Chinese population. We used two main study designs, a hypothesis free genome-wide 
association study that enables discovery of novel candidate genes and a hypothesis based 
evaluation of previously reported candidate genes. 
 
 




1) To collect and ascertain a large population of Singapore Chinese with well defined clinical 
and epidemiological information which enable clear definition of cases and controls for 
allergic phenotypes thereby facilitating a well matched case control genetic association study 
for atopy and allergic rhinitis (AR).  
 
2) To perform a two stage genome-wide association study (GWAS) for atopy and allergic 
rhinitis using high throughput genotyping platforms to identify novel candidate genes this 
might influence genetic predisposition to these phenotypes. 
 
3) To evaluate the association of known candidate genes for allergic phenotypes in our 
Singapore Chinese population for atopy and AR by designing a large association study of 
about 1000 cases and 1000 controls 
 
4) To study the effect on gene-gene interactions risk of developing atopy and AR using two 
different approaches (a) candidate gene based interaction and (b) whole genome based pair 
wise interaction for identifying novel gene-gene interactions.  
 
5) By using an ex-vivo approach, to evaluate the functional significance of statistically 
associated candidate genes identified through the above-mentioned approaches and to help 
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CHAPTER 2: EPIDEMIOLOGY OF ALLERGIC RHINITIS 
2.1 Prevalence of Allergic Rhinitis 
Allergic rhinitis is a common disease, the symptoms of which can often be misinterpreted as 
common cold. The common symptoms include sneezing, rhinorrhea, pruritis and nasal 
blockage with occasional symptoms such as nasal bleeding, itchy watery eyes and snoring. In 
a study focusing on Singapore, the prevalence of the above mentioned symptoms in a large 
population of over 4000 volunteers was 15.8% for sneezing, 11.7% for rhinorrhea, 10.6% for 
pruritis and 10.2 for nasal blockage [1]. If we considered two of these symptoms as 
identifying allergic rhinitis, then the prevalence was 13.1%. Three and four symptoms had 
prevalence of 6.5% and 3% respectively.  However one-fourth of the volunteers who 
participated in the study reported as experiencing at least one of these nasal symptoms. 
Singapore consists of 3 major races Chinese (about 75% of the population), Malay (14%) and 
Indians (8-9%). The prevalence of 2 symptoms or more based on race identified that Indians 
had the highest prevalence of 15.1%, followed by Malays with 12.3% and Chinese having 
12.1%. When considering age, the 10-19 year olds had the highest AR prevalence of 16.3% 
with an age-adjusted odds ratio of 1.71. The study suggested that neither occupation nor 
family size had an influence on prevalence. The major allergen in Singapore is house dust 
mites and in particular Blomia tropicalis and Dermatophagoides pteronyssinus [2, 3]. As 
these dust mites are present throughout the year the AR symptoms also persist always and 
hence making perennial allergic rhinitis (PAR) a major concern for Singapore.  
 
2.2 Study population recruitment 
The volunteers recruited in this study are mainly students at the National University of 
Singapore (NUS) with some staff members also participating in the study occasionally. The 
age group of volunteers in this cohort mostly ranged between 19-22 years. The study 
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documents volunteers recruited through multiple epidemiological volunteer recruitment 
drives held within the campus of NUS. All participants to enroll in the study had to first be 
above 18 years of age. In the event, that they are less than 21 years of age, then parental 
consent is mandatory for participation in the study. The consent of the volunteer was obtained 
in a ―written form‖ collected using the Participant Information Sheet (PIS) which had 
information about the study and also had the section on parent/guardian consent for those 
over 18 years but still less than 21 years of age. Once the PIS had been read through and the 
volunteer consents to participate they would be required to (i) complete a standardized 
questionnaire on allergy and related disease (ii) perform a buccal mouth wash using 0.9% 
saline water (for the purpose of DNA extraction) and (iii) undergo a skin prick test (SPT) to 
identify their allergies to specific allergens. SPT was performed using a panel of common 
allergens in Singapore such as Dermatophagoides pteronyssinus and Blomia tropicalis (house 
dust mite species), Elaeis guineensis (oil palm pollen) and Curvularia lunata (fungi). This 
study was reviewed and approved for to be carried out by the NUS-IRB (National University 
of Singapore - Institution Review Board). The approval codes are NUS07-023 and NUS10-
343. The study was also performed in compliance with the Helsinki declaration. Genomic 
DNA was extracted from buccal cells obtained from a mouthwash of 0.9% saline solution 
following an in-house standardized protocol. In short, the buccal cells were pelleted and 
lysed; DNA was extracted using the phenol-chloroform phase-separation technique purified 
by two washes in ethanol, with the DNA pellet resuspended in reduced Tris-EDTA buffer [4]. 




2.3 Sample ascertainment 
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2.3.1 Definition of allergic rhinitis 
We have used the definition of allergic rhinitis as mentioned in the ARIA guidelines (2008). 
The major criteria are as follows 
 
(i) Positive skin prick: An individual must have a positive skin prick test reaction of one of 
the two house dust mite allergens tested. A wheal diameter of 3 mm or greater is considered 
as a positive SPT response. A positive control with histamine and a negative control of saline 
were always used. SPT was performed on the volunteers only if they have not taken any anti-
allergic drugs especially antihistamines for at least 3 days prior to the test. This positive SPT 
reaction to either one of the dust mite allergens is termed as ―Atopy‖. 
 
(ii) AR symptomology: An individual to be classified as allergic rhinitis must have in 
addition to a positive SPT, two or more of the major symptoms which include sneezing, 
rhinorrhea, pruritis and nasal blockage. The questionnaire does contain two other symptoms 
nasal bleeding which are not commonly observed. In addition, the questionnaire also contains 
information on the duration and frequency of the above mentioned symptoms which could be 
used to classify the volunteers as having either ―seasonal‖ or ―perennial‖ allergic rhinitis. 
Severity of allergic rhinitis as either mild or moderate to severe could be evaluated from the 
presence of the other troublesome symptoms and loss/disturbance to sleep or daily activities 
at school/work which can also be obtained from information in the questionnaire. 
 
(iii) Asthma definition: Cases for the phenotype of asthma were defined based on positive 
response, ―Yes‖ to the doctor diagnosis question, ‗Have you ever been told by a doctor you 




The questionnaire used in the study consists of questions which help obtain information from 
the volunteers on their personal particulars (age, gender, race, nationality, number of years in 
Singapore, number of siblings, etc). There is also information obtain on their medication 
history for common antibiotics and pain killers, and also allergy symptom specific 
medications such as bronchodilators, nasal spray, anti-histamine usage and also drug allergies 
if any. Then there are three main sections, one each on asthma, allergic rhinitis and atopic 
dermatitis. Here the information collected would help us define the allergic disease status of 
the individual and also help estimate the severity of the disease using responses to questions 
on the duration of the disease, the frequency of the symptoms and also co-occurrence of 
diseases. For example, nearly 50-60% of individuals who suffer from allergic asthma also 
have symptoms of allergic rhinitis and in some cases this estimate could be as high as 80% 
[5, 6, 7, and 8]. The other sections of the questionnaire obtain volunteers‘ dietary information 
and frequency of intake of different varieties of food. Smoking history of the patient is also 
recorded through questions which query whether they are current smokers and/or have quit 
smoking with information on the number of cigarettes they consume every day, and also 
passive smoking identifying if they live in the presence of smokers. Finally there is 
information on their parents and siblings allergic history status with questions on their report 
of diseases like asthma, allergic rhinitis and atopic dermatitis.  Parental history is one the 
highest risk factors for allergic diseases [10, 11, 12, 13, and 14]. In a Singapore Chinese 
study, it was identified that the risk of developing allergic rhinitis if either of the parents had 
AR was 2.7 if only father had and 2.2 if only the mother was diagnosed with AR. However 
the risk increased almost a further 2 fold to 4.5 if both parents were affected [9]. Strikingly, 
the sibling allergic history was also crucial in identifying risk of the younger siblings. In the 
same study, it was also estimated that when the elder sibling alone had AR, the risk of the 
younger sibling developing AR as well was 3.9. Again, when the parents of these siblings 
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also both had AR the risk of the younger sibling again increases significantly to 7.0 when 
both the parents and the elder sibling had AR [9].  Additionally we also estimated the 
socioeconomic status of the families of the volunteers by querying their total family income 
and the type of residency. The total family income was classified as < S$/2000/month, 
S$2000-3999/month, S$4000-5999/month and > S$6000 month; while the housing/residency 
type was categorized as HDB (public housing), Condominium and landed or private property. 
In previous studies prevalence of allergic diseases has generally been shown to vary with 
income level, with reduced prevalence in lower income groups in Singapore [15] and Hong 
Kong [16] but increased prevalence with lower income in countries like United States [17]. 
Environmental factors might therefore be an important confounder, for which income is one 
of the potential surrogate markers in our study population.  
 
2.4 RESULTS 
A total of 5887 volunteers were collected through multiple recruitment drives conducted at 
the National University of Singapore. From this study population, a total of 5409 (91.88%) 
were of ethnic Chinese origin, 206 (3.5%) were of Indian origin, 118 (2%) of Malay ancestry 
while 154 (2.62%) were of other ancestries (Table 1). In terms of gender, 2489 (42.28%) 
volunteers recruited were male while the other 3396 (57.69%) were females. The age 
distribution was pretty narrow with 3263 (55.4%) subjects between 18-21 years of age, while 
an additional 2441 (41.5%) between 22-27 years of age. Only a small proportion of 
volunteers recruited 3.1% (183) were above 27 years of age. Hence the effect of age as a 






Table 1: Demographics of Study population 
Demography                  Total volunteers surveyed - 5887                                    n (%) 
Age group 18 -21 years of age 3263 (55.4) 
  22 -27 years of age 2441 (41.5) 
  Above 27 years of age 
183 (3.1) 
Gender Male 2489 (42.28) 
  Female 3396 (57.69) 
  Gender not stated 2 (0.03) 
Race Chinese 5409 (91.88) 
  Indian 206 (3.5) 
  Malay 118 (2.0) 
  Other 154 (2.62) 
Housing HDB 3796 (64.48) 
  Private/Condominium 915 (15.54) 
  Landed Property 735 (12.49) 
  Housing not stated 
441 (7.49) 
Family Income <S$2000/month 1471 (24.99) 
    S$2000-4000/month 2069  (35.15) 
    S$4000-6000/month 1029 (17.48) 
  >S$6000/month 1040 (17.67) 




2.4.1 Prevalence of major symptomology of allergic rhinitis 
The four major symptoms characteristic of allergic rhinitis are itchy nose, sneezing, 
runny nose and blocked nose. From our study population, the prevalence of itchy nose 
was 26.84% in males and 26.66% in the females (Table 2a). The prevalence across 
the various ethnicities was comparable with 26.66% in Chinese, 26.27% in Malays 
and a slightly lower 23.79% in the Indian population (Table 2b). A higher 34.25% of 
males and 32.39% of females reported sneezing as a symptomology (Table 3a). The 
prevalence of sneezing among the various races was, Chinese (33.19%), Indians 
(36.89%) and Malays (30.51%) (Table 3b). A similar prevalence was reported for 
runny nose with a slightly higher 34.63% in males to 30.04% in females and 31.98% 
(Table 4a)., 27.12% and 34.47% among Chinese, Malays and Indians respectively 
(Table 4b). Finally for nose blockage as a symptom, the females had a higher reported 
prevalence of 33.91 in comparison to the males 28% (Table 5a). The prevalence 
(Table 5b) among all the three races was around 30% (Chinese – 30.32%, Malays – 
29.66% and Indians – 30.58%). 
Symptomology of allergic rhinitis could also be expressed as a total symptom 
score (TSS) which is obtained by combining the number of major AR symptoms 
(mentioned above) a particular individual reports to suffer from when they are not 
suffering from a cold or flu. This however does not consider the skin prick test status. 
Figure 1 summarizes the distribution of people with 0, 1, 2, 3, 4 symptoms in the form 
of a pie-chart. The reported prevalence was highest for 4 symptoms (19.6%), and 
lower for the 3 symptoms (9.7%) and 2 symptoms (5.5%) respectively. A larger 
proportion of the population (60.6%) reports no symptoms of allergic rhinitis. The 
proportion of the subjects when stratified by gender as males and females do present 
similar prevalence‘s with a slight increase in 4 symptoms from 18.6% in the females  
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Table 2(a) Prevalence for Itchy Nose stratified by gender 
 
Itchy Nose Gender 
  Female, n(%) Male, n(%) Total, n 
Yes 904 (26.62) 668 (26.84) 1572 (26.73) 
No 2492 (73.38) 1821 (73.16) 4313 (73.27) 
Total, n(%)  3396 (100) 2489 (100)   N =  5885  
 
 
Table 2(b) Prevalence for Itchy Nose stratified by race 
 
Itchy Nose                         Race 
  Chinese, n(%) Indian, n(%) Malay, n(%) Others, n(%) 
Yes 1442 (26.66) 49 (23.79) 31 (26.27) 50 (32.47) 
No 3967 (73.34) 157 (76.21) 87 (73.73) 104 (67.53) 




Table 3(a) Prevalence for Sneezing stratified by gender 
 
Sneezing Gender 
  Female n(%) Male n(%) Total, n(%) 
Yes 1100 (32.39) 860 (34.55) 1960 (33.42) 
No 2296 (67.6) 1629 (65.45) 4313 (66.58) 




Table 3(b) Prevalence for sneezing stratified by race 
 
Race 
Sneezing Chinese n(%) Indian n(%) Malay n(%) Others n(%) 
Yes 1793 (33.15) 76 (36.89) 36 (30.51) 55 (35.71) 
No 3616 (66.85) 130 (63.11) 82 (69.49) 99 (64.29) 







Table 4(a) Prevalence for itchy nose stratified by gender 
 
Itchy nose Gender 
  Female n(%) Male n(%) Total, n(%) 
Yes 1020 (30.04) 862 (34.63) 1882 (32.34) 
No 2376 (69.96) 1627 (65.37) 4048 (67.67) 
Total, n(%)      3396 (100)   2489 (100)       N= 5885  
 
 
Table 4(b) Prevalence for runny nose stratified by race 
 
Race 
Itchy nose Chinese n(%) Indian n(%) Malay n(%) Others n(%) 
Yes 1730 (31.98) 71 (34.47) 32 (27.12) 49 (31.82) 
No 680 (12.57) 26 (12.62) 9 (7.63) 27 (17.53) 




Table 5(a) Prevalence for nose blockage stratified by gender 
 
Total Gender 
  Female n(%) Male n(%) Total, n(%) 
Yes 951 (28.00) 844 (33.91) 1795 (30.96) 
No 2445 (72.0) 1645 (66.09) 334 (69.04) 
Total, n(%)      3396 (100)   2489 (100)       N= 5885  
 
 
Table 5(b) Prevalence for nose blockage stratified by gender 
 
Race 
Nose blockage Chinese n(%) Indian n(%)   Malay n(%) Others n(%) 
Yes 1640 (30.32) 63 (30.58) 35 (29.66) 57 (37.01) 
No 759 (14.03) 34 (16.5) 6 (5.08) 18 (11.69) 








to 21% in the males (Figure 1). According to the ARIA guidelines 2 or more 
symptoms usually indicate the presence of rhinitis in an individual as observed from 
clinical evaluation of patients with rhinitis.   
 
2.4.2 Prevalence of rhinoconjunctivitis  
Rhinoconjunctivitis characterized by ‗itchy eyes‘ has often been reported as a 
symptom by subjects suffering from allergic rhinitis. Hence we also recorded the 
prevalence of allergic rhinoconjunctivitis in the population. Of the total male 
volunteers recruited, 21.78% reported a condition of itchy eyes, while 22.38% of 
females reported the presence of the same symptomology (Table 6). When looking 
closely at the different ethnicities for the prevalence of the itchy eyes condition, 
21.74% of Chinese and 20.34% of Malays reported this symptom. However a higher 
prevalence of 29.13% was reported in the Indian population.  
 
2.5 AR classification based on ARIA guidelines 
Allergic Rhinitis Impact on Asthma (ARIA) has suggested the definition of AR based 
on two criteria (a) a positive skin prick test to the common allergen specific to the 
environment studied and (b) two or more of the major AR symptoms (sneezing, 
rhinorrhea, pruritis and nasal blockage). For this analysis we used a positive skin 
prick test defined based on a wheal response of 3mm diameter for any one of the two 
dust mite species (Dermatophagoides pteronyssinus and Blomia tropicalis) tested. In 
our population, a total of 32.29% (n=1891) of the study cohort have identified to be 
AR cases as defined by ARIA guidelines (Table 7). The prevalence in the males was 
33.34% (n=830), while 31.24% (n=1061) of the females were AR cases. When 
stratified by race, the Chinese had 32.11% AR cases while Indians with 33.01% and 
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Figure 1: Distribution of reported symptoms of rhinitis in our study population           
                                        
Distribution of reported symptoms stratified by gender  
(a) Female      (b) Male 
         
Color legends 
Pink – No symptoms of allergic rhinitis 
Blue – 1 symptom of allergic rhinitis 
Green – 2 symptoms of allergic rhinitis 
Yellow – 3 symptoms of allergic rhinitis 




Table 6 Reported history of itchy eyes (Allergic Rhinoconjunctivitis) 
 
Total Gender Race 
  Male, n(%) Female, n(%) Chinese, n(%) Indian, n(%) Malay, n(%) Others, n(%) 
Yes 542 (21.78) 760 (22.38) 1176 (21.74) 60 (29.13) 24 (20.34) 42 (27.27) 
No 1947 (78.22) 2636 (77.62) 4233 (78.26) 146 (70.87) 94 (79.66) 112 (72.73) 
Total 2489 (100) 1281 (100)   5409 (100) 206 (100) 118 (100) 154 (100) 
 
 
Table 7 Prevalence of allergic rhinitis (definition as per ARIA guidelines) 
 
Total Gender Race 
  Male, n (%) Female, n (%) Chinese, n (%) Indian, n (%) Malay, n (%) Others, n (%) 
Yes 830 (33.34) 1061 (31.24) 1737 (32.11) 68 (33.01) 33 (27.97) 53 (34.41) 
No 1659 (66.66) 2335 (68.76) 3672 (67.89) 138 (66.99) 85 (72.03) 101 (65.59) 
 
Table 8 Prevalence of allergic asthma (definition as per GINA guidelines) 
 
Total Gender Race 
  Male, n (%) Female, n (%) Chinese, n (%) Indian, n (%) Malay, n (%) Others, n (%) 
Yes 421 (16.91) 428 (12.6) 767 (14.18) 29 (14.07) 28 (23.73) 25 (16.23) 






others with 34.41 had comparable prevalence (Table 7). In the Malay population, a 
slightly lower incidence was reported at 27.97% although our sample size for this 
population is small. 
2.6 Allergic asthma prevalence  
 
Allergic asthma was defined based on two criteria (a) a positive skin prick test for any 
one of the two dust mite species (Dermatophagoides pteronyssinus and Blomia 
tropicalis) tested and (b) self-reported history of asthma. To determine asthma 
history, a positive response to the question, ―Have you ever had asthma or been told 
by a doctor you have asthma?‖ was used. In our population, a total of 14.76% (n=849) 
of the study cohort have identified to be asthma cases as defined by the above criteria 
(Table 8). The prevalence in the males was 16.91% (n=421), slightly higher than that 
in the females at 12.6% (n=428). When stratified by race, the Chinese had 14.18% 
allergic asthma cases while Indians with 14.07% and others with 16.23% had 
comparable prevalence (Table 8). In the Malay population, a slightly higher incidence 
was reported at 23.73% although our sample size for this population is small. Hence 
further sampling with special focus on the Malay population is essential to confirm 
this observed higher incidence rate of asthma. 
 
2.7 Comorbidities  
2.7.1 Prevalence of co-morbidity of allergic rhinitis and asthma  
Allergic rhinitis is often considered as a risk factor for asthma and the patients with 
allergic rhinitis have reported symptoms of asthma as well. In our cohort we then 




Table 9 Comorbidity of allergic rhinitis with asthma 
Disease condition Prevalence, n (%) 
Allergic Rhinitis without asthma 697 (11.84) 
Allergic rhinitis and asthma 394 (6.7) 
Asthma symptoms with AR 220 (3.74) 




N = 5887 
 
 
Table 10 Comorbidity of allergic rhinitis symptoms with rhinoconjunctivitis 
Disease condition Prevalence, n (%) 
AR symptoms with itchy eyes                    1075 (18.26) 
AR symptoms without itchy eyes 802 (13.62) 
Itchy eyes with no AR symptoms 28 (0.47) 










of allergic rhinitis and asthma and how many were suffering from AR in the absence 
of asthma. In our population we observed that 394 subjects (6.7% of the total 
population of 5887 individuals) studied had both reported to be cases for allergic 
rhinitis and asthma.  An additional 697 subjects (11.84%) reported the symptoms of 
allergic rhinitis while reporting no symptoms of asthma. This also emphasizes the 
relevance and significance to observe and document the symptomologies of both 
diseases while treating any one, as there are some common mechanisms which might 
be underlying both diseases. 
 
2.7.2 Prevalence of co-morbidity of allergic rhinitis symptoms with itchy eyes 
(rhinoconjunctivitis) 
Itchy eyes are a common symptom reported by patients suffering from allergic rhinitis 
and the occurrence of both together is referred to rhinoconjunctivitis. But it is difficult 
to define this accurately and hence we reported the presence of itchy eyes along with 
AR symptoms or in its absence. Table 10 helps us to observe the presence of itchy 
eyes as a symptom mostly in patients with symptoms of AR with a prevalence 
18.26% of the population (n=1075) and itchy eyes in the absence of AR symptoms in 
only 0.47% of the population (n=28). However on the contrary not all patients with 
AR symptoms have itchy eyes as a symptom with 13.26% (n=802) subjects have AR 
symptoms and do not report the symptom of itchy eyes. 
 
2.8 Sensitization to house dust mites (Atopy) 
‗Atopy‘ as defined by a positive skin prick test has been confirmed to be a major risk 
factor for the development of diseases like asthma, allergic rhinitis and atopic
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Table 10 Sensitization to house dust mite Blomia tropicalis 
SPT Gender Race 
  Male, n(%) Female, n(%) Chinese, n(%) Indian, n(%) Malay, n(%) Others, n(%) 
Positive 1736 (69.75) 1715 (50.5) 3267 (60.4) 69 (33.5) 63 (53.4) 53 (34.42) 
Negative 728 (29.25) 1631 (48.02) 2077 (38.4) 131 (63.6) 54 (45.76) 98 (63.64) 
Not done 25 (1) 50 (1.5) 65 (1.2) 6 (2.9) 1 (0.8) 3 (1.95) 
    
 Table 11 Sensitization to house dust mite Dermatophagoides pteronyssinnus 
SPT Gender Race 
  Male, n(%) Female, n(%) Chinese, n(%) Indian, n(%) Malay, n(%) Others, n(%) 
Positive 1522 (61.14) 1450 (42.7) 2816 (52.06) 53 (25.73) 52 (44.07) 51 (33.12) 
Negative 942 (37.84) 1896 (55.83) 2528 (46.74) 147 (71.36) 65 (55.08) 100 (64.94) 







dermatitis. Hence we analyzed the observed sensitization rates in our population using 
two prevalent house dust mite allergens.  
 
2.8.1 Sensitization to Blomia tropicalis 
Blomia tropicalis is a storage mite more prevalent in the south East Asian countries 
such as Singapore, Malaysia and sometimes in Thailand and Indonesia. In our study 
population a total of 69.7% of the males and 50.5% of the females were positive to 
the skin prick test against this mite. This represents that a large proportion of our 
population is sensitized to this mite possibly due to its high load and also due to its 
‗perennial‘ presence. The Chinese (60%) and Malay (53.5%) populations had high 
incidences of sensitization while Indians (33.5%) had a lower rate, but this might be 
due to small sample sizes for the Indian population. 
 
2.8.2 Sensitization to Dermatophagoides pteronyssinnus 
 In contrast to Blomia tropicalis which is a tropical mite, Dermatophagoides 
pteronyssinnus is the most prevalent house dust mite species worldwide. Positive skin 
prick test subjects in our population were 61.2% of all males and 42.7% of females. 
When stratified by race, Chinese had a 52% skin prick test positive to this mite and 
Malays had a comparable 44%, while the Indians (33.5%) again had a lower rate, 
similar to the rate for the tropical mite. As mentioned before, this might be due to 
small sample sizes for the Indian population and hence remains to be seen if it is 







The above results reemphasize the significance of evaluating sensitization to local 
allergens especially in the context of allergic diseases and also more importantly in a 
country like Singapore where the house dust mite load is high and also present 
throughout the year, in contrast to the European countries where the allergens such a 
grass and pollen result in allergic diseases in a seasonal context. Another important 
factor is to identify the repertoire of allergens which might have the potential to 
sensitize an individual thereby increasing his/her risk to developing allergic 
phenotypes. In our Singapore context, the environment is saturated with a large load 
of house dust mites and thus we could probably hypothesize that this might be the 
most important allergen to monitor and also document responses to. However we 
must take note that there are other forms of allergy such as food allergy, exercise 
induced allergy, occupational allergy, etc which might be not necessarily IgE 
mediated or also not necessarily mediated by sensitization to house dust mites. These 
forms of allergy however are beyond the scope of this thesis and hence would not be 
discussed. The focus of this thesis is to study IgE mediated allergy mostly house dust 
mite mediated as document using a skin prick test response to these allergens. Also in 
Singapore a majority of allergic phenotypes have been reported to be caused by the 
codominant indoor allergen sources consisting of Blomia tropicalis and 
Dermatophagoides pteronyssinnus [18, 19, and 20]. Understanding the 
immunological response of the individual to these house dust mites would help us 
understand why a large proportion of individuals are sensitized to the house dust 
mites but only a fraction develop symptoms of allergic diseases. Another important 
consideration is the timing of when the response occurs in relation to the 





early exposure to multiple perennial allergens might possibly lead to a higher risk for 
asthma, however this remains to be confirmed in other populations studied.   
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Genome-wide association study (GWAS) is one of the recent methods of identifying 
genetic association for diseases by using a large-scale genotyping approach that 
covers single nucleotide polymorphisms along the entire length of the genome [20, 
21, 22, 23, 24]. It is a ―hypothesis free‖ or ―hypothesis generating‖ approach in 
contrast to the conventional ―hypothesis-driven‖ candidate gene based association 
studies. The advent of technology facilitated the discovery of high-throughput 
genotyping platforms that enabled genotyping of close to a million SNPs on one 
single DNA chip at a fast pace and affordable cost [24, 25, 26, and 27].  Thus whole 
genome DNA chips were designed to tag the common variants as identified using the 
Human Genome Project 
(http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml) and Hap Map 
Project (http://hapmap.ncbi.nlm.nih.gov/). For complex diseases, the main hypothesis 
was ‗Common Disease Common Variant‘; and hence the common tags could help us 
identify the disease variants and thus help discover ‗disease candidate genes‘ [28,29]. 
This approach has been very suscceful in identifying new chromosomal regions 
and/or genes and variants associated with phenotypes and disorder. The online 
resource for GWAS (http://gwas.nih.gov/) has identified that close to a thousand 
GWAS have been performed for multiple diseases ranging from simple mendelian 
rare to common complex diseases like asthma, atopic dermatitis, multiple sclerosis, 





quantitative traits such as IgE levels, serum concentrations of adhesion molecules 
such as sICAM-1.  
In the context of our Singapore population multiple candidate gene based association 
studies performed yielded minimum if not no significant results when tested for 
association to asthma, AR and atopic dermatitis [1, 2, 3, 4, and 5]. This trend is 
comparable to the worldwide genetic association studies where candidate genes 
reported by research groups are not replicated in other ethnicities and in some cases 
even not replicated in the same ethnicities in other parts of the world [6, 7, 8, 9, 10, 
11, 12, and 13]. The online resource dbGAP databases all the various genetic 
association studies and in their association to specific phenotypes and 
disorders/diseases (http://www.ncbi.nlm.nih.gov/gap). Considering the genetic 
association studies performed for allergic phenotypes such as atopy, asthma, allergic 
rhinitis and atopic dermatitis have also yielded similar results in which most of the 
attempted candidate genes have failed to replicate in other studies and different 
populations [14, 15, 16, 17, 18, and 19]. A review by Vercelli summarizes that when 
considering the 200 over candidate genes for asthma, only other research groups 
replicated a fraction of these candidates in independent studies [14].  
Taking together the failure of candidate gene based association studies in our 
population and the opportunity to evaluate known as well as novel SNPs/genes along 
the entire genome, we employed GWAS approach to search for novel and known 
SNP association to atopy and AR in a Singapore Chinese population.  
Information in this chapter has been published in the below mentioned article. 
Genome-Wide Association Study for Atopy and Allergic Rhinitis in a Singapore 
Chinese Population. Andiappan AK, Wang DY, Anantharaman R, Parate PN, Suri 





3.2 MATERIALS AND METHODS 
3.2.1 Ethics Statement 
This study has been performed with the approval of the Institutional Review Board of 
National University of Singapore (IRB, Reference - NUS07-023 and NUS10-343) and 
is also in compliance with the Helsinki declaration. DNA samples used in this study 
were collected from ethnic Chinese participants following standard protocols of 
informed consent. The consent obtained was a ―written consent‖ collected using the 
Participant Information Sheet which had information about the study. 
 
3.2.2 Study subjects 
A total of 4461 study subjects were recruited from the Singapore Chinese ethnicity 
through multiple volunteer recruitments in Singapore. Study subjects were 
subsequently classified as atopy cases, AR cases and non-atopic and non-rhinitis 
(NANR) healthy controls according to their disease status as determined by ARIA 
document [30, 31] based questionnaires. Diagnosing procedure included interview of 
medical history using a standardized questionnaire and skin prick test (SPT) using a 
panel consisted of common allergens in Singapore such as Dermatophagoides 
pteronyssinus, Blomia tropicalis, Elaeis guineensis and Curvularia lunata. A wheal 
diameter of 3 mm or greater is considered as a positive SPT response. A positive 
control with histamine and a negative control of saline were always used. SPT was 
performed on the volunteers only if they have not taken any anti-allergic drugs 
especially antihistamines for at least 3 days prior to the test. Atopy is defined by a 
positive SPT reaction to either one of the dust mite allergens. AR is thus diagnosed 
based on the presence of atopic status and typical AR symptoms as defined by the 





rhinorrhea, nasal itching, sneezing) persisting for four or more days a week during the 
past year. Conversely, the subjects with NANR are confirmed with no atopy and no 
typical AR symptoms. Subjects who could not be recruited into any of the above 
categories were excluded from study. 
Genomic DNA was extracted from buccal cells obtained from a mouthwash of 
0.9% saline solution following an in-house standardized protocol. In short, the buccal 
cells were pelleted and lysed; DNA was extracted using the phenol-chloroform phase-
separation technique purified by two washes in ethanol, with the DNA pellet 
resuspended in reduced Tris-EDTA buffer [32]. Samples were quantified in triplicate 
on the Nanodrop (ND-1000). Atopy (n = 2849) is defined by a positive SPT reaction 
to either one of the dust mite allergens. AR (n = 1142) is thus diagnosed based on the 
presence of atopic status and typical AR symptoms as defined by the ARIA 2008 
guidelines [30, 31] i.e., two or more AR symptoms (nasal congestion, rhinorrhea, 
nasal itching, sneezing) persisting for four or more days a week and lasting for more 
than 4 weeks continuously. Conversely, the subjects with NANR (n = 1013) are 
confirmed with no atopy and no typical AR symptoms. A total of 599 subjects who 
could not be diagnosed into any of the above categories or those whose DNA samples 













A two-stage design for this study: an initial GWAS screening (the discovery phase) 
and a follow-up (the replication phase) analysis was performed. 
 
3.2.3.1 Discovery phase 
A total of 1065 unrelated samples were genotyped using the Illumina HumanHap 
550k BeadChip, version 3 (Illumina, San Diego, California) at the Genome Institute 
of Singapore, Genotyping core facility. Genotypes were determined using the 
Illumina Genome Studio Module, following recommended protocol. As a part of 
quality control, SNPs were excluded if they showed either a call rate lower than 98% 
in cases or controls, a minor allele frequency <1% in the population or significant 
deviation from the Hardy-Weinberg equilibrium (HWE) in the controls with HWE P 
value <10−7. Furthermore, all SNPs on the X, Y and mitochondrial chromosomes as 
well as the CNV-related SNPs and probes were excluded from statistical analysis. 
 
3.2.3.2 Replication phase 
Genotyping of new additional 2834 samples for SNPs selected for replication were 
performed using matrix assisted laser desorption/ionization time of flight mass 
spectrometry (MALDI-TOF MS) for the determination of allele specific primer 
extension products using Sequenom's MassARRAY system and iPLEX technology 
(Sequenom Inc, San Diego). The design of oligonucleotides was carried out according 
to the guidelines of Sequenom and performed using MassARRAY Assay Design 
software. Multiplex PCR amplification of amplicons containing SNPs of interest was 
performed using Qiagen HotStart Taq Polymerase using 5 ng of genomic DNA. 





for iPLEX chemistry. Assay data were analyzed using the Sequenom TYPER 
software. Clustering of genotype calls was evaluated to determine that the clustering 
was sufficient for inclusion in the statistical analysis. All SNPs were also checked for 
Hardy-Weinberg equilibrium (HWE) and SNPs were not analyzed further if they 
failed HWE. 
 
3.2.4 STATISTICAL ANALYSIS 
All statistical analyses were performed by using R program version 2.10.1 and 
PLINK version 1.05. As a part of quality control, we examined the potential genetic 
relatedness based on pairwise identity by state for all the successfully genotyped 
samples using the PLINK v1.05 software. For any pair of samples identified as first 
degree relatives, the sample with lower SNP call rate was removed. The remaining 
samples were subsequently assessed for all population outlier and stratification using 
a principal component analysis (PCA) based approach [33]. The original script from 
EIGENSTRAT was modified so as to extract the principal component analysis and 
plot them. Firstly, PCA was used to identify genetic outlier using all samples which 
were genotyped successfully and passed the QC as mentioned above along with the 
Hapmap samples. The Hapmap reference samples were drawn from the International 
Hapmap Project: 57 Yoruba in Ibadan, Nigeria (YRI), 44 Japanese in Tokyo, Japan 
(JPT), 45 Han Chinese in Beijing, China (CHB) and 60 CEPH (Utah residents with 
ancestry from northern and western Europe) (CEU). We employed very stringent 
criterion for the removal of the genetic outliers. A total of 25 samples were removed 
with first principal component less than 0.001 and fourth principal component greater 
than 0.1 were removed from the genome-wide analysis. Second, PCA was used to 





Two outlier samples (both cases) were removed and a genomic control of λGC = 
1.0132 was applied to the association analysis to account for the minimal population 
stratification that existed. We checked MAF of the remaining samples again 
and14763 SNPs with MAF <1% were further removed. After all the SNP and sample 
quality control analyses, genotype data of 460183 SNPs in 515 cases and 486 NANR 
controls in Singapore population were used in the GWAS. We performed genome-
wide association analyses of Atopy and AR in a set of 515 Atopy cases (456 cases 
with AR) and 486 NANR controls. 
We performed genotype-phenotype association analysis using the Cochran-
Armitage trend test with PCA-based correction for population stratification and 
calculated odds ratio (OR) per allele. We used the quantile-quantile (Q-Q) plot to 
evaluate the overall significance of the genome-wide association results and the 
potential impact of population stratification. The impact of population stratification 
was also evaluated by calculating the genomic control inflation factor (λGC). There 
was minimal population stratification reflected by a λGC = 1.0132 which was 
accounted for while calculating the association results. Similar analysis for the AR 
phenotype consisting of 456 AR cases and 486 NANR controls revealed a λGC = 
1.001. Association analysis for the SNPs genotyped in the replication phase were 
carried out using the PLINK v1.05 software. All p-values from the replication 
analysis were reported without correction for multiple testing. Association analysis of 
the combined samples from the discovery phase and replication phase samples was 









Untyped genotypes were imputed in the GWAS samples by using IMPUTE (v2.0) 
and the haplotype information from the Hapmap CHB and CHD samples. As part of 
the quality control, SNPs with a call rate <90%, MAF <0.01 or significant deviation 
from Hardy-Weinberg Equilibrium in the controls (7*10-5) were removed. The 
association test was performed using a logistic regression analysis adjusted for study 
and population stratification of GWAS samples as described above. Regional plots 
were generated using R to show the −log10 P values. 
 
3.3 RESULTS 
3.3.1 Discovery phase 
The demographics and clinical characteristics of the samples used in the study have 
been described in Table 1. In the Stage 1, 1065 samples (551 cases and 514 controls) 
were genotyped in 551766 SNPs by using Illumina Human 550k genotyping chip. 
After stringent quality control filtering for SNPs and samples (see Methods for more 
details), population stratification was assessed by using an approach based on 
principal-components analysis (PCA). A total of 25 samples with mixed parentage 
were identified and removed, and subsequently, PCA for the remaining case and 
control samples was carried out with a further 3 outliers removed. From the PCA plot, 
the cases and controls still showed minimal genetic stratification [34]. After all the 
SNP and sample quality control analyses, genotype data for 460183 SNPs in 515 
atopy cases and 486 Non-allergic non-rhinitis (NANR) controls were retained for 
statistical analysis. A small λGC value of 1.01 indicated little inflation of the GWAS 
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Subjects 515 456 486 2323 676 511 
Age, 
mean 
21.3 21.4 21.6 19.99 19.92 19.62 


























* Atopy is defined by a positive SPT reaction to either one of the dust mite allergens 
(Dermatophagoides pteronyssinus, Blomia tropicalis) 
$ 
Allergic Rhinitis (AR) was classified based on 2 or more major symptoms which 
include (nasal congestion, rhinorrhea, nasal itching, sneezing) and a positive skin 
prick test reaction to one of the allergens tested. (Based on 2008 guidelines set by 
Allergic Rhinitis Impact on Asthma (ARIA) consortium) 
^ 
NANR controls are individuals classified based on no symptoms and history of 





We then tested for genotype-phenotype association analysis using the Cochran-
Armitage trend test. The analysis revealed moderate association at multiple loci 
throughout the genome (Figure 1A). The quantile-quantile (Q-Q) plot of observed P 
values for genome-wide association is shown in Figure S1. There were no SNPs 
which met the genome wide significance threshold (5×10
−8
). However, there were 56 
SNPs which showed association with atopy at the significance level of 1×10−4. We 
analyzed the subgroup of Atopic patients with Allergic Rhinitis (AR) clinical 
symptomology. Figure 1B and Figure S1 shows the results of the genome-wide 
association study for AR. The GWAS analysis for allergic rhinitis revealed 64 SNPs 
which had a P of less than 1×10
−4
. A total of 31 SNPs were found to be common for 
both the phenotypes and hence a total of 77 unique SNPs were tested for validation in 
the replication cohort of 2323 cases and 511 NANR controls, all ethnic Chinese from 
Singapore (Tables S1 and S2). 
 
3.3.2 Replication Phase and combined analysis 
The replication study of atopy identified consistent association at rs8111930 in 
MRPL4 (Mitochondrial ribosomal protein L4) gene (OR = 0.78, P = 0.029) and 
rs505010 located in the 5′ upstream region of the BCAP (B cell adaptor for 
phosphatidylinositol 3-kinase) gene (OR = 0.74, P = 0.06) (Table 2). The Q-Q plot of 
the p values of the 77 SNPs does not provide evidence for excess associations in the 
validation samples for the atopy phenotype (Figure S2A). Interestingly, the QQ plot 
of the 77 SNPs in the validation samples of AR (Figure S2B) does show a clear 
deviation from the null, suggesting that there are likely some true associations within 
the 77 SNPs. However, none of the associations for AR reached the genome-wide 












Table 2: Summary of results of SNPs significant in the validation study for Atopy phenotype   
Table 3: Summary of results of SNPs significant in the validation study for AR phenotype 
Ptrend  - P values calculated using Cochran Armitage Trend test; *  P value of association < 0.05 in the replication study; 
Pcombined - P values calculated combining results from both the GWAS discovery and validation phase using logistic regression. 
   GWAS Replication 
GWAS+Replication 
(2838 cases vs 997 controls) 





Ptrend OR (L95 – U95) Ptrend OR (L95 – U95) Pcombined OR 




C T 1.19E-04 0.40  (0.25 - 0.64)  6.09E-02 0.74  (0.55 - 1.01) 1.10E-04 0.61  (0.48 - 0.79) 
   GWAS Replication 
GWAS+Replication 
(1132 cases vs 997 controls) 





Ptrend OR (L95 – U95) Ptrend OR (L95 – U95) Pcombined OR 
10 rs505010 BCAP (5'utr) C T 1.11E-03 0.44 (0.27 – 0.72) 2.69E-02* 0.63 (0.42 – 0.95) 1.34E-04 0.55 (0.40 – 0.74) 
19 rs8111930 MRPL4 A G 1.25E-04 0.49 (0.34 – 0.71) 4.95E-02* 0.76 (0.57 – 1.0) 7.26E-05 0.64 (0.52 – 0.80) 
5 rs13188584 CSF1R T C 2.29E-04 1.62 (1.25 – 2.10) 7.77E-02 1.27 (0.97 – 1.66) 9.95E-05 1.44 (1.20 – 1.73) 
1 rs10493377 DNAJC6 
(3'utr) 





combined GWAS and validation samples reveal suggestive associations at the two 
SNPs (rs8111930, OR = 0.69, Pcombined = 7.92×10−5; rs505010, OR = 0.64,              
Pcombined = 4.09×10−04), however both of them failed to reach genome-wide 
significance levels. Furthermore, the replication study of allergic rhinitis also revealed 
consistent association at rs8111930 (OR = 0.76, P = 0.049) and rs505010 (OR = 0.63, 
P = 0.027) (Table 3). The combined analysis revealed similar association for the atopy 
phenotype (rs8111930, OR = 0.54, Pcombined = 1.34×10−04; rs505010, OR = 0.64, 
Pcombined = 6.61×−10−05), but the evidence for this association is only suggestive. 
Furthermore, suggestive associations were also observed at 2 other SNPs, rs13188584 
in CSF1R gene (OR = 1.46, Pcombined = 7.56×10−05) and rs10493377 in the 5′ or 
3′flanking region of DNAJC6 (OR = 1.35, Pcombined = 9.50×10−04). 
 
3.3.3 Imputation Analysis 
To further investigate the observed associations, we imputed the genotypes of 
additional SNPs within the regions surrounding rs8111930 and rs505010 that were 
not genotyped by using IMPUTE (v2.0) and the haplotype information from the 
HapMap CHB and CHD samples. Only the imputed genotypes with a posterior 
probability score of >0.90 were used for association analyses. The regional plots for 
the two regions have been shown in Figure 2A, 2B, and the imputed SNPs, however, 
did not reveal any stronger association than the genotyped SNPs. 
 
3.3.4 Bioinformatics analysis of validated SNPs for putative TFBS 
The SNPs which were validated in the replication population were analyzed for 
potential transcription factor binding sites (TFBS) using TRANSFAC [35] and 








Figure 2: Regional plots of association results within two susceptibility loci. 
Association results of both genotyped (triangles) and imputed (circles) SNPs in the 
GWAS samples for the regions of ~1000kb containing rs505010 and rs8111930. For 
each plot, the −log10 P values (y axis) of the SNPs with a grey horizontal line 
included to indicate suggestive genome-wide significance (10−3).  The genotyped and 
imputed SNPs are indicated by red-triangles and green-circles respectively. The top 





http://www.gene-regulation.com/pub/programs/alibaba2/index.html. Accessed 2010 
Nov 15]. The results have been summarized in Table S1. Information about the 
transcription factors potentially binding to the validated SNPs has been summarized 
in Table S2. Bioinformatics analysis predicts that the introduction of the SNP 
rs505010 (C→T) results in the loss of transcription factor binding sites (TFBS) for 2 
important transcription factors (TF), NFAT (Nuclear factor of activated T-cells) and 
PU (Ets-like transcription factor identified in lymphoid B-cells). Interestingly this 
polymorphism results in the introduction of a new TFBS for E2F, which is involved 
in cell cycle regulation, interacts with Rbp107 protein. The SNP rs8111930 (A→G) 
results in the loss of TFBS for AREB6 (Atp1a1 regulatory element binding factor 6) 
and introduces a new TFBS for CREB2 (cAMP-responsive element binding protein). 
 
3.3.5 Non-synonymous SNPs and the predicted function of the associated SNPs 
We also evaluated the associations of non-synonymous SNPs to atopy and allergic 
rhinitis separately, and the SNPs with at P values<0.01 has been described in Table 
S6. The Q-Q plot for these SNPs (Figure S3), however, does not provide strong 
evidence for excess associations among these SNPs. The SNPs, rs273957 
(CREB3L2), rs2472553 (CHRNA2), rs897945 (THAP9), rs625372 (SN), rs1919127 
(C2orf16) with P values <0.001 were subjected to further evaluation for putative 
effects on the amino acid and in turn the protein. Tables S7 and S8 describe the 
putative effect of these SNPs using the SIFT algorithm and the FASTSNP algorithm. 
The SIFT algorithm describes whether the change in amino acid could be ―tolerated‖ 
or may be damaging for the protein. Similarly FASTSNP uses a SNP prioritization 
ranking and gives a risk score for each SNP also considering conserved regions. Thus 





replication in other population cohorts and also functional studies are needed to 
validate if these SNPs actually have an effect on the disease. 
 
3.4 DISCUSSION  
This is the first GWAS study for AR. We had carried out the study in two phases: a 
discovery phase which consisted of 515 atopic cases including 456 AR cases and 486 
NANR controls with no medical history of allergy and a validation phase of 2323 
atopic cases including 676 AR cases and 511 NANR controls. No associations were 
discovered at genome-wide significance; however we observed suggestive 
associations at rs8111930, an intronic SNP on MRPL4 gene on chromosome 19p13.2 
and rs505010 a 5′ flanking SNP to BCAP gene on chromosome 10q24.1 which 
showed consistent association evidence between the discovery and validation 
samples. The 19p13.2 locus (rs8111930) was previously reported to be associated 
with inflammatory adhesion process and also influencing soluble ICAM1 (sICAM1) 
levels [37] and sICAM1 has been reported by multiple studies to be a key regulator of 
nasal allergic reaction [38]. The SNP rs8111930 is an intronic SNP within MRPL4 
gene that codes for the 39S mitochondrial ribosomal protein L4. The protein is 
believed to play a role in maintaining the structural integrity of the ribosome and also 
in mitochondrial protein translation. Interestingly, transcription of the MRPL4 gene is 
shown to be down-regulated in TGF-β differentiated cells [39]. Since MRPL4 is an 
important component of the mitochondrial machinery, its regulation by various 
transcription factors might be vital in understanding how this gene might be involved 
the allergic inflammation pathway. In silico analysis of rs8111930 (A→G) results in 
the loss of TFBS for AREB6 (Atp1a1 regulatory element binding factor 6) and 





AREB6 is a negative regulator of IL-2 gene transcription after activation of T-cells 
and is also suggested to be involved in tissue-specific gene expression and also in 
early development [40], [41]. Thus studying the regulation of the MRPL4 gene by its 
polymorphisms might reveal important clues how they predispose and/or moderate 
allergic inflammation. 
SNP rs505010 is present in the 5′ flanking region of BCAP gene. BCAP is cytosolic 
adaptor that bridges the B cell receptor associated kinases to phosphatidylinositol 3-
kinase (PI3K) pathway by regulating the localization of PI3K [42, 43]. It is also 
involved in the activation, development, and maturation of B cells and recent reports 
have shown their role in activation in natural killer (NK) cells [44, 45]. BCAP is 
demonstrated to be complimentary in function to CD19 in PI3K activation and 
suggested to have an important immunoregulatory role in the survival of mature B 
cells via activation of c-Rel [43, 46]. BCAP-deficient mice have a considerably lower 
number of mature B cells and whose expansion is compromised on BCR stimulation 
[43, 45]. This impaired function in mice lacking BCAP results in a loss of function 
phenotype for B cells [45, 47]. In contrast NK cells from mice deficient for BCAP are 
considerably more long lived, resistant to apoptosis and have a more mature 
phenotype with increased functional activity and enhanced cytokine production 
compared to natural killer cells from normal wild type mice [45]. Mutant mouse 
models of other signalling molecules such as PLC gamma 2, Btk, Vav, and p85 alpha 
subunit of PI3K have also resulted in reduced B cell development [43, 45, 48, 49]. 
However the NK cells of these mutant mice are hypo-responsive, contrary to the NK 
cells from BCAP-deficient mice. Hence therapeutic manipulation of BCAP to expand 
development and function of NK cells while promoting B cell apoptosis would help in 





SNP, predicts that the SNP rs505010(C→T) results in the loss of transcription factor 
binding sites (TFBS) for 2 important transcription factors (TF), NFAT (Nuclear factor 
of activated T-cells) and PU (Ets-like transcription factor identified in lymphoid B-
cells). Nuclear factor of activated T cells (NFAT) is a T-cell-specific transcription 
factor which enhances the transcriptional activation of GATA3 by targeting the IL-4 
promoter [50]. Recently various studies have also suggested that NFAT inhibitors in 
models of allergic disease will help understand the efficacy of the calcineurin 
inhibitors which are currently being tested in the clinic [51]. PU.1 strikingly 
modulates the levels of TCR expression in CD4 (+) T cells by regulating the DNA-
binding activity of GATA-3 [52]. PU.1 has been also shown to be a key regulator of 
transcription of the cathepsin G gene, which has been associated with allergic rhinitis 
previously [53]. Interestingly this polymorphism results in the introduction of a new 
TFBS for E2F, which is involved in cell cycle regulation and also interacts with 
Rbp107 protein. Thus BCAP gene polymorphisms could be significant in allergic 
predisposition and progression. 
HIF-1α has been reported to be playing significant roles in inflammatory 
responses and its inhibition results in reduced bronchial hyper responsiveness [54]. 
The PTEN/PI3K pathway has been targeted towards treatment for asthma and other 
allergic phenotypes [55]. Interestingly in a murine model of allergic airway diseases, 
mast cells have shown to regulate the activity of HIF-1α by a PI3K/Akt signalling 
pathway [56, 57]. They also demonstrated that increased PI3K activity resulted in 
higher HIF-1α levels, which were reduced on treatment with inhibitors of PI3K. 
These results suggest that HIF-1α is a one of the downstream targets of PI3K. 
However, MRPL4 has been recently identified to be a downstream target of HIF-1α 





BCAP and other molecules involved in the HIF-1α and PI3K/Akt signalling pathways 
might help understand how they are regulated and in turn shed light on the 
pathophysiology of allergic rhinitis and other atopic phenotypes. Taken together these 
data suggest that pathway controlling signalling of HIF-1α would interact with 
molecules in the PI3K signalling pathways which might lead to the development and 
progression of allergic phenotypes such as atopy and allergic rhinitis. Hence the study 
of MRPL4, BCAP other molecules involved in the HIF-1α and PI3K/Akt signalling 
pathways might help understand the pathophysiology of allergic rhinitis and other 
atopic phenotypes. Recent research has also shown promise of therapeutic 
intervention of the HIF-1α as well PI3K/Akt signalling pathways for treatment of 
asthma and other related allergic conditions [59, 60, and 61]. 
 
3.5 Replication of previously known candidate genes 
Interestingly, evaluation of SNPs in candidate genes/regions previously reported in 
GWAS studies for asthma related traits revealed a strong overlap between atopy, 
allergic rhinitis and asthma as the QQ plots showed a significant deviation from null 
(Figure S4). Taking a closer look at the SNPs in Table S3, it is evident that genes such 
as HLA-DQB1, HLA-DRB1, HLA-DQA2, NPSR1 and PIP-3E are indeed 
functionally significant in allergy and related phenotypes. Hence the overlap among 
the various phenotypes is quite justified in light of their role in the central 










The study does have its limitations. The first limitation is the sample size for the 
GWAS and the replication study. The power calculation for Minor allele frequencies 
(MAF) thresholds and different effect sizes based on Odds Ratio was calculated using 
the CaTS power calculator [http://www.sph.umich.edu/csg/abecasis/Ca
TS/reference.html. Accessed 2011 April 6]. There was no SNP which met the 
genome-wide significance and none of the replication SNPs met the Bonferroni 
correction threshold for multiple testing. Another limitation is that we only selected 
77 SNPs (0.00015% of SNPs genotyped in the GWAS phase) to attempt for 
replication. Through our findings in this study, we suggest that it is unlikely to have 
any genetic risk factors with effect sizes of OR>1.8 which would have been observed 
otherwise. However it would be interesting to use the data available to perform meta-
analysis or replication in other population in future studies to evaluate the significance 
of our results. 
 
3.7 Summary 
In summary using a cohort of 4461 ethnic Chinese from Singapore we performed the 
GWAS for atopy and AR and suggested 2 novel susceptibility loci for atopy and 
allergic rhinitis. Further studies would help to confirm and elucidate the role of these 
loci in relation to allergic phenotypes. Some of the polymorphisms previously 
identified through GWAS for asthma and related phenotypes also showed suggestive 
associations in our GWAS samples, including the SNPs within previously known 
candidate regions such the HLA locus on chromosome 6 and the NPSR1 locus. Hence 
these results suggest that genetic susceptibility to complex diseases such as atopy, 





variations, ranging between rare alleles with strong effects to intermediate to common 
alleles with small to moderate effect sizes [62]. Hence further studies with bigger 
samples and also the functional characterization of these disease associated variants 
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Appendix for Chapter 3 
Table S1: Predicted effect of SNPs validated in replication study on Transcription Factor Binding Sites  
 
 




















rs505010 201 C -> T lost V$NFAT/NFAT.01 0.95 189 207 - 1 0.96 
rs505010 201 C -> T lost V$ETSF/PU1.01 0.89 190 210 - 1 0.894 
rs505010 201 C -> T new V$E2FF/E2F.01 0.75 195 211 - 1 0.839 
rs8111930 208 A -> G lost V$ZFHX/AREB6.02 0.97 206 218 + 1 0.97 
rs8111930 208 A -> G new V$CREB/CREB.02 0.89 200 220 - 1 0.918 
Family/matrix Further information 
V$NFAT/NFAT.01 Nuclear factor of activated T-cells 
V$ETSF/PU1.01 Pu.1 (Pu120) Ets-like transcription factor identified in lymphoid B-cells 
V$E2FF/E2F.01 E2F, involved in cell cycle regulation, interacts with Rb p107 protein 
V$ZFHX/AREB6.02 AREB6 (Atp1a1 regulatory element binding factor 6) 






Table S3: P-values of SNPs from previous GWAS reported loci for asthma phenotype in the Singapore Chinese GWAS 
 
 
SNP id (rs) Alleles Strand Chr Coordinate Gene Symbol Position  Atopy p-value AR  p-value 
rs9275312 A/G + 6 32773706 HLA-DQB1 flanking_5‘UTR 9.25E-04 9.12E-04 
rs9275328 C/T + 6 32774800 HLA-DQB1 flanking_5‘UTR 9.40E-04 9.14E-04 
rs660895 A/G + 6 32685358 HLA-DRB1 flanking_5‘UTR 1.36E-03 1.48E-03 
rs7310659 A/G + 12 14201016 GRIN2B flanking_5‘UTR 2.17E-03 2.09E-03 
rs13285154 C/T + 9 31495016 ACO1 flanking_5‘UTR 4.03E-03 2.41E-03 
rs1542112 C/T + 15 96669517 FLJ39743 flanking_3‘UTR 5.69E-03 6.74E-03 
rs3916765 A/G + 6 32793528 HLA-DQA2 flanking_5‘UTR 7.26E-03 5.23E-03 
rs11079992 A/G + 17 47572536 CA10 Intron 1.33E-02 2.99E-03 
rs6544127 C/T + 2 38073146 FAM82A Intron 4.51E-02 8.35E-03 
rs655198 A/G + 1 42098604 HIVEP3 Intron 1.09E-02 9.79E-03 
rs8085335 A/G + 18 45363289 SMAD2 3‘ UTR 1.81E-04 3.52E-04 
rs17085260 A/C + 6 154639352 PIP-3E Intron 2.27E-04 7.54E-04 
rs324389 C/T + 7 34744239 NPSR1 Intron 5.77E-05 1.45E-04 
rs10270663 G/T + 7 34752923 NPSR1 Intron 3.56E-05 9.96E-05 
rs10267134 A/G + 7 34769628 NPSR1 Intron 7.07E-05 1.03E-04 
rs10278663 A/G + 7 34774996 NPSR1 Intron 7.07E-05 4.36E-04 










Figure S1: Quantile-quantile (Q-Q) plots of the observed P values versus the expected values from P value of association for (A) Atopy and (B) 






(A)          (B) 
 
Figure S2: Quantile-quantile (Q-Q) plots of the observed P values versus the expected values from P value of association for the replication 







Figure S3: Quantile-quantile (Q-Q) plots of the observed P values versus the expected values from P value of association of the non-









Figure S4: Quantile-quantile (Q-Q) plots of the observed P values versus the expected values from P value of association for the previously 





4. EVALUATING THE TRANSFERABILITY OF HAPMAP SNPS TO A 
SINGAPORE CHINESE POPULATION 
 
Information in this chapter has been published in the following article in BMC 
Genetics 
Evaluating the transferability of Hapmap SNPs to a Singapore Chinese population 
Anand Kumar Andiappan, Ramani Anantharaman, Pallavi Parate Nilkanth, De Yun 
Wang and Fook Tim Chew.BMC Genetics 2010, 11:36doi:10.1186/1471-2156-11-36. 
 
4.1 BACKGROUND 
The International Hapmap Project is a multi-centre effort aimed at identifying genetic 
variations across the human genome among different individuals to aid biomedical 
researchers in identifying genetic links to various diseases and variable drug response 
[1-3]. The Hapmap Consortium developed a human haplotype map by genotyping 
270 samples from four populations with diverse geographic ancestry. These samples 
included 30 trios (mother, father, and adult child) from the Yoruba in Ibadan, Nigeria 
(YRI); 30 trios from the Centre d'Etude du Polymorphisme Humain (CEPH) 
collection of Utah residents of Northern and Western European ancestry; 45 unrelated 
Han Chinese in Beijing (CHB); and 45 unrelated Japanese in Tokyo (JPT) [4]. While 
the latest published update to the Hapmap project indicates the availability of data for 
more than 3.1 million single nucleotide polymorphisms (SNPs) in the four 
populations [3]; this number has grown to more than 26 million SNPs as per the 
NCBI database. The common patterns of DNA sequence variants, their frequencies 
and correlations have been made available online at the Hapmap database [5] and 





serve as a valuable resource for linkage disequilibrium (LD) based marker selection in 
genetic association studies [2, 7], there is a need to evaluate its extensibility to other 
populations. Studies comparing LD patterns and transferability of tag SNPs [8-13] 
have shown that allele and haplotype frequencies of independent populations are 
relatively similar with those obtained from the Hapmap populations. The concordance 
is however, not always near 100%. In analyzing regions spanning 750 kb in various 
European populations, Mueller et.al [10] reported that only two out of the four studied 
regions were well represented in the Hapmap CEPH population [7]. While such 
studies on European populations are plenty, only a few have focused on Asian 
populations and their concordance with the Han Chinese or Japanese Hapmap 
populations. A recent study looked at a 21 Mb region on chromosome 1q21-q25 in 80 
Chinese Hans from Shanghai as part of the International Type 2 Diabetes 1q 
Consortium [14] where 3042 SNPs were identified to match with Hapmap data from 
the CHB population. Another study focused on the linkage disequilibrium of a region 
on chromosome 7p15, in Korean, Japanese, and Han Chinese samples also reports 
similar results [12]. These results are not surprising given that the study and reference 
populations were of the same ethnic origin from the same region. What is currently 
lacking is a similar validation on an ethnic Chinese population which is far removed 
from China. The Singapore Genome Variation Project recently published, compares 
three Singaporean populations (Chinese, Malay and Indian) against the Hapmap 
populations. Interestingly they showed that most Singapore Chinese were similar to 
southern Han Chinese [15]. There was also evidence of population sub-structure when 
the Hapmap Han Chinese samples were compared with samples from the northern 
Han Chinese population, although the data was not conclusive due to the small 






Genome-wide single nucleotide polymorphism data is a valuable resource of close to 
million SNPs for a particular individual which could be used for a variety of estimates 
other than the convention gene-disease association evaluation. In this context for our 
Singapore Chinese population from our research group we had two sets of whole 
genome SNP data generated using the Affymetrix Gene Chip Human Mapping 500 K 
Array Set and the Illumina Human Hapmap 550 k chip. This would help us evaluate 
the performance of these GWAS chips for association studies in our Singapore 
Chinese population and also validate the use of the Hapmap CHB (Han Chinese from 
Beijing) as a reference population for our genetic association studies.  This would also 
serve to validate the use of these genome wide chips in disease based genetic 
association studies for a Hapmap based population from a different geographical 
location. To supplement the whole-genome comparison, data from a resequencing 
project primarily generated for an asthma candidate gene based study was also used to 
evaluate the effect of the chips in covering specific biased genes, in this case the 
highly replicated asthma susceptibility locus on chromosome 5q31-33. 
 
4.3 MATERIALS AND METHODS 
4.3.1 Samples and genotyping  
The samples used for this analysis were extracted as previously mentioned in the 
Chapter 3.1 following standardized protocols.  All samples used in this analysis were 
collected from Singapore and of the ethnic Chinese ancestry. A total of 114 and 1028 
samples were genotyped on the Affymetrix 500 k and Illumina Hapmap 550 k chips 
(Illumina Infinium HumanHap550 Duo or Illumina Infinium HumanHap610 Quad) 





500 k Assay Manual and Infinium II Assay Workflow respectively. Genotypes were 
obtained using the BRLMM algorithm as implemented in the Genotyping Console 
v2.1 for the Affymetrix platform, and from the BeadStation software for the Illumina 
platform. Cryptic relatedness was tested to remove any relatives within the samples 
and gender test was also performed to ensure all predicted sexes matched the actual 
gender. 
 
4.3.2 Statistical Analysis 
Concordance correlation coefficient was calculated to determine "correlation" as a 
measure of accuracy between actual and estimated allele frequencies. R software 
package and PASW statistics 17(SPSS Inc) were used to calculate the correlation 
statistics. Unless otherwise stated, all measures of correlation were deemed 
statistically significant at p < 0.05. Mean absolute deviation (MAD) was used as a 
more robust estimator of dispersion of errors than standard deviation or variance. 
Principal Component Analysis (PCA) statistics were calculated using the 
EIGENSTRAT software package [16]. LD blocks were developed using Haploview 
version 4.0 http://www.broad.mit.edu/mpg/haploview website. The r2 values were 
used to determine pair-wise linkage using the default Gabriel et al. algorithm. A 
"proxy SNP" is defined as a SNPs which is covered by another SNP at an r2 value of 











4.4.1 Correlation of SNP frequencies for Illumina 550 k Genotyping chip 
The distribution of average minor allele frequencies (MAF) for all 561466 SNPs 
appears to be biased towards common SNPs with more than 70% of the SNPs having 
a MAF of more than 0.1. While we were able to probe for all the SNPs on the 
Illumina 550 k chip, comprehensive genotyping data was not available for all the four 
Hapmap populations. As such, only the SNPs common to each of the Hapmap 
populations and our study population were selected and used for comparison. The 
tally of common SNPs and the concordance between the allele frequencies of these 
SNPs in the Hapmap populations with those from our study population are listed in 
Table 1. The distribution of MAF for the common SNPs in the Hapmap CHB 
population (Figure 1a) appears to be more evenly distributed than what was observed 
in our study population (Figure 1b). Comparing the MAF, a Pearson's correlation of 
0.954 is obtained which reveals that our study population of Singapore Chinese is 
highly similar to the Hapmap CHB population (Figure 2a). This high concordance is 
confirmed by the relatively small (0.09%) proportion of the 550763 common SNPs 
showing a difference of more than 0.2 in MAF (Table 2). Comparing the MAF of 
Singapore Chinese with the other Hapmap populations, the Hapmap Japanese 
population (Figure 2b) remained fairly concordant with r of 0.91 with 1727 out of 
356129 (0.49%) common SNPs having a difference in MAF of over 0.2. The allele 
frequencies from the Hapmap CEPH and YRI populations were significantly different 
from our study population with Pearson's correlation of 0.46 and 0.17 respectively 






Table 1. Concordance Correlation Coefficient for Hapmap populations against 
Singaporean Chinese population using Illumina 550k chip 
Hapmap Population Common SNPs Correlation  
CHB 557063 0.95 
JPT 356129 0.90 
CEPH 557455 0.53 
YRI 557063 0.21 
Table 2. Difference in average MAF for SNPs for Singaporean Chinese population to 
Hapmap Han Chinese population 
Difference in MAF Number of SNPs MAD 
0.4 – 0.5 47 (0.01%) 0.4431 
0.3 – 0.399 92 (0.02%) 0.3439 
0.2 – 0.299 363 (1.4%) 0.23 
0.1 – 0.199 25916 (4.65%) 0.1224 
0.05 – 0.099 118249 (21.23%) 0.0688 
0 – 0.05 412396 (74%) 0.0187 
Total 550760  
Table 3. Concordance Correlation Coefficient for Hapmap populations against 
Singaporean Chinese population using Affymetrix 500k chip 
Hapmap Population Common SNPs Correlation  
CHB 492496 0.94 
JPT 492496 0.89 
CEPH 492471 0.53 






Figure 1. Distribution of MAF for common SNPs in a) Hapmap CHB and b) 
Singapore Chinese  
 
Figure 2. Bi-plot of MAF in Singapore Chinese against the Hapmap populations 








4.4.2 Correlation of SNP frequencies for Affymetrix 500 k Genotyping chip 
Minor allele frequencies for the 500 568 SNPs on the Affymetrix 500 k chip were 
generated and their distribution plotted. SNPs common to each of the four Hapmap 
populations were compared with our genotyping data and the results match closely to 
those obtained from the Illumina platform (Table 3). The MAF of common SNPs with  
Hapmap CHB population also appears to be similarly distributed (Figure 3). With the 
Affymetrix 500 k Gene Chip a total of 1286 or 0.26% of SNPs had allele frequencies 
differing by more than 0.2 in comparison with the Hapmap CHB population, a degree 
of high concordance (r = 0.947) was still evident (Table 4, Figure 4). 
 
4.4.3 Chromosome based Analysis 
To detect any patterns in chromosomal aggregation of similarities between Singapore 
Chinese and Hapmap CHB, the MAF comparison was performed at a chromosomal 
level. Pearson's correlation was found to be consistently high along each of the 
chromosomes with the lowest value being 0.948 (Figure S2). This high concordance 
was not related to the number of SNPs from the Illumina 550 k chip on each 
chromosome or the length of the chromosome (Figures S1, S2, and S3). Of the 
561466 SNPs on the chip, 502 were found to be discordant compared to the Hapmap 
CHB data, with MAFs differing by up to 0.2. To identify if these SNPs were in any 
potential chromosomal hotspots, they were mapped to regions within each 








Table 4. Difference in average MAF for SNPs for Singaporean Chinese population to 
Hapmap Han Chinese population 
Difference in MAF Number of SNPs MAD 
0.4 – 0.5 212 (0.043%) 0.446048 
0.3 – 0.399 376 (0.076%) 0.342023 
0.2 – 0.299 1286 (0.2612%) 0.234257 
0.1 – 0.199 27712 (5.627%) 0.125867 
0.05 – 0.099 98826 (20.07%) 0.069757 
0 – 0.05 364082 (73.93%) 0.034877 
Total 492496  
Table 5. SNP coverage for the 20 studied genes on 5q31-33 in various Hapmap 
populations 












Table 6. Microarray coverage for Singapore Chinese population for the region 
containing the 20 genes resequenced on 5q based on Illumina 550k chip 
 Coverage (%) 
 
SNPs on microarray  13 
r
2 
>= 0.8    71 
r
2 





Figure 3. Differences in MAF between Hapmap CHB and Singapore Chinese using 
a) Illumina and b) Affymetrix chips 
 
Figure 4. Bi-plot of MAF in Singapore Chinese against the Hapmap populations 








4.4.4 Principal Component Analysis (PCA) 
PCA was used to evaluate the population structure of the Singapore Chinese samples 
in comparison to the Hapmap populations. Plots of the first five principal components 
were generated using data from our 1028 ethnic Chinese samples genotyped on the 
Illumina BeadChip and from 206 Hapmap samples. The Hapmap samples used in the 
analysis consisted of 60 CEPH samples (Utah residents with ancestry from northern 
and western Europe), 57 YRI samples (Yoruba in Ibadan, Nigeria), 44 JPT samples 
(Japanese in Tokyo, Japan) and 45 CHB samples (Han Chinese in Beijing, China). 
Scatter plots of the first two components (PC1 vs PC2) show that these components 
clearly differentiated the Asian populations (CHB and JPT) and Singapore Chinese 
from the Caucasian (CEU) and Yoruba (YRI) samples (Figure 5a). 
The majority of individuals from our cohort who were classified according to self-
reported ethnic identities clustered well with the Hapmap Han Chinese samples. 
Scatter plots of the third, fourth and fifth dimensions (PC3, PC4, PC5) progressively 
revealed the differences between the Chinese and the Japanese samples (Figure 5b 
and Figure 6a and 6b). Although the Chinese and Japanese samples are considered to 
be comparable in terms of Linkage Disequilibrium (LD) we observed in the plot of 
PC1 vs PC5 that these samples also show differences in population structure. 
Of the 1028 ethnic Chinese samples in our cohort, 1003 samples were used for 
subsequent statistical analyses after removing 25 samples which were observed to be 
outliers. The scatter plots of the first and up to the fifth principal components (Figure 
7 and Figure 8) showed that our study population was largely homogenous with no 
significant evidence of population stratification amongst the case and control groups. 
However, there still appeared to be 83 samples (8%) which drifted away from the 





Figure 5. Principal component plots for PC1 against PC2 and PC3 for 1028 
Singapore Chinese and 206 Hapmap samples 
 
  







Figure 6. Principal component plots for PC1 against PC4 and PC5 for 1028 










Figure 7. Principal component plots for PC1 against PC2 and PC3 for 1001 








Figure 8. Principal component plots for PC1 against PC4 and PC5 for 1001 







while they were indeed of ethnic Chinese origin, they were born in China unlike all 
our other Chinese samples those who were born in Singapore. We believe this 
difference can be explained by the fact that Singapore Chinese are largely 
descendents of immigrants from southern China [15] whereas those 83 samples were 
likely to have originated from northern China.  
 
4.4.5 Identification of SNPs by resequencing Asthma Candidate Genes 
To investigate the applicability of the Hapmap CHB population to our Singapore 
Chinese population at the gene level, 20 genes from the 5q31-q33 region (Figure 9) 
which was previously found to be associated with asthma, as well as two genes 
outside of this region were re-sequenced as part of an ongoing association study. All 
exons, introns containing exon-intron junctions, and up to 0.5-kb promoter regions 
were re-sequenced, on 40 unrelated Singapore Chinese individuals. A total of 237 
genetic variants were identified distributed proportionately among the 20 genes. 
Minor allele frequency calculations showed that the majority of the SNPs (198 or 
85%) were common (MAF >0.05). In the context of a candidate gene study, the 
identification of common SNPs specific to the study population aids in the selection 
of SNPs for genotyping and subsequent association testing. 
 
4.4.6 SNP Coverage of 5q31-33 Region in Public Databases 
The 237 SNPs detected in this study were evaluated against the Hapmap and dbSNP 
databases to compare their coverage of the 5q31-q33 region. A significantly lower 





Figure 9. Twenty candidate genes for asthma and atopy on chromosome 5q31-33 
 
Figure 10. Linkage disequilibrium pattern for 5q31-33 region in Singapore Chinese 
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information for about 74% and Hapmap about 40% of the SNPs (Table 5). However 
an additional 24% SNPs had a proxy in Hapmap. 
 
4.4.7 Microarray Coverage 
The resequencing data was used to estimate the microarray coverage of the Illumina 
550 k chip for the 20 genes resequenced. Out of the 237 SNPs identified, only 182 
were reported previously and 52 have not been documented previously. Thus only the 
previously reported SNPs were used to estimate coverage of the whole genome chip. 
It was identified that only 13% of the SNPs were present on the chip, however the 
coverage increased to 71% if we considered SNPs that were covered by these SNPs at 
an r2 value of 0.8. This coverage increased even further to 86% for an r2 value of 0.5. 
(Table 6) 
 
4.4.8 Linkage Disequilibrium Analysis 
Given the small number of common SNPs within the 5q31-q33 region which were 
available in the SNP databases, allele frequency comparisons would not have been 
meaningful. However, patterns of linkage disequilibrium would be an indication of 
whether the available SNPs were sufficient to represent the gross variation within the 
chromosomal region. 15 blocks of linkage were identified from the 237 SNPs 
genotyped in our Singapore Chinese population. LD blocks for the common SNPs 
from dbSNP were then generated for the four Hapmap populations and Singapore 
Chinese (Figures 10a, b, c, d, and 10e). Comparing these LD patterns to what was 
obtained from our targeted re-sequencing; it was obvious that the SNP coverage in 
existing SNP databases is not comprehensive enough at this point in time for us to 





4.4.9 Correlation of SNP frequencies 
We also performed a comparison of the MAF of the 11 Hapmap populations for the 
SNPs identified through sequencing as discussed above. There were 60 SNPs that 
were common across all the 11 Hapmap populations and Singapore Chinese. A scatter 
plot matrix was plotted to observe the correlations in the allele frequencies across 
these populations (Figures 11 and Figure 12). The correlation patterns were similar to 
those obtained from the genome-wide comparison. Singapore Chinese samples 
correlated well with the Hapmap CHB population and to a lesser extent with the 
Hapmap JPT samples. An important observation was that, on comparison with the 
other 7 populations added in Hapmap Phase III, no significant correlation with the 
Singapore Chinese samples was observed (Table 7). 
Table 7. Correlation of SNP frequencies between Singapore Chinese and Hapmap 
populations 
















Figure 11. Pair-wise correlation of Singapore Chinese against Hapmap populations 







Figure 12. Pair-wise correlation of Singapore Chinese against Hapmap populations 












Genes underlying common complex diseases - such as asthma and other allergic 
diseases are likely to be multiple, each with a relatively small effect, but act in concert 
or with environmental influences to lead to clinical presentation [18]. The Hapmap 
project was designed to allow researchers to identify common disease-causing 
variants based upon the "common disease, common variant" hypothesis, which 
suggests that genetic influences on many common diseases are attributable to a 
limited number of allelic variants (one or a few at each major disease locus) that are 
present in more than 1-5% of the population [19-21]. Linkage Disequilibrium (LD) 
data is also available in Hapmap to facilitate the design of genome wide chips for 
association studies. This study attempts to explore the genetic architecture of the 
Singapore Chinese population. By considering our population in the context of the 
Hapmap populations, this study reveals significant insights that are relevant in 
conducting genetic studies in a population of Chinese ancestry. 
 
4.5.1 Hapmap data and the world populations 
Hu et.al., [8] had described that Shanghai Chinese are very similar to Hapmap Han 
Chinese based on 4,500 SNPs in a 21 Mb region on chromosome 1q21-q25 in 80 
unrelated Shanghai Chinese and 45 Hapmap Beijing Han Chinese. They had a 
correlation coefficient of R = 0.94, p < 0.001 for 3042 SNPs (some SNPs were 
filtered out based on their data quality control criteria). They also reported a similar 
correlation coefficient of R = 0.88, p < 0.001 for comparison of Shanghai Chinese to 
Hapmap Japanese. Takeuchi et.al [22] performed a similar comparison of Japanese 
individuals against Hapmap Japanese by combining resequencing and high-density 





SNPs in the Japanese population, and this needs to be considered when association 
results are interpreted. Researchers elsewhere have also performed comparative 
studies between CEU SNP data and several other populations, including Spanish, 
Finnish, and Estonia [10, 12, 13, and 23]. They all came to the same conclusion that 
the CEU SNP dataset was a robust dataset for comparative and association studies in 
these populations. These various observations by different groups studying the 
effectiveness of Hapmap dataset for different populations were not really consistent. 
Even though Hapmap serves as a good reference population for some populations, its 
applicability to other populations not evaluated in the Hapmap project needs to be 
assessed closely. 
 
4.5.2 Hapmap and Singapore Chinese 
The genotype data for Singapore Chinese from both Illumina and Affymetrix have 
given us a high correlation coefficient of 95% in comparison to the Hapmap Han 
Chinese. On the contrary, comparison with the Caucasian and African populations 
showed very low correlation. However in a comparison of close to 1 million SNPs, 
5% deviance is still somewhat significant. In an attempt to localize this deviation, a 
chromosome based correlation analysis was performed. A consistently high 
correlation (more than 95%) was observed across all the chromosomes with deviating 
SNPs not associated with minor allele frequencies or any specific chromosomal 
location. This indicates that the 5% deviation observed between Hapmap CHB and 
our local population was likely to be random and not due to any major differences in 
the two populations. 
The HumanHap550 BeadChip from Illumina displays a genomic coverage 





populations respectively (Illumina Inc) as measured by Phase I+II Hapmap genotype 
data. The mean MAFs determined using the HumanHap550 BeadChip was 0.23, 0.21 
and 0.22 for the CEU, CHB+JPT and YRI populations, respectively [7]. It should be 
noted that though the mean MAF is similar for all 3 populations, the distribution of 
SNPs in terms of MAF is quite different. The mean MAF determined for our 
Singapore Chinese population is 0.215 which is similar to the estimates for Asian 
population as reported by Illumina. The high genomic coverage for the Asian 
population set, as well as the comparable mean MAF suggest that the BeadChip 
designed based on linkage disequilibrium data from Hapmap can be extended for 
genome-wide analysis of other similar population cohorts not previously genotyped, 
such as the Singapore Chinese in our case. A very recent study by Chen et.al [24] 
describes the genetic architecture of Han Chinese from all over the world and found a 
''north-south'' population structure which was also clearly visible in our population. 
The study had also included 570 Han Chinese samples from Singapore and found they 
were more similar the southern Han Chinese population. These differences need to be 
addressed while performing association studies including samples from both northern 
and southern Han Chinese samples in the same study. 
Using the resequencing data of the 5q31-33 region, we compared and 
estimated the coverage of the genes in this region with that in the Hapmap project. Of 
the 237 SNPs we identified through resequencing; 73 (31%) were identified in 
Hapmap. This meant that more than two-thirds of the variation in Singapore Chinese 
was not reported in the Hapmap CHB population. While a further 24% of our 'novel' 
SNPs had proxies in Hapmap, the fact remains that even the Hapmap CHB 
population, likely to be genealogically closest to Singapore Chinese, was unable to 





In the study of complex diseases, such as asthma, it is of the utmost importance to 
capture as much of the genetic variation in the study population as possible so that 
they can be screened for potential associations. In such situations, Hapmap by itself 
may be insufficient and targeted resequencing may be essential to capture all the 
variation in a specific population. A study by Tantoso et al [25] has also demonstrated 
that the Hapmap SNPs are not robust enough to capture the untyped variants for most 
of genes. They estimated a marginal coverage of about 55% for European and Asian 
samples and the coverage is as low as 30% for the Hapmap YRI panel. A recent study 
also evaluated the coverage of different SNP chips used for genome-wide association 
studies [11]. Such information would be useful in selecting the chip which would 
provide a better coverage for the population under investigation. 
4.6 CONCLUSIONS 
In this study we evaluated the correlation between MAF of Hapmap SNPs and that 
obtained from a Singapore Chinese population. We found that minor allele 
frequencies of 976219 unique Hapmap SNPs for the Han Chinese population 
correlated with those from a Singapore Chinese population with a concordance 
correlation coefficient of 0.95. This clearly demonstrates the effectiveness of using 
Hapmap Han Chinese population as a reference population for future whole genome 
based association studies in Singapore Chinese. It also emphasizes the fact that the 
SNPs selected in the Genome wide chips are performing as expected as the MAF are 
quite similar to the actual MAF in the Hapmap project. Although the principal 
component analysis reveals no significant population stratification, the migration 
pattern of the samples needs to be addressed while designing and interpreting 
genome-wide association studies. While we showed that the SNPs deposited in 





patterns observed between both Hapmap Han Chinese and Singapore Chinese 
populations, targeted resequencing, as used in a candidate gene based approach, may 
still be necessary to capture all the variation in specific target genes. This SNP 
information can also help to develop SNP chips which are more targeted towards a 
specific population which clear population signatures. 
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5. 1 CANDIDATE GENE BASED ASSOCIATION STUDY 
5.1.1 Background 
Multiple candidate genes identified as associated through genetic association studies 
have confirmed the genetics of allergic rhinitis and other atopic phenotypes such as 
asthma. Candidate gene based studies are “hypothesis driven” genetic association 
studies designed to validate or confirm the relevance of candidate genes identified by 
other research groups in the other ethnic populations. Multiple candidate genes 
identified for AR and asthma have been described in detail elsewhere [1-15]. The 
candidate genes thus identified were evaluated for multiple reports of genetic 
association by independent groups to allergic phenotypes such as AR and asthma. A 
total of 60 genes were then chosen to genotyped in a cohort of Singapore Chinese 
collected in Singapore through multiple volunteer recruitment drives. 
 The genes have been described with information on the chromosome on which 
they are situated in the human genome and its coordinates have been tabulated. Genes 
were then evaluated for tagSNPs to represent the genetic variation in the genes. These 
tagSNPs were then taken forward for genotyping. A minor allele frequency cutoff of 
0.05 was used to only include „common‟ SNPs in the genotyping. Also the linkage 
disequilibrium threshold of r2 =0.8 was used to identify the tagSNPs. The Hapmap 
population CHB (Han Chinese in Beijing) was used as the reference population to 
select tagSNPs. We have already evaluated using data from whole genome SNP 
arrays and conventional Sanger sequencing to demonstrate that this reference 
population (Hapmap CHB) is almost 95% similar to our Singapore Chinese 
population [16, 17, and 18]. Also the use of SNPs greater than minor allele frequency 





difference between the two populations which may be a real issue when studying 
SNPs present at lower MAFs such as rare SNPs [19, 20, 21].  
 
5.1.2 Materials and Methods 
5.1.2.1 Study population and DNA extraction 
All participants to enroll in the study had to first be above 18 years of age. In the 
event, that they are less than 21 years of age, then parental consent is mandatory for 
participation in the study. The consent of the volunteer was obtained in a “written 
form” collected using the Participant Information Sheet (PIS) which had information 
about the study and also had the section on parent/guardian consent for those over 18 
years but still less than 21 years of age.  
Genomic DNA was extracted from buccal cells obtained from a mouthwash of 0.9% 
saline solution following an in-house standardized protocol. In short, the buccal cells 
were pelleted and lysed; DNA was extracted using the phenol-chloroform phase-
separation technique purified by two washes in ethanol, with the DNA pellet 
resuspended in reduced Tris-EDTA buffer [22, 16]. Samples were quantified in 
triplicate on the Nanodrop (ND-1000) 
 
5.1.2.2 Ethics statement 
This study was reviewed and approved by the NUS-IRB (National University of 
Singapore - Institution Review Board). The approval codes are NUS07-023 and 








5.1.2.3 Candidate gene selection 
Several approaches such as genome-wide linkage scan, positional cloning methods, 
genome wide association studies (GWAS), candidate gene based association studies 
and sequencing studies have led to the identification of genes as candidates for 
allergic phenotypes. Table 1 summarizes the unique set of candidate genes selected 
for evaluation as allergic rhinitis candidate genes. These genes were reported to be 
associated with atopy, allergic rhinitis and/or allergic asthma and in some cases also 
to atopic dermatitis [1-15]. These candidate genes are observed to be randomly 
distributed on several chromosomes and also of varying lengths and function. 
However there are certain groups of genes which do appear to be associated with 
allergic phenotypes: (1) chemokine ligands such as CCL5, CCL11, CCL24, CCL26 
and chemokine receptor CCR3 (2) HLA genes such as HLA-DQB1, HLA-DRB1, 
HLA-DPB1 and HLA-G (3) interleukin genes such as IL3, IL4, IL4R, IL5, IL9, IL10, 
IL12B, IL13, IL17, IL17B, IL17F and IL18 (4) prostaglandin genes such as PGDS, 
PTGDR and PTGS2 (5) toll-like receptor genes such TLR4, TLR7 and TLR8. 
 
5.1.2.4 TagSNPs selection for candidate genes 
The SNPs on these candidate genes were identified and the linkage disequilibrium 
(LD) among SNP pairs was evaluated using Haploview [23] to determine the extent 
of LD as measured by r
2
. A minor allele frequency (MAF) of 5% was set as the 
threshold to select for common variants for this candidate gene based association 
study. Sets of bins were then tabulated by arranging SNPs linked at a minimum r
2 
of 
0.8 or more in one bin. TagSNPs were then chosen using this LD information to 
represent all the LD blocks in the gene [24, 25]. These tagSNPs were then forwarded 






The genotyping technology used for assaying the SNPs is Illumina‟s Beadxpress 
platform. This is a medium-throughput platform used to genotype 48 – 384 SNP 
assays in a solution based multiplex system (www.illumina.com). The multiplex 
capacity of the platform enables assaying many hundreds of SNPs simultaneously. 
The tagSNPs from the candidate gene were then subjected to assay design to 
determine the best multiplex set to ensure high genotyping success. The SNP assays 
were then ordered and the samples were genotyped at the University of Utah (Salt 
Lake City, UT, USA), HSC Core research facility 
(http://www.cores.utah.edu/labs/genomics/services.html). The samples were 
evaluated to determine DNA quality and then subjected to genotyping using the 
Beadxpress platform according to manufacturer recommendations 
 
5.1.2.6 Quality control and statistical analysis 
This study was well powered to detect associations consistent with complex genetic 
traits, due to the large sample sizes utilized with a combined total of 1176 allergic 
rhinitis (795 cases with skin prick positive and AR symptomology as defined by 
ARIA guidelines [28, 29]) and allergic asthma subjects (718 cases with skin prick 
positive and doctor diagnosis as defined by questionnaire) and 717 non-allergic 
control subjects with no medical history of allergy [26, 27]. This resulted in a power 
of 70- 80% for P value of 8.83x10
-5 
for disease prevalence ranging from 15-20% to 
detect effect sizes with odds ratio of 1.5 and with disease allele frequencies ranging 
from 0.1–0.2. Hardy–Weinberg equilibrium (HWE) was measured in control subjects 
as a quality control measure. The primary test of allelic association was performed 





allele to the disease phenotype. We then performed a two d.f (degree of freedom) 
global test of genotypic association. If the results showed significant p-values, we 
then applied the dominant model as it was well powered to detect the association. All 
p-values, odds ratios with 95% confidence intervals, were estimated using the PLINK 
program version 1.06. Linkage disequilibrium was calculated as defined by Gabriel et 
al., (http://pngu.mgh.harvard.edu/~purcell/plink/) with the program Haploview 
(http://www.broadinstitute.org/scientific-community/science/programs/medical-and-
population-genetics/haploview/haploview). A P value less than 0.05 were considered 
significant for all tests. 
 
5.1.3 Results 
5.1.3.1 Population description 
The study population used this candidate gene based association study was collected 
as described previously in Chapter 2. The demographics and clinical characteristics of 
the samples used in this candidate gene based association study have been described 
in Table 2 and also described in other manuscripts [26, 27].  It could be inferred that 
the population used is well controlled for age with mean age between 20-22 years. 
The use of skin prick test results helps to define the allergic state of an individual for 
allergic phenotypes such as allergic rhinitis and allergic asthma as suggested by the 
ARIA guidelines [28, 29].  
 
5.1.3.2 Association results for candidate genes 
The association results for the tagSNPs from the selected candidate genes were then 
evaluated. These results have been summarized in Table 3. A total of 26 SNPs were 





significant SNPs were distributed on the following 13 genes: HLA-DRB1, HLA-
DPB1, HLA-DQB1, BDNF, UGRP1, ICOS, CTLA4, IL4R, ORMDL3, PGDS, 
SDAD1, SPINK5 and CTLA4. Allergic rhinitis is often a risk factor for allergic 
asthma with nearly 25% of individuals with allergic rhinitis going on to develop to 
allergic asthma. Hence we evaluated these significant SNPs for association to the 
allergic asthma phenotype. The results for association to allergic asthma have been 


















Table 1: Candidate gene selected for evaluation of genetic association to allergic rhinitis 
Gene Description Chr Start Position End Position 
ACE  angiotensin converting enzyme, somatic isoform   17 58908166 58952935 
ADAM33  ADAM metallopeptidase domain 33  20 3596621 3610738 
ADH5  Alcohol dehydrogenase 5   4 100349541 100367191 
ADRB2  adrenergic, beta-2-, receptor, surface  5 148186369 148188379 
BDNF  brain-derived neurotrophic factor  11 27633020 27699851 
CCL11  chemokine (C-C motif) ligand 11  17 29636800 29639312 
CCL24  chemokine (C-C motif) ligand 24  7 75085765 75087684 
CCL26  chemokine (C-C motif) ligand 26 7 75043493 75046225 
CCL5  chemokine (C-C motif) ligand 5 17 31222611 31231490 
CCR3  chemokine (C-C motif) receptor 3  3 46258692 46283166 
CD14  monocyte differentiation antigen CD14   5 139991505 139992960 
CD86  T-lymphocyte activation antigen CD86   3 123256911 123322673 
CMA1  chymase 1, mast cell  14 24044552 24047311 
CRSP9  Cofactor required for Sp1 transcriptional activation subunit 9   5 156498017 156502453 
CSF2  colony stimulating factor 2 (granulocyte-macrophage)  5 131437384 131439758 
CTLA4  ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4   2 204558017 204564189 
CYFIP2  cytoplasmic FMR1 interacting protein 2  5 156628930 156752809 
CYSLTR2  cysteinyl leukotriene CysLT2 receptor   13 48178952 48181499 
DCNP1  dendritic cell nuclear protein 1   5 134807804 134810937 
DEFB1  Defensin, beta 1   8 6715525 6722860 
GATA3  trans-acting T-cell-specific transcription factor GATA-3   10 8137473 8156859 
HAVCR2  T-cell immunoglobulin and mucin domain-containing protein 3   5 156445421 156468697 





HLA-DQB1  major histocompatibility complex, class II, DQ beta 1 6 32735642 32742419 
HLA-DRB1  major histocompatibility complex, class II, DR beta 1  6 32654527 32665559 
HLA-G  major histocompatibility complex, class I, G  6 29903497 29906859 
ICOS  inducible T-cell costimulator   2 204627009 204651806 
IFNG  interferon gamma   12 66834816 66839770 
IL10  interleukin 10,  Cytokine synthesis inhibitory factor   1 203329343 203334234 
IL12B  interleukin 12B (natural killer cell stimulatory factor 2, p40)  5 158674369 158690059 
IL13  interleukin 13  5 132021764 132024700 
IL17B  Neuronal interleukin-17-related factor  beta 5 148734025 148739031 
IL17F  interleukin 17F  6 52209445 52217186 
IL18  interleukin 18 (interferon-gamma-inducing factor)  11 111519186 111540050 
IL3  interleukin 3 (colony-stimulating factor, multiple)  5 131424246 131426795 
IL4  interleukin-4,  B-cell stimulatory factor 1   5 132037272 132046267 
IL4R  interleukin-4 receptor  16 27248888 27283596 
IL5  interleukin 5 (colony-stimulating factor, eosinophil)  5 131905035 131907113 
IL9  interleukin-9, T-cell growth factor p40   5 135255834 135259415 
IRF1  interferon regulatory factor 1  5 131846679 131854326 
ITGAM  integrin, alpha M (complement component receptor 3, alpha; 16 31178812 31251691 
ITK  IL2-inducible T-cell kinase  5 156540485 156614687 
LTA  lymphotoxin alpha (TNF superfamily, member 1)  6 31648072 31650077 
MMP9 
 matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV 
collagenase)   20 44070954 44078606 
NAB2  NGFI-A binding protein 2 (EGR1 binding protein 2)  12 55769157 55775526 
NAT2  N-acetyltransferase 2 (arylamine N-acetyltransferase)  8 18293035 18302962 
ORMDL3 ORM1-like protein 3   17 35330822 35337380 





PHF11  PHD finger protein 11  13 48969250 49001113 
PTGDR  prostaglandin D2 receptor (DP)  14 51804181 51813192 
PTGS2 
 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase  
and cyclooxygenase)  1 183372626 183381213 
RNASE3  ribonuclease, RNase A family, 3  14 20429402 20430347 
SDAD1  SDA1 domain-containing protein 1   4 77228248 77260314 
SPINK5  serine peptidase/protease inhibitor, Kazal type 5  5 147423759 147497037 
STAT6  signal transducer and activator of transcription 6, interleukin-4 induced  12 55775462 55791428 
TBX21  T-box transcription factor TBX21   17 43165609 43178484 
TGFB1  transforming growth factor, beta 1  19 46528068 46551628 
TLR4  toll-like receptor 4  9 117546138 117557607 
TLR7  toll-like receptor 7  X 12644863 12666567 












Table 2: Demographic and clinical characteristics of the samples used in study 
 
A positive skin prick test reaction to one of the allergens tested. (Based on 2008 
guidelines set by Allergic Rhinitis Impact on Asthma (ARIA) consortium) 
# 
Asthma case was classified based on doctor diagnosis of the disease with a positive 
skin prick test reaction to one of the allergens tested. (Based on WHO and GINA 
guidelines for asthma) 
$
Allergic Rhinitis (AR) was classified based on 2 or more major symptoms which 
include (nasal congestion, rhinorrhea, nasal itching, sneezing) and a positive skin 
prick test reaction to one of the allergens tested.  
^ 
Healthy controls are individuals classified based on no symptoms and history of 








Subjects, n 795 718 717 
Median age, years 20.24 21.06 22 
Gender, %Female
 51.6 47.5 72.6 
Skin Prick Test positive reaction 
(Allergen tested) 
   
Dermatophagoides pteronyssinus 92% 90.2% N.A 
Blomia tropicalis 85% 81.5% N.A 
Smoking Status    
Current 0.9% 1.5% N.A 
Ex-smoker 0.4% 0.2% N.A 





Table 3: Summary of positive results for candidate gene based association study for allergic rhinitis (AR) phenotype 
CHR
#
       SNP      Position       Gene 
Minor 
allele         Case MAF*  Control MAF*       P value
^
 
                    
       OR 
6 rs9269794 32549249 HLA-DRB1 C 0.3295 0.2535 4.83E-06 1.447 
2 rs3087243 204738919 CTLA4 A 0.2551 0.1905 2.27E-05 1.455 
6 rs2300825 32631458 HLA-DQB1 C 0.3057 0.378 5.89E-05 0.7244 
6 rs2071353 33183903 HLA-DPB1 T 0.341 0.4071 0.0002 0.7537 
6 rs1431403 33186677 HLA-DPB1 T 0.2598 0.321 0.00022 0.7426 
6 rs2856816 33185146 HLA-DPB1 C 0.3976 0.4636 0.00026 0.7636 
6 rs3135021 33185204 HLA-DPB1 A 0.1891 0.244 0.00026 0.7224 
2 rs733618 204730944 CTLA4 C 0.3778 0.4392 0.00063 0.7756 
2 rs4675374 204802578 ICOS T 0.3928 0.4529 0.00087 0.7814 
16 rs3024668 27371949 IL4R A 0.06607 0.0993 0.00091 0.6417 
11 rs10767664 27682562 BDNF A 0.485 0.42 0.00097 1.304 
2 rs231775 204732714 CTLA4 A 0.365 0.3147 0.00399 1.252 
16 rs3024608 27363686 IL4R G 0.07522 0.1041 0.00549 0.7004 
16 rs2074570 27375157 IL4R C 0.08481 0.05858 0.00549 1.489 
5 rs2895795 148204966 ADRB2 T 0.3639 0.3161 0.00581 1.238 
4 rs11097414 95260301 PGDS G 0.3704 0.3294 0.01871 1.198 
5 rs1042718 148206917 ADRB2 A 0.3586 0.3191 0.02236 1.193 
2 rs4675377 204814676 ICOS C 0.2705 0.3066 0.02914 0.8389 
5 rs2287772 147444785 SPINK5 A 0.1766 0.2077 0.03025 0.8181 
5 rs4529181 147468971 SPINK5 G 0.1736 0.2045 0.03076 0.8175 
4 rs17001275 76874996 SDAD1 C 0.05177 0.06993 0.03659 0.7261 





5 rs7726552 147235795 UGRP1 T 0.14 0.17 0.039 0.81 
2 rs10932034 204812993 ICOS A 0.2949 0.3296 0.04016 0.8508 
4 rs35744894 95256649 PGDS G 0.2241 0.1939 0.04204 1.201 
17 rs8076131 38080912 ORMDL3 G 0.2462 0.2787 0.04273 0.8453 
 
Table 4: Summary of SNPs positive for allergic rhinitis (AR) phenotype for association to allergic asthma phenotype 
CHR SNP Position Gene 
Minor 
Allele Case MAF Control MAF P OR 
5 rs1042718 148206917 ADRB2 A 0.3464 0.3191 0.122 1.131 
2 rs10932034 204812993 ICOS A 0.2669 0.3296 0.00025* 0.7405 
4 rs11097414 95260301 PGDS G 0.3771 0.3294 0.00775* 1.233 
6 rs1431403 33186677 HLA-DPB1 T 0.2729 0.321 0.00501* 0.7941 
4 rs17001275 76874996 SDAD1 C 0.05961 0.06993 0.2624 0.843 
6 rs2071353 33183903 HLA-DPB1 T 0.365 0.4071 0.02193* 0.8372 
16 rs2074570 27375157 IL4R C 0.08333 0.05858 0.00989* 1.461 
5 rs2287772 147444785 SPINK5 A 0.1834 0.2077 0.1016 0.8565 
6 rs2300825 32631458 HLA-DQB1 C 0.2998 0.378 2.29E-05* 0.7047 
19 rs2304240 10449392 ICAM3 A 0.1497 0.1157 0.00751* 1.345 
2 rs231775 204732714 CTLA4 A 0.3589 0.3147 0.01356* 1.219 
6 rs2856816 33185146 HLA-DPB1 C 0.4245 0.4636 0.03507* 0.8532 
5 rs2895795 148204966 ADRB2 T 0.3489 0.3161 0.06339 1.159 
16 rs3024608 27363686 IL4R G 0.06503 0.1041 0.00018* 0.599 
16 rs3024668 27371949 IL4R A 0.05853 0.0993 5.51E-05* 0.5639 





6 rs3135021 33185204 HLA-DPB1 A 0.1945 0.244 0.00143* 0.748 
4 rs35744894 95256649 PGDS G 0.2328 0.1939 0.01114* 1.262 
5 rs4529181 147468971 SPINK5 G 0.1801 0.2045 0.09883 0.8545 
2 rs4675374 204802578 ICOS T 0.3627 0.4529 9.77E-07* 0.6877 
2 rs4675377 204814676 ICOS C 0.2482 0.3066 0.0005* 0.747 
17 rs4795898 32614442 CCL11 C 0.1208 0.1473 0.03728* 0.795 
2 rs733618 204730944 CTLA4 C 0.3827 0.4392 0.00219* 0.7918 
17 rs8076131 38080912 ORMDL3 G 0.2144 0.2787 6.58E-05* 0.7062 
6 rs9269794 32549249 HLA-DRB1 C 0.3243 0.2535 3.02E-05* 1.413 
11 rs10767664 27682562 BDNF A 0.484 0.42 0.00018* 1.30 
5 rs7726552 147235795 UGRP1 T 0.16 0.16 0.96 1.01 
 
#
CHR – Chromosome 
*MAF – Minor Allele Frequency 
^
P value <0.05 (only SNPs with P<0.05 have been tabulated here) 








5.2 CHROMOSOMAL LOCUS 2Q AS A CANDIDATE FOR 
ALLERGY 
5.2.1 BACKGROUND 
5.2.1.1 Co-stimulatory molecules and T-cell activation 
In general, T-cells which have not encountered antigen (naïve T cells) require two 
basic signals for activation: (i) in the presence of antigen, the interaction of T-Cell 
Receptor (TCR) with peptide-HLA complexes on the Antigen Presenting Cell (APC) 
provides the first signal; and (ii) the co-stimulatory receptors providing the second 
signal. This, subsequently, leads to the expansion of the antigen-specific T-cells and 
differentiation into effector cells. Co-stimulatory receptors could produce positive or 
negative signals to determine the fate of an immune response (30-32). Hence these 











5.2.1.2 Specific roles of the co-stimulatory receptors 
CD28 is an activating co-stimulator which increases cytokine production in T-cells by 





reduces the number of engaged TCR that are needed for proliferation thus lowering 
the threshold for T-cell activation (33,34). CD28 is expressed constitutively on T-cells 
and it binds to ligands B7-1 (CD80) and B7-2 (CD86) found primarily on APCs (35). 
CD28-knockout mice do not produce systemic IgE or eosinophilic airway 
inflammation after antigen challenge. However, there was continued production of 
interferon-gamma which indicates that CD28 critically regulates the allergic T-helper 
2 phenotypes (36). CTLA4 on the contrary, produces a negative signal and binds with 
higher affinity (compared to CD28) to the previously mentioned CD28 ligands (37). 
CTLA4 is induced on T-cells, and after activation, CTLA4 functions in the 
termination of the immune responses and increases the threshold for T-cell activation 
contrary to CD28 (38). CTLA4-deficient mice have massive lymphoproliferative 
disorders, fatal multiorgan destruction and early death (39). 
ICOS, an inducible co-stimulator which is only expressed on activated T-cells, 
enhances effector T-cell proliferation and/or cytokine responses in a manner similar to 
CD28 (40) . Specifically, ICOS induces the production of IL10 (an anti-inflammatory 
cytokine) at a very high level, and also co-induces the secretion of IL-4, IL-5, IL-6, 
GM-CSF, TNF-α and IFN-γ (41). It is also observed to be enhanced on T-cells 
activated by CD28 (42). Recently, ICOS co-stimulation has been identified to be 
required for the generation of IL-17-producing effector T-cells that take part in the 
regulation of tissue inflammation. In addition, impaired IL-17 production has been 
observed in ICOS-deficient humans (43). The mechanism or cell type that reflects this 
impaired IL-17 production however has not been identified. Strikingly, in contrast to 
ICOS, PDCD1 (Programmed cell Death protein 1 or PD-1) acts as an inhibitor of T-
cell proliferation and reduces cytokine production and is constitutively expressed in 





develop autoimmune-like phenotypes (rheumatoid arthritis and systemic lupus 
erythematosus) which suggest that PDCD1 pathway may be involved in self-tolerance 
(46). It can thus be hypothesized that, genetic variants in these regulatory genes may 
confer a significant fraction of the genetic risk associated with inherited inflammatory 
disorders. 
 
5.2.1.3 Genetics of the co-stimulatory locus 2q33-37 and disease 
Figure 2: The human 2q33-37 loci adapted from Shinohara et al., 1994 
 
The immune co-stimulatory loci comprising of the CD28-CTLA4-ICOS-PDCD1 loci 
have previously been reported to be the region associated with genetic susceptibility 
to various diseases such as Graves‟s disease, Rheumatoid Arthritis (RA), Coeliac 
Disease (CD) and Insulin Dependent Diabetes Mellitus (IDDM) (47-52). Through 
genome-wide scans in multiple populations, this region has also been identified as an 
asthma susceptibility locus (53,54). Individual candidate gene based studies have also 
been performed on these genes in multiple populations (55-58). However, the results 
are mixed as to whether genetic polymorphisms on these genes are associated with 
asthma (59-61). Studies on the functional relevance of polymorphisms within these 
genes, individually or in tandem, should provide insights into the pathogenesis of 








5.2.2.1 Cell preparation  
Individuals with the risk Haplotype, ―Haplotype 2‖ as discussed in the Haplotypes 
association analysis and the protective Haplotype, ―Haplotype 1‖ were selected for 
the functional assay. A total of 60 volunteers from the cohort used for the genetic 
association were recalled for functional evaluation of the genotypes. The PBMC 
samples used for the functional assays were collected and frozen during volunteer 
recall based on Haplotypes. The PBMCs were frozen in appropriate liquid nitrogen 
based bio-banking facility until they were thawed the morning of the functional 
assays.   
5.2.2.2 Flow cytometry based staining of PBMC 
 
The cell preparation for the FACS staining has been separated into experiment 
designs based on the cell surface staining or intracellular staining. 
 
5.2.2.2.1 Protocol for cell surface staining of PBMCs 
 
Thawed cells were counted and resuspended at a density of 10 million cells/ml of 
FACS staining buffer. A total volume of 150 ul cells was added to each well of 96W 
V bottom plate leaving a gap of 1 well in between each well loaded with cells. These 
plates were then centrifuged at 1500 rpm / 5 min / 4 deg C. (Note: Care was taken to 
flick and aspirate the supernatant out carefully so as to avoid dislodging the cell 
pellet).  The cell pellet was then loosened by tapping or vortexing. Biotinylated 
antibodies diluted in FACS buffer were then added to a volume of 50 ul per well. This 
mixture was then pipetted multiple times and incubated at RT in dark for 45-60 min. 
150 ul of FACS buffer was then added to each well and centrifuged at 1500 rpm / 5 





each well and centrifuged at 1500 rpm / 5 min / 4 deg C. The cell pellet was loosened 
by tapping or vortexing and then 50ul of antibody cocktail was added to each well and 
mixed gently by pipetting up and down a few times. This was then incubated at RT in 
dark for 45 – 60 min. 150 ul of FACS buffer was then added to each well and 
centrifuged at 1500 rpm / 5 min / 4 deg C. 200 ul of FACS buffer was added to each 
well following aspiration and then centrifuged at 1500 rpm / 5 min / 4 deg C . 
Following aspiration of the supernatant, the cell pellet was loosened by tapping or 
vortexing. The cells were then resuspended in 200 ul of FACS buffer and transferred 
to 1 ml FACS tubes containing additional 200 ul of FACS buffer. The tubes were then 
mixed by vortexing and stored at 4 deg C for acquisition in LSR II 5 Laser flow 
cytometry. 
 
5.2.2.2.2 Protocol for intra-cellular staining of PBMCs 
 
Thawed cells were counted and resuspended at a density of 10 million cells/ml of 
FACS staining buffer. A total volume of 150 ul cells was added to each well of 96W 
V bottom plate leaving a gap of 1 well in between each well loaded with cells. These 
plates were then centrifuged at 1500 rpm / 5 min / 4 deg C. (Note: Care was taken to 
flick and aspirate the supernatant out carefully so as to avoid dislodging the cell 
pellet).  The cell pellet was then loosened by tapping or vortexing. Biotinylated 
antibodies diluted in FACS buffer were then added to a volume of 50 ul per well. This 
mixture was then pipetted multiple times and incubated at RT in dark for 45-60 min. 
150 ul of FACS buffer was then added to each well and centrifuged at 1500 rpm / 5 
min / 4 deg C. After aspirating the supernatant 200 ul of FACS buffer was added to 
each well and centrifuged at 1500 rpm / 5 min / 4 deg C. The cell pellet was loosened 
by tapping or vortexing and then  50ul of antibody cocktail was added to each well 





RT in dark for 45 – 60 min. 150 ul of FACS buffer was then added to each well and 
centrifuged at 1500 rpm / 5 min / 4 deg C. 200 ul of FACS buffer was added to each 
well following aspiration and then centrifuged at 1500 rpm / 5 min / 4 deg C . 
Following aspiration of the supernatant, the cell pellet was loosened by tapping or 
vortexing.  The cells were then resupended in 200 ul of FACS buffer and transferred 
to 1 ml FACS tubes containing additional 200 ul of FACS buffer. Following the 
wash, cells were then resuspended in 250 ul of  BD Fixation/Permeabilization Buffer. 
The mixture in the wells wer pipetted up and down a few times taking care to avoid 
bubbles. These plates were then incubated for 20 min in dark at 4 deg C. This was 
followed by centrifugation at 1600 rpm / 5 min / 4 degC. Care was taken not to 
dislodge the pellet as it is quite loose and can be easily dislodged. The supernatant is 
removed by aspiration and the cell pellet is loosened by tapping or vortexing. 250 ul 
of 1x BD Perm/Wash buffer was then added to each well and centrifuged at 1600 rpm 
/ 5 min / 4 deg C. The wash step was repeated as above and the cell pellet loosened. 
20 ul of intracellular antibody cocktail (diluted in 1x BD Perm/Wash buffer) was then 
added to each well and mixed by tapping or vortexing and the plates were incubated 
at 4 deg C overnight. The cells were washed again by adding 250 ul of 1x BD 
Perm/Wash buffer to each well and the plates were centrifuged at 1600 rpm / 5 min / 
4 deg C. The washing step was repeated as mentioned above using 1x BD Perm/Wash 
buffer and cells were resuspended in a volume of 200 ul of FACS buffer and 
transferred to 1 ml FACS tubes containing 200ul of FACS buffer. The data is then 
acquired in LSR II 5 Laser flowcytometer. 
 
5.2.2.2.3 Panels used for the flow cytometry analysis 





There were two T cell staining panels used. The first T cell Panel ‗T1‘ was used to 
mainly study CTLA4 through intracellular staining. The second T cell Panel ‗T2‘ 
evaluated the expression of ICOS molecule as expressed on the cell surface of the T 
cells.  
5.2.2.2.3.1 B cell Panel 
There were two B cell staining panels used. The first B cell Panel ‗B1‘ was used to 
mainly study intra-cellular staining of PBMCs for intracellular IgE expression. The 
second B cell Panel ‗B2‘ evaluated the immunoglobulin subsets IgG3, IgD and IgA in 
the B cells.  
 
5.2.2.3 Cell preparation for activation assay and analysis 
Individuals with the risk Haplotype, ―Haplotype 2‖ as discussed in the Haplotypes 
association analysis and the protective Haplotype, ―Haplotype 1‖ were selected for 
the activation assay. For antibody-mediated activation, T-cell subsets purified by 
negative selection from the PBMC of the selected individuals were incubated with   
0.1 μg/mL of anti-CD3 antibody in the presence of 0.2 μg/mL of anti-CD28 antibody 
for 48 h. The measurements were then performed to determine the expression of 
CTLA4 and ICOS in the CD4+ T cell subset and CD8+ T cell subset after the 
activation as analyzed by flow cytometry and statistical analysis was performed to 
determine significance. 
 





The concentrations of the cytokines were measured in the cell culture supernatants 
obtained after the activation experiment using the luminex multiplex assay platform. 
Luminex assays are based on xMAP® technology (multi-analyte profiling beads) 
enabling the detection and quantitation of multiple RNA or protein targets 
simultaneously. The xMAP system combines a flow cytometer, fluorescent-dyed 
microspheres (beads), lasers and digital signal processing to efficiently allow 
multiplexing of up to 100 unique assays within a single sample. Specific Th1 IFNG, 
IL10 and Th2 cytokines IL4, IL13 and TNF alpha were quantitatively measured after 
T cell activation to identify differences based on the risk and the protective 
Haplotypes in the cell culture supernatants.  
5.2.2.5 Serum IgE measurement 
Measurement of serum total IgE and specific IgE to Dermatophagoides pteronyssinus 
and Blomia tropicalis was performed using Immunocap based in vitro assays designed 
by Phadia Pvt. Ltd at the Allergy Lab, Singapore. 
 
5.2.2.6 Statistics 
Values in the text are the means ± SD. Data was compared using Student's t test for 
two-group comparison or ANOVA for multigroup comparison. Kruskal Wallis test 
was used when the distribution was not confirmed to be normal to account by a non-
parametric test. Differences were considered significant at P < 0.05. 
 
5.2.3 RESULTS 
5.2.3.1 SINGLE SNP ASSOCIATION  





The tagSNPs in the genes CTLA4 and ICOS were analyzed in a total of 2880 
unrelated Singapore Chinese for association to allergic asthma as described before in 
Section 4. This large sample size gave us statistical power to detect variants which 
confer very low disease risk as well. A total of 718 cases (doctor-diagnosed asthma 
with wheezing symptoms, and positive skin prick responses to common allergens) 
were identified, with the remaining of the population with no history of asthma. A 
total of 8 tagSNPs for CTLA4 gene and 8 tagSNPs for ICOS gene were genotyped. A 
number of tagSNPs on the CTLA4 gene were observed to be significantly associated 
with asthma – the strongest signal being on rs3087243 (referred to as CT60 G>A (or) 
+6230G>A polymorphism in the literature), P value for association of 8.3 X 10-6, 
with an Odds Ratio for asthma of 1.5 (Table 1). Notably, 3 SNPs – one each in the 
promoter region, first exon and 3‟ untranslated region, were found to be associated 
with asthma. The strongest SNP rs3087243 is present in the 3‟ untranslated region 
and hence probably involved in regulating the mRNA stability of the gene. Within the 
ICOS gene loci, a cluster of tagSNPs was found to be significantly associated with 
asthma – the most significant on rs4675374 (P value of 7.6 X 10-7, Odds Ratio 0.68, 
Table 2). Interestingly these SNPs were localized towards the 5‟ region of the gene 
and the first intron. This suggests that the functionality of the gene could probably be 
controlled by this regulatory region towards the start of the gene and specifically in 
controlling the levels of  gene expression which might be instrumental in determining 

















Table 2: Association between ICOS tagSNPs to allergic asthma phenotype 
 
 




(Minor Allele Count) 
Control 





rs1879877 614/902 367/655 5.427 0.0198* 1.215 
rs3769687 34/1416 28/970 0.5084 0.4758 0.8318 
rs10932017 512/1006 308/708 3.24 0.07185 1.17 
rs3116496 173/1347 94/924 2.988 0.0839 1.262 
rs12693993 214/1290 123/893 2.358 0.1247 1.204 







    Case  
(Minor Allele Count) 
   Control                
(Minor Allele Count)  
Chisq       P 
rs3087243 370/1052 272/1156 19.85 8.40E-06*  
rs733618 545/879 628/802 9.387 0.002185*  
rs231775 501/895 440/958 6.095 0.01356*  
rs16840252 150/1270 183/1249 3.395 0.065 
rs4553808 143/1287 172/1254 3.093 0.079 
CTLA4-
G4970A 
76/1352 87/1347 0.739 0.39 
SNP 
Case 





rs4675374 518/910 644/778 24.46 7.58E-07* 
rs10932034 379/1041 472/960 13.48 0.00024* 
rs4675377 354/1072 439/993 12 0.00053* 
rs4312468 134/1288 185/1249 8.816 0.00299* 
rs11883722 511/799 430/522 8.613 0.00334* 
rs4335928 158/1274 197/1231 5.083 0.02415* 
rs10172036 614/808 653/775 1.817 0.1777 
rs11571314 287/1133 312/1118 1.094 0.2955 






5.2.3.1. 2 Genetic Association of CD28 SNPs to asthma 
Previous reported as described above have highlighted the significance of CTLA4 to 
allergic asthma and more recently ICOS as well. However there is another gene CD28 
situated adjacent to CTLA4 contiguously downstream. There have been some earlier 
reports of this CD28 gene being relevant in allergic diseases (63). However there is no 
conclusive evidence of SNPs in CD28 to have a genetic predisposition for asthma and 
or other allergic phenotypes. Negative reports of CD28 not being association have 
made the role of CD28 SNPs in allergy debatable (64,65). For regulation of IgE as 
well SNPs in CTLA4 were found to be significant while no association was observed 
for CD28 (66). However in our Singapore Chinese we evaluated the relevance of 
CD28 SNPs to allergic asthma as the locus is reported to be very important for asthma 
predisposition through multiple studies. Thus we selected a total of 7 tagSNPs to 
represent the entire linkage disequilibrium block of the CD28 gene. We then used the 
sequenom mass-array based genotyping technique to assess the relevance of these 
SNPs.  
 After genotyping one SNP was detected to not be in HWE and hence was not 
taken forward for statistical analysis. The six other SNPs were assessed for 
association to allergic asthma as described previously for ICOS and CTLA4. From the 
association test only one SNP rs1879877 was observed to be significant at a moderate                        
P-value = 0.0198 with an odds ratio of 1.215 (Table 1). All other tagSNPs genotyped 









5.2.3.1.3 Genetic Association of PDCD1 SNPs to asthma 
The locus on chromosome containing the 3 genes as described above containing 
CD28, CTLA4 and ICOS is present in the 2q33 region. However there have been 
reports of the 2q37 region also being important for allergic phenotypes such as 
asthma. James et al had shown that SNPs in PDCD1 present in the chromosome 2q37 
region was significantly associated with specific immunoglobulin E response to grass 
allergens in sensitized individuals (67). Another report also shows PDCD1 SNPs as 
one of many regulatory genes which might be contributing to immunoglobulin E 
(IgE) production (68). Although association was found to rheumatoid arthritis and 
systemic lupus erythematosus they also suggested that PDCD1 could be a second 
immunomodulatory gene in addition to CTLA4 in inherited inflammatory disorders.  
Recent article highlights the functional significance of PDCD1 in the reversal of 
airway hyperresponsivemess and airway inflammation (69). Hence we proceeded to 
also evaluate the association of PDCD1 SNPs to allergic asthma by selecting 7 
tagSNPs representing the entire LD block of the gene. Genotyping was performed as 
mentioned above using Sequenom system and then quality control was performed. 
One SNP was not meeting the quality control requirement as it was not in HWE and 
hence was removed from further statistical analysis. From the other 6 tagSNPs 
analyzed a single SNP rs7421861 was associated at a marginal P-value = 0.02 with 
odds ratio of OR=0.7748. All other 5 tagSNPs genotyped were not associated with                
P-value >0.05.  
Taken together the 4 genes CD28, CTLA4, ICOS and PDCD1 give a complete 
representation of the 2q33-37 locus as indicated in Figure 2 adapted from Shinohara 
et al.,1994 and in turn the functional locus on chromosome 2q which might be crucial 



















rs7421861 202/1322 169/857 5.105 0.02* 0.7748 
rs28368764 719/797 481/529 0.009368 0.9229 0.9922 
rs4072221 558/942 393/609 1.042 0.3074 0.9179 
rs2227982 788/728 510/508 0.8621 0.3531 1.078 
rs11568821 6/1524 6/1018 0.4926 0.4828 0.668 
rs2227981 390/1130 259/761 0.02266 0.8803 1.014 
 
Table 5: Haplotype association using SNPs with P<0.05 from 2q region 
 
(a) 2- SNP model by sliding window method 
 
 
(b) 3-SNP model for sliding window method 
 
LOCUS HAPLOTYPE F_A F_U CHISQ P SNPS 
WIN1 AC 0.2602 0.1905 19.85 8.40E-06* rs3087243|rs4675374 
WIN1 GT 0.7398 0.8095 19.85 8.40E-06* rs3087243|rs4675374 
WIN2 CG 0.03835 0.03174 0.4952 0.4816 rs4675374|rs7421861 
WIN2 TG 0.09579 0.1215 2.748 0.09737 rs4675374|rs7421861 
WIN2 CA 0.2159 0.1586 8.201 0.00418* rs4675374|rs7421861 
WIN2 TA 0.65 0.6882 2.565 0.1093 rs4675374|rs7421861 
WIN3 GG 0.06151 0.06237 0.005074 0.9432 rs7421861|rs1879877 
WIN3 AG 0.3586 0.3098 4.147 0.0417* rs7421861|rs1879877 
WIN3 GT 0.07383 0.09135 1.625 0.2024 rs7421861|rs1879877 
WIN3 AT 0.5061 0.5365 1.45 0.2286 rs7421861|rs1879877 
LOCUS HAPLOTYPE F_A F_U CHISQ P SNPS 
WIN1 ACG 0.03943 0.03033 1.755 0.1852 rs3087243|rs4675374|rs7421861 
WIN1 GTG 0.09618 0.1145 2.536 0.1112 rs3087243|rs4675374|rs7421861 
WIN1 ACA 0.2208 0.1601 16.98 3.77E-05* rs3087243|rs4675374|rs7421861 
WIN1 GTA 0.6436 0.695 8.506 0.00353* rs3087243|rs4675374|rs7421861 
WIN2 CGG 0.03103 0.02479 0.5503 0.4582 rs4675374|rs7421861|rs1879877 
WIN2 TGG 0.0311 0.03666 0.3798 0.5377 rs4675374|rs7421861|rs1879877 
WIN2 CAG 0.1671 0.1223 6.182 0.012* rs4675374|rs7421861|rs1879877 
WIN2 TAG 0.1963 0.1898 0.1062 0.7445 rs4675374|rs7421861|rs1879877 
WIN2 TGT 0.0666 0.08491 1.941 0.1636 rs4675374|rs7421861|rs1879877 
WIN2 CAT 0.04983 0.03757 1.366 0.2424 rs4675374|rs7421861|rs1879877 





 (c) 4- SNP model for sliding window method 
LOCUS HAPLOTYPE F_A F_U CHISQ P SNPS 
WIN1 ACGG 0.03063 0.02495 0.4554 0.4998 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 GTGG 0.03063 0.0369 0.4821 0.4875 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 ACAG 0.1677 0.1216 6.456 0.011* 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 GCAG 0.1968 0.1892 0.1446 0.7037 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 GTGT 0.06597 0.08546 2.189 0.139 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 ACAT 0.04993 0.03751 1.39 0.2385 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1 GTAT 0.4584 0.5044 3.306 0.06901 
rs3087243|rs4675374|rs7421861|
rs1879877 
WIN1, WIN2, WIN3 refers to Haplotype blocks indicated as sliding windows as 
generated considering combination of significant SNPs.  
P refers to the P-value of association as determined by Haplotype test of association 
using PLINK software. 
* P <0.05. 
 
5.2.3.2 Haplotype analysis for association to asthma  
These four genes present on chromosome 2q could be considered to be a functional 
block containing associations significant in predisposing individuals to asthma. The 
previous analysis mentioned above have considered each of the genes as individual 
gene signals and thus used tagSNPs from each of the candidates to identify positive 
association. However these genes placed contiguously on chromosome 2q might be 
inherited as a functional Haplotype block and hence it is crucial to observe if there 
any Haplotype effects on the associated SNPs identified. For this purpose we selected 
the most significant SNP from each of the candidate genes: rs3087243from CTLA4 
(P=8.3 X 10-6, OR=1.5), rs4675374 from ICOS (P=7.6 X 10-7, OR= 0.68), 
rs1879877 from CD28 (P = 0.0198, OR=1.215) and rs7421861 from PDCD1                        
(P = 0.02, OR=0.7748). These SNPs were used to generate Haplotype blocks using 





We first used a 2-SNP window to generate functional Haplotype consisting of the 2 
most significant combinations of the 4 SNPs. The results of the Haplotype association 
using the 2-SNP models are summarized in Table 5a. The SNP combination 
consisting of rs3087243 from CTLA4 and rs4675374 from ICOS genes were 
observed to be the most significantly associated at P=8.40x10
-6
. This was not 
surprising as these were the two most significant associations in the single candidate 
association tests as well. The next significant pair consisted of rs4675374 from ICOS 
and rs7421861 from PDCD1 with P=0.004. The final significant pair consisted of 
rs1879877 from CD28 and rs7421861 from PDCD1 with a marginal P=0.041. 
Similarly we then used the 3-SNP model to evaluate if the combinations segregated 
the cases and controls in a more significant manner. Table 5b shows that the 3 SNP 
combination consisting of Haplotype ―AAA‖ from rs3087243, rs4675374 and 
rs7421861 were the most significant with P= 3.77x10
-5
. This Haplotype was more 
frequent in cases at 0.22, compared to 0.16 in the controls. Interestingly another 
Haplotype from the same SNPs combination ―GGA‖ which was more frequent 
(0.6436 in Cases and 0.695 in Controls) was also significant, P= 3.53x10
-3
. Finally we 
used all four SNPs to determine the association when considering the 4-SNP model. 
The results identified a particular Haplotype ―AAAG‖ to be more frequent in cases 
0.168 than in controls, 0.12.  
 In summary, from the various sliding windows for the Haplotype association 
test it can be inferred that the most important SNPs (Haplotype ―AA‖) which 
segregate the population are the SNPs rs3087243 from CTLA4 and rs4675374 from 
ICOS. However the Haplotype could be more informative with the addition of the 2 
other SNPs from PDCD1 and CD28. Thus the functional block consisting of the four 





from each of the four SNPs from rs3087243, rs4675374, rs7421861 and rs1879877. 
This information could be of importance while studying the effects of genetic 
predisposition in terms of phenotype assessment  and functional analysis.  
 
5.2.3.3 Ex-vivo analysis in a recall population 
5.2.3.3.1 Evaluating the effect of single SNPs 
Now that we had identified SNPs in the chromosome 2q region significant for genetic 
predisposition to the asthma phenotype we evaluated the effect of these SNPs on 
functional parameters. We selected individuals based on the genotypes for the SNP 
with the strongest association in CTLA4 (rs3087243) and ICOS (rs4675374). We had 
recalled successfully 50 individuals consisting of n=21 for genotype ―TT‖ for the 
SNP rs4675374 predicted to be causative from the genetic association study, n=18 for 
the heterozygous ―TC‖ and n=11 for the genotype ―CC‖ for the same SNP. The 
genotype distributions for the rs3087243 SNP was as follows: n= 14 for ―AA‖ 
genotype which was predicted to be causative from the genetic association, n=12 for 
the heterozygous ―AG‖ and n=24 for the ―GG‖ genotype.  
 We then evaluated the effect of the SNP genotypes on the expression of the 
respective genes: rs4675374 on ICOS and rs3087243 on CTLA. 
 
5.2.3.3.1.1Effect of rs4675374 on expression of ICOS in T helper 1 cells (Th1) 
The expression of ICOS on the T helper cell type 1 (Th1) has been shown in Figure 3. 
The values have been expressed as logarithmic values. Stratification of the samples 
based on the genotype for the rs4675374 SNP, it is observed that the genotype ―TT‖ 





―CC‖. A P-value of 0.036 was estimated to significantly differentiate the expression 
based on rs4675374 genotypes. 
 
5.2.3.3.1.2 Effect of rs4675374 on expression of ICOS on T helper 2 cells (Th2) 
Figure 4 summarizes the expression of ICOS on Th2 (T helper type 2) cells. The 
levels of ICOS were slightly higher in the Th2 cells than the Th1 cells. However 
similar to the Th1 cells, the expressions of ICOS in Th2 cells were considerably 
higher in the volunteers with the ―TT‖ genotype in comparison with the other 
individuals. The p-value for the stratification was not significant however (P= 0.34). 
Expression of ICOS in the Th1 and Th2 cells have been reported commonly, however 
the levels of ICOS in the Th17 cells has not been extensively reported and hence it 
was important to compare the expression in these cells in comparison to the well 
studied Th1 and Th2 cells. 
 
5.2.3.3.1.3 Effect of rs4675374 on expression of ICOS on T helper 17 cells (Th17) 
 The expression of ICOS interestingly in the Th17 cells was comparable to the Th1 
cells (Figure E1). The trend for the rs4675374 genotype stratification was maintained 
in these cells as well with the expression higher in the ―TT‖ individuals albeit not 
significant (P= 0.30). 
 
5.2.3.3.1.4 Effect of rs4675374 on ICOS expression in the T follicular helper                
cells (Tfh) 
The ICOS expression levels in the Tfh cells were again similar to the Th1 and Th17 
cells (Figure E2). The genotype ―TT‖ resulted in a slightly higher expression 















5.2.3.3.1.5 Effect of r3087243 on total T cells positive for CTLA4                                     
(Cells expressing CTLA4) 
The trends for expression of ICOS stratified by genotypes resulted in general in a 
higher expression in the protective genotype ―TT‖ in comparison to the individuals 
with the genotypes ―TC‖ or ―CC‖ for the SNP rs4675374 on the ICOS gene. Here we 
consider the effect of the SNP in CTLA4 rs3087243 on expression of CTLA4. We 
first evaluate the percentage of total T cells which express CTLA4 i.e., CTLA4 
positive T cells. Figure 5 summarizes the total T cell percentage of CTLA4 positive 
cells stratified by rs3087243. The risk genotype ―AA‖ resulted in a total of 4.5% of 
the total T cells expressing CTLA4. In comparison individuals with the ―AG‖ and 
―GG‖ genotypes had a lower percentage of CTLA4 of slightly less than 3%. This is 
close to a 30% drop in CTLA4 positive cells based on rs3087243 genotype. A one-




5.2.3.3.1.6 Effect of r3087243 on expression of CTLA4 on regulatory T cells 
(Treg) 
We have observed that the risk genotype (AA) of the CTLA4 gene results in a higher 
CTLA4 positive cell percentage in total T cells. We next wanted to evaluate the actual 
CTLA4 expression in a cell-specific manner in particular, the regulatory T cells. The 
expression has been summarized in Figure 6. On stratifications based on the genotype 
the trend observed is similar to the previous observation of increased CTLA4 positive 
percentage in the risk genotype. CTLA4 expression was higher in the individuals with 
―AA‖ genotype in comparison to the genotypes ―AG‖ and ―GG‖ with a significant 









                       
5.2.3.3.2 Functional evaluation of Haplotype blocks 
The Haplotype based association analysis in Section 5.2.2.2 revealed the most 
significant block as consisting two of the most significant SNPs from the single SNP 
analysis: rs4675374 from the ICOS gene and rs3087243 from the CTLA4 gene. We 
thus wanted to evaluate if these Haplotypes had a significant effect on the biological 
parameters measured for ICOS and CTLA. ―Haplotype 1‖ refers to the protective 
Haplotype while ―Haplotype 2‖ refers to the Haplotype with a higher risk of 
developing asthma as predicted by the association analysis.  
 
5.2.3.3.2.1 Haplotype specific expression of ICOS in Th1 and Th2 cells 
Haplotype specific stratification of ICOS expression in Th1 cells reveals a trend 
similar to that observed for rs4675374 (Figure 7). Haplotype 1 has a higher 
expression of ICOS in comparison to Haplotype 2, but the P value for stratification is 
not significant (P=0.30). Similarly in the Th2 cells, expression of ICOS (Figure 8) is 
higher in the Haplotype 1 (P=0.51).  
 
5.2.3.3.2.2 Haplotype specific expression of ICOS in  Th17 and Tfh cells 
On considering the Th17 cells, ICOS expression is quite similar in both Haplotypes 
which is shown by a P value of 0.97 (Figure E3). However, the expression on the Tfh 
cells reveals a slightly different picture (Figure E4). Here the Haplotype 2 has a 
higher expression when compared with Haplotype 1. The P value for significance 
however is not significant at P=0.81 and hence the power for this trend is very low 













5.2.3.3.2.3 Haplotype specific expression in total T cells positive for CTLA4                   
(Cells expressing CTLA4) 
Total number of CTLA4 positive T cells was significantly associated with the CTLA4 
SNP rs3087243. Here we wanted to investigate if the above mentioned Haplotypes 
are associated with the CTLA4 based functional parameters. Hence we stratified the 
total percentage of CTLA4 positive T cells by Haplotypes and found that the 
Haplotype 1 has a lower percentage of cells in comparison to Haplotype 2 (Figure 9). 
The one way ANOVA P-value was significant at P=0.01 suggesting that the 
Haplotypes still segregated the individuals who had a higher CTLA4 positive T cell 
percentage.  
 
5.2.3.3.2.4 Haplotype specific expression of CTLA4 on regulatory T cells (Treg) 
Now that the total T cell percentages were significantly different in the two 
Haplotypes, we evaluated the CTLA4 expression of Treg cells based on the same 
Haplotypes as well. The analysis depicted in Figure 10 summarizes that there was a 
significant difference in the expression of CTLA4 on Treg cells with a P = 0.02.  
Similar to the CTLA4 positive T cell percentage the CTLA4 expression was 
significantly lower in Haplotype 1 in comparison to Haplotype 2. Taken together our 
results suggest that Haplotype 2 might indeed be the risk Haplotype with reduced 
ICOS expression and increased CTLA4 expression. This is in agreement with 
published literature where CTLA4 levels have been shown to be elevated in the 












5.2.3.3.3 Effect of Haplotype on serum immunoglobulin E (IgE) levels    
Serum immunoglobulin E (IgE) is a key determinant of allergic phenotypes. A high 
serum IgE is indicative of allergy and is the strongest risk factor for allergic 
conditions such as allergic asthma,  Allergic rhinitis (AR) and atopic dermatitis (AD).  
Here we evaluated if the Haplotype which are demonstrated to be significantly 
segregating the population for risk towards developing disease, also stratifies 
significantly those high levels of IgE which a hallmark of atopic diseased individuals.  
 
5.2.3.3.3.1 Effect of Haplotype on total IgE 
Total IgE measured using the ImmunoCAP technique was stratified based on the 
Haplotypes as previously shown for other biological parameters. Figure 11 shows that 
the Haplotype 2 indeed had a higher mean total IgE than Haplotype 1, however the P 
value was not significant at 0.73. 
 
5.2.3.3.3.2 Effect of Haplotypes in specific IgE towards Blomia tropicalis 
Finally we tested if the levels of specific IgE towards the dust mite Blomia tropicalis 
was significantly different based on these Haplotypes (Figure 12). Similar to the total 
IgE and specific IgE to the other house dust mite, these results had exactly the same 
trend with Haplotype 2 having the higher mean specific IgE levels. 
5.2.3.3.3.3 Effect of Haplotypes on specific IgE for Dermatophagoides 
pteronyssinnus 
 We then performed the test for the specific IgE towards the dust mite 
Dermatophagoides pteronyssinnus stratified by the Haplotypes. Similar to the results 
for the total IgE, these results also showed Haplotype 2 having a higher specific IgE 





Figure 11: Total IgE levels based on Haplotype  
 
Figure 12: Specific IgE levels towards Blomia tropicalis 
 






Taken together the serum IgE measurements also add evidence to the hypothesis that Haplotype 
2 could be the risk Haplotype which predisposes individuals to a higher IgE levels and finally to 
the manifestation of allergic asthma.  
 
5.2.3.3.4 Effect of Haplotype on B cells 
The B cell subsets positive for each of the immunoglobulins IgE, IgG3, IgA and IgD are 
important in determining the allergic profile or the amount of IgE. First we measured the 
percentage of B cells which are positive for CD19 and also positive for IgE and negative for 
FCER1. The amount of these IgE secreting cells was significantly different in considering the 
risk Haplotype with the Haplotype 1 (Figure 14). Haplotype 2 had a higher percentage of IgE 
positive B cells of about 0.09 to 0.10 whereas the less risk group had a mean of slightly higher 
than 0.05. Similar results have been reported by other risk groups where allergic disease 
individuals had a higher percentage of IgE positive cells compared to non-allergic individuals. 
Next we evaluated the variability in the percentage of IgG3 positive B cells in our population. 
Interestingly, the risk Haplotype ‗Haplotype 2‘ again had higher percentage of close to 3% in 
contrast to ‗Haplotype 1‘ which was lesser than 2% (Figure 15). We also then evaluated the 
percentage of the other immunoglobulins IgA and IgD positive B cell populations based on the 
Haplotypes. However no significant trend was observed between Haplotype 1 and Haplotype 2 
(Figure 16, 17).  The percentage of IgA and IgD positive B cells are much higher in comparison 








Figure 14: Percentage of IgE positive B cells stratified by Haplotype 
 






Figure 16: Percentage of IgA positive B cells stratified by Haplotype 
 
 







5.2.3.3.5 Expression of ICOS and CTLA4 in T cell subsets after activation 
T cell activation was performed using anti-CD3 and anti-CD28, and after 48 hours of treatment, 
analysis was performed using flow cytometry. There were 2 main T cell subsets: CD4++ T cells 
and CD8+ T cells, we used to understand the expression of ICOS and CTLA4 after the 
activation. The expression of ICOS in the CD4+ T cell subset was significantly different between 
Haplotype 1 and 2 (Figure 18). The individuals having the risk Haplotype ―Haplotype 2‖ had a 
substantially lower ICOS level in the CD4+ T cells after activation compared to the Haplotype 1. 
These results are similar in trend to the ICOS expression levels observed under steady state with 
no stimulation performed.  We next evaluated the expression of ICOS in the CD8+ T cells after 
activation. ICOS expression was similarly higher in the CD8+ T cell subset of the Haplotype 1 
which had a lower risk towards developing allergic phenotypes such as allergic asthma (Figure 
19). When observing the expression of CTLA4 under activation stratified based on the 
Haplotype, there was no significant difference observed in either of the T cell subsets i.e., both 
the CD4+ and CD8+ T cells                (Figure 20).  
5.2.3.3.6 Cytokine levels in the supernatants obtained after activation 
We then wanted to examine the levels of important Th1 and Th2 cytokine molecules in the 
supernatant of the T cells subjected to activation. The cells activated for a period of 48 hours 
were then assessed using the luminex multiplex platform.  The levels were then stratified based 
on the risk and protective Haplotypes to identify any difference in values based on the genetic 
variation. Th1 cytokines such as IL-2, IL-10 and IFNG were higher in the Haplotype compared 





cytokines such as IL-4, IL-5, IL-13, and TNF- alpha, their levels were elevated in the samples 
containing the Haplotype which served as the Haplotype (Table 5).  
Table 5: Cytokine levels measured by luminex after activation stratified by Haplotype 
Cytokine P-value H-statistic Degree of freedom 
Luminex concentration IL-10 5.94E-01 0.284210526 1 
Luminex concentration IL-2 3.94E-01 0.727272727 1 
Luminex concentration IFN-g 5.70E-01 0.323232323 1 
Luminex concentration IL-4 6.57E-01 0.197368421 1 
Luminex concentration IL-5 8.31E-01 0.045454545 1 
Luminex concentration IL-13 1.65E-01 1.928571429 1 
Luminex concentration TNF-a 3.94E-01 0.727272727 1 
                                                          







Figure 19: Expression of ICOS in CD8+ T cells after activation 
 






5.2.4. Discussion  
The role of the co-stimulatory molecules CTLA4, ICOS, CD38 and PDCD1 have been 
extensively studied and researched for their relevance in allergic phenotypes such as asthma, AR 
and also other inflammatory diseases (70). Complex interactions among these molecules results 
in a wide variety of disease phenotypes. CD28 and ICOS serve as the positive co-stimulatory 
molecules which interact with the negative signals from CTLA4 and PDCD1. In addition genetic 
variants of these genes have also been associated with allergic asthma, allergic rhinitis and atopic 
dermatitis as described in the introduction. In our study we attempted the association of tagSNPs 
in these genes to allergic asthma.  
 
 
5.2.4.1 Single SNP analysis for genetic association  
Our results for the association study identified that all four genes have significant SNPs 
associated with allergic asthma. Considering the ICOS gene, a total of 5 significant tagSNPs 
were significant with the most significant SNP identified as rs4675374 (P value of 7.6 X 10-7, 
Odds Ratio 0.68). Similarly for the CTLA4 gene, a total of 3 significant tagSNPs were 
significant with the most significant SNP identified as rs3087243 (P value of 7.6 X 10-7, Odds 
Ratio 0.68).  This SNP has been previously identified in multiple studies and reported as CT60 
G>A (or) +6230G>A polymorphism in literature. In contrast, for the CD28 gene and PDCD1 
gene only 1 significant SNP was identified in each of the genes: rs1879877 from  CD28 gene (P-
value = 0.0198 with an odds ratio of 1.215) and SNP rs7421861 from PDCD1 gene was 
associated at a marginal (P-value = 0.02 with odds ratio of OR=0.7748). Thus the genetic signals 





compared to the CD28 and PDCD1 gene with marginal P values and also number of significant 
SNPs in each gene. We then performed the association analysis using the combination of the 
SNPs most significant in each of the four genes tested.  
 
5.2.4.2 Haplotypes based association analysis 
Association analysis based on the Haplotype was performed using the 2-SNP, 3-SNP and 4-SNP 
model. There were a total of four main SNPs chosen from each of the candidate genes with best 
association values from the single SNP model. The analysis was performed using the PLINK 
software using the sliding window approach. The association results for the Haplotype test as 
summarized in Table 4 revealed that the most significant SNP combination was the 2-SNP model 
consisting of the ICOS SNP rs4675374 and CTLA4 SNP rs3087243.    
Taken together the association analysis identified that the main association signals were from the 
CTLA4 and ICOS genes and hence we further wanted to characterize the above mentioned two 
SNPs in a cohort recalled with respect to its functional impact on their genes. For this purpose 
we selected a recall cohort of 60 individuals with genotype combinations based on the two SNPs 
which included both the high risk and the low risk groups. The Haplotype 1 as described in the 
results section referred to the Low risk or protective group which had an OR<1 i.e., higher 
frequency in the controls. In contrast Haplotype 2 refers to the high risk or causative Haplotype 
which was more frequent in the cases compared to the controls (OR>1).  
 
5.2.4.3 Ex-vivo functional analysis 
The recall population consisting of the 60 individuals was stratified based on the genotype first 





measured for ICOS expression as detected in Th1, Th2, Th17 and Tfh cells while CTLA4 
parameters evaluated where the proportion of the total CTLA4% positive T cell population and 
the expression of CTLA4 in the regulatory T cell (Treg) population. Among the various T cell 
subsets with expression of ICOS, only the Th1 cell ICOS expression stratified by rs4675374 was 
significant at P=0.036. A higher level was observed in the genotype ―CC‖ which was protective 
in the association test. A report by Marks et al., (71)  has shown that mice lacking ICOS couldn‘t 
have T cell mediated immunity against infection and hence our report that the Th1 cells have 
higher ICOS levels could suggest a possible protective role. Similar trends were also observed in 
the Th2, Th17 and the Tfh cells when stratified by the ICOS SNP. The rs4675374 SNP is in 
complete linkage equilibrium (LD r
2
=1) with the ICOS promoter SNP reported in the initial 
report by Shilling et al., -1413 SNP. Further studies however are needed to understand the 
Th1/Th2 balance which is important in determining allergic states.  
 The CTLA4 based parameters were stratified by using the rs3087243 SNP from the 
CTLA4 gene. The most significant measurement is the CTLA4 positive total T cell population. 
The risk genotype ―AA‖ had a higher percentage CTLA4 positive T cells. A higher percentage of 
CTLA4 positive T cells have been observed in atopic dermatitis patients (72). Hence our 
observation that a higher proportion has been observed in the ―AA‖ genotype individuals which 
is more common in the cases compared  to the controls suggest that the genotype could probably 
increase risk towards developing allergic asthma. Further when we observed the expression of 
CTLA4 in the regulatory T cells stratified by rs3087243 there was a significant difference. 
Similar to the total T cell CTLA4 positive percentage, the expression of CTLA4 in the Tregs was 
higher in the risk genotype ―AA‖ compared to the other genotypes. Such higher expression has 





been showed to be significantly associated moderate to severe asthma compared to both mild 
asthmatics and non allergic healthy individuals (73).         
SNP combination analysis had revealed interaction of genotypes from the two SNPs rs3087243 
(CTLA4) and rs4675374 (ICOS) showed the maximum separation of the case and control 
population. Hence we used these Haplotypes generated from the 2-SNPs to evaluate their effect 
on the biological measurements performed. ICOS expression among the T cell subsets Th1, Th2, 
Th17 and Tfh showed trends similar to the SNP genotype stratification with the risk Haplotype 
‗Haplotype 2‘ having a lower expression in all the subsets compared to the Haplotype 1, however 
the one-way ANOVA P-values were not significant. Considering the CTLA4 based 
measurements, the CTLA4 positive total T cell percentage was higher in the risk Haplotype 
‗Haplotype 2‘ and the same Haplotype also had a higher expression of CTLA4. The results from 
the functional ex vivo analysis has indeed identified that genetic variants do control phenotypes 
of certain cell sub types among the T cells and also have a slight impact on the immunoglobulin 
E (IgE) levels which indicate they are associated with disease. However the co-stimulatory 
molecules work in interaction with each other through complex pathways and hence parameters 
should be considered in parallel. It should be evaluated how the levels of ICOS impact the 
expression of CD28 and similarly CTLA4 on the CD28 molecule. This aspect would be the focus 












Our study has demonstrated that genetic variants in the chromosomal 2q region are indeed 
associated with allergic phenotypes allergic asthma and allergic rhinitis. Through functional ex 
vivo analysis we have identified parameters which vary depending on the genotype and 
Haplotype combinations considered. This approach of considering the genetics and biology in 
parallel is a powerful approach to understand the SNP causality to the gene in isolation and also 
to the biology of the entire pathway in the bigger picture. Further extensive characterization of 
these co-stimulatory molecules CTLA4 and ICOS considering the other molecules CD28 and 
PDCD1 would help understand the complex etiology behind allergic phenotypes which have 
been a mystery for many decades. Understanding these complex networks would provide points 
of intervention possibly which could open avenues for therapeutic purposes to treat and alleviate 
these disorders. 
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6. GENETIC VARIATION IN BDNF IS ASSOCIATED WITH ALLERGIC ASTHMA 
AND ALLERGIC RHINITIS IN AN ETHNIC CHINESE COHORT IN SINGAPORE 
 
6.1 Introduction 
Allergic diseases such as asthma, allergic rhinitis and atopic dermatitis affect more than 25% of 
the world population and are the leading cause of illness in children [1-3]. The complex interplay 
among genetic, environmental and immunological risk factors results in the manifestation of 
allergic diseases [4-7]. The pathophysiology of allergic diseases includes an intricate response 
triggered in the specific target tissues such as the airways, defined by a complex activation 
involving the innate and adaptive immune network [8-10]. This response activates the transport 
of inflammatory cells to the target tissues and also the production of specific IgE antibodies, 
cytokines and other inflammatory mediators [11, 12]. It has been well established that allergic 
inflammation triggers neuronal dysfunction which in turn results in specific inflammatory 
mechanisms and possibly structural changes in the diseased tissue [11, 13-15]. Neurotrophins are 
a family of structurally related proteins initially discovered to be involved with regulation of 
neuronal development and are primarily involved in peripheral and central nerve growth [16-18].  
Interestingly, the role of these proteins has not been restricted to neuronal cells [19]. Various 
reports have shown that non-neuronal cells such eosinophils, macrophages, mast cells, and T and 
B cells produce neurotrophins [12, 17]. These growth proteins have been confirmed as an 
integral part of the response of the immune cells during allergenic inflammation [20]. Serum 
levels of neurotrophins have been observed to be increased in allergic diseases such as allergic 





BDNF is a secretory protein belonging to the neurotrophin family and having a role in a range of 
neural processes during human development [20, 24]. In the early stages of development BDNF 
is essential for neurogenesis, survival and maturation of neuronal pathways. In the adult, along 
with neurotransmitters, hormones and other neurotrophins, BDNF maintains synaptic plasticity, 
dendritic growth and consolidation of long-term memory [25-27]. The biological effect of BDNF 
is mediated by its binding to the trkB receptor [28]. The trkB receptors and BDNF are also 
expressed by eosinophils and are functionally activated on stimulation with BDNF.  This might 
be an important pathway regulating the inflammatory cascade leading to allergic disease [15, 
29]. In patients with allergic asthma, segmental allergen provocation resulted in increased BDNF 
and other neurotrophins in the bronchoalveolar lavage fluid (BAL) [30].  Release of these 
neurotrophins on allergen challenge might link these changes to increased bronchial hyper 
responsiveness [31]. Production of BDNF was also up regulated in macrophages and T cells 
which infiltrate the asthmatic airways in an animal model for allergic inflammation [19]. Mouse 
models have also suggested a post inflammatory role for BDNF [32]. Christina et al., have also 
demonstrated a functional role for BDNF on eosinophils viability and activation [31]. This is 
significant because a high influx of activated eosinophils in the bronchial lumen is characteristic 
of the late phase reaction in asthma which also corresponds to the release of eosinophils products 
into the airways which in turn correlates with diseases severity such as bronchial hyper 
responsiveness [31, 33, 34]. Neurotrophin mediated activation of bronchial eosinophils might 
play a role in the regulation of eosinophilic inflammation in allergic asthma [31]. 
The BDNF gene was localized to chromosome 11p13 and consists of multiple 
alternatively spliced variants resulting in discrete transcripts [35]. Genetic polymorphisms in 





[37-39] [40] in different populations. A functional polymorphism rs6265 (Val66Met) has been 
shown to regulate intracellular trafficking and also affect the secretion of BDNF [41]. This 
polymorphism along with other genetic variants in BDNF has been associated with asthma in 
German children [37] . In contrast, other studies have suggested that though BDNF is a 
significant biomarker for allergic phenotypes, genetic variations in BDNF are not associated with 
allergic diseases [36, 39]. Thus the association of genetic polymorphisms in BDNF gene to 
allergic diseases remains controversial. We therefore conducted a population genetic study to 
evaluate the association of polymorphisms in the BDNF gene to allergic rhinitis and allergic 
asthma in an ethnic Chinese cohort in Singapore. 
6.2 Materials and methods 
6.2.1 Ethics Statement 
This study has been performed with the approval of the Institutional Review Board                         
(IRB, Reference - NUS07-023) of National University of Singapore and is also in compliance 
with the Helsinki declaration. DNA samples used in this study were collected from ethnic 
Chinese participants following standard protocols of informed consent. 
6.2.2 Subjects 
The DNA samples used in this study were collected from ethnic Chinese participants following 
standard protocols of informed consent, as part of an on-going whole-genome asthma and 
allergic disease case-control association study in Singapore [42]. Experimental research that is 
reported in the manuscript has been performed with the approval of NUS Institutional Review 
Board (IRB) Reference - NUS07-023 and is also in compliance with the Helsinki declaration. 





solution following a standardized protocol [43]. Samples were quantified in triplicate on the 
Nanodrop (ND-1000). Phenotypic characteristics of the cohort have been described in Table 1.  
Recruited subjects were classified as asthma cases, AR cases and healthy controls according to 
their disease condition as determined by a questionnaire designed based on ARIA and ISAAC-
derived questionnaires [2, 44] and a skin prick test (SPT) using a panel consisting of common 
allergens in Singapore such as Dermatophagoides pteronyssinus, Blomia tropicalis, Elaeis 
guineensis and Curvularia lunata. SPT response is considered positive when the wheal diameter 
is 3 mm or greater. SPT tests used positive (histamine) and negative (saline) controls. AR is then 
diagnosed based on the presence of a positive SPT response to either Dermatophagoides 
pteronyssinus, Blomia tropicalis and typical AR symptoms as defined by the ARIA 2008 
guidelines [2, 44] i.e., two or more AR symptoms (nasal congestion, rhinorrhea, nasal itching, 
sneezing) persisting for four or more days a week during the past year. Asthma subjects were 
identified based on self reported doctor-diagnosed asthma with wheezing symptoms based on 
questionnaire and positive skin prick reaction to either of the dust mite allergens. Conversely, 
control subjects are confirmed with no positive skin prick reaction to any of the allergens tested 
and no history of allergy.  
6.2.3 Selection of tagSNPs  
The genotype for Hapmap Han Chinese from Beijing (CHB) was used to determine tagSNPs for 
the BDNF gene. The CHB population consists of 45 unrelated individuals from Beijing, China 
genotyped in the Hapmap project to develop the common haplotypes that exist in the Chinese 






Table 1: Demographic and clinical characteristics of the samples used in the study 
 
# 
Asthma case was classified based on doctor diagnosis of the disease with a positive skin prick 
test reaction to one of the allergens tested. (Based on WHO and GINA guidelines for asthma) 
$
Allergic Rhinitis (AR) was classified based on 2 or more major symptoms which include (nasal 
congestion, rhinorrhea, nasal itching, sneezing) and a positive skin prick test reaction to one of 
the allergens tested. (Based on 2008 guidelines set by Allergic Rhinitis Impact on Asthma (ARIA) 
consortium) 
^ 
Healthy controls are individuals classified based on no symptoms and history of allergic disease 









Subjects, n 795 718 717 
Mean age, years 20.24 21.06 22 
Gender, %Female
 51.6 47.5 72.6 
Skin Prick Test positive reaction 
(Allergen tested) 
   
Dermatophagoides pteronyssinus 92% 90.2% N.A 
Blomia tropicalis 85% 81.5% N.A 
Elaeis guineensis 6.4% 7.2% N.A 
Curvularia lunata 3.3% 2.8% N.A 
Smoking Status    
Current 0.9% 1.5% N.A 
Ex-smoker 0.4% 0.2% N.A 





and depth of genome-wide chips which have been used for genome-wide association studies for 
the Chinese population. Our group has also published a manuscript describing the use of the 
Hapmap CHB population as a reference population for our Singapore Chinese cohort [41].   All 
genetic variants described in Hapmap [45] for the CHB population was retrieved and tagging 
were performed using Gabriel et al., algorithm [46]. There were a total of 21 polymorphisms 
reported for the CHB and tagging revealed that 4 tagSNPs could represent the entire SNPs an LD 
threshold of r
2
 = 0.8. Thus these 4 tagSNPs were genotyped for association testing. The LD 
block for the BDNF gene has been described in Supplementary Figure 1. 
6.2.4 Genotyping 
Genotyping was performed on purified DNA samples using the Illumina BeadXpress Assay 
(Illumina Inc., San Diego, CA, USA) at the University of Utah Genomics Core Facility                   
(Salt Lake City, UT, USA) according to manufacturer recommendations. 
6.2.5 Statistical Analysis 
This study was well powered to detect associations consistent with complex genetic traits with 
1176 (combined) allergic rhinitis and allergic asthma subjects and 717 non allergic control 
subjects. With this large sample size, we had >80% power to detect an odds ratio of 1.3–1.5 
under the dominant model of association within a range of minor allele frequencies (0. 05–0.3). 
Linkage Disequilibrium (LD) blocks were generated with the SNPs identified through 
resequencing using the Haploview software version 4.2. Genotypes of the tagSNPs were then 
tested for Hardy-Weinberg equilibrium (HWE) in control subjects by χ2 test. The primary test of 
allelic association was performed using the Cochran Armitage trend test which evaluates the 





genotypic association.  If the results showed significant p-values then we performed the analysis 
using a dominant model as it was well powered to detect the association. All p-values, odds ratio 
with 95% confidence intervals were estimated using the PLINK program version 1.06. Linkage 
disequilibrium was calculated as defined by Gabriel et al., [47] with the program Haploview 
[48]. Two-SNP haplotype analysis was completed using the PLINK program version 1.06. A P 
value less than 0.05 was considered significant for all tests. 
6.3. Results  
6.3.1 Association of BDNF SNPs to Allergic Rhinitis 
All SNPs considered in the analysis were in Hardy Weinberg Equilibrium (HWE). A total of 795 
AR cases and 717 non allergic healthy controls were genotyped for the 4 tagSNPs of BDNF.  
SNPs were then subjected to clustering analysis to evaluate if there were any bad clusters using 
the Genome Studio software (Illumina). Samples which fell out of the cluster were removed to 
ensure the genotypes were then called with precision. This resulted in an overall genotyping 
efficiency was 96.28 %.The allele based association analysis using the Cochran Armitage Trend 
(CAT) test identified a strong association of the SNP rs10767664 to AR at a PAllele = 0.00097 
(Table 2) and OR = 1.3 (95% CI: 1.114 - 1.527). The other 3 tagSNPs showed no association. 
We then performed a genotype based association analysis using the Chi-square test. A significant 
association was observed using the dominant model with PDominant = 0.0007 (Table 4 (a)). These 








Table 2: Allele based association test for Allergic Rhinitis (AR) phenotype            
 




Ptrend is calculated by the Cochran Armitage trend test using the PLINK v 1.06 software. 
*  Ptrend < 0.05 for the association test for AR.  
OR – Odds ratio; CI – Confidence Interval. 




















rs11030101 27637320 T 0.248 0.262 A 0.4281 0.934 0.789 1.106 
rs12273539 27639887 T 0.15 0.163 C 0.3358 0.905 0.739 1.109 
rs10767664 27682562 A 0.484 0.420 T 0.0018* 1.30 1.101 1.526 


















rs11030101 27637320 T 0.248 0.262 A 0.4108 0.9334 0.792 1.1 
rs12273539 27639887 T 0.164 0.163 C 0.9779 1.003 0.826 1.217 
rs10767664 27682562 A 0.485 0.420 T 0.00097* 1.304 1.114 1.527 





6.3.2 Association of BDNF SNPs to asthma phenotype 
A total of 718 asthma cases and 717 non allergic healthy controls were genotyped for the                     
4 tagSNPs of BDNF. The CAT test identified a strong association of the SNP rs10767664 to 
asthma at a PAllele = 0.0018 (Table 3) and OR = 1.3 (95% CI: 1.101 - 1.526) at the allele level. 
The other 3 tagSNPs similar to the analysis for AR showed no association. Genotype based 
association analysis for asthma using the dominant model identified a PDominant = 0.0005 for 
rs10767664 (Table 4 (b)). These results are significant because even after applying Bonferroni 
correction the P value still remains significant PBonferroni = 0.0072 for the allele and                    
PBonferroni = 0.002 for the genotype based association respectively. 
6.3.3 Haplotype based association analysis 
The LD measures for our population have been summarized in Supplementary Figure 1. We then 
performed two-locus based haplotype association analysis using the sliding window algorithm as 
implemented in the PLINK software. Haplotype analysis results using two SNP sliding windows 
are displayed in Table 5 for association AR and Table 6 for asthma. Analysis identified 
significant associations between SNP haplotypes within the BDNF gene with both AR and 
asthma phenotypes. Two specific haplotypes H2 (rs12273539 and rs10767664) and H3 
(rs10767664 and rs962369) are significantly different in cases compared to controls for both AR 
and asthma phenotypes. However, the SNP driving the associations with these haplotypes was 
the same SNP identified in the single SNP analysis, and the magnitude of the haplotype 





Table 4: Genotype based association test  
 (a) Allergic Rhinitis (AR) phenotype 
 
 (B) Asthma phenotype 
*  P value calculated using χ2 test of association for all the three genotypes. 
 
#  





Major   
Allele Model Genotype      Case (%)   Control (%)   χ2     P 
         
rs10767664     A    T Full genotype AA  162 (22.81)       103 (18.43) 
   12.17 0.0023* 
        TA     365 (51.41)  263 (47.05) 
        TT   183 (25.78)       193 (34.52) 
                  
      Dominant AA+TA   527 (74.22) 366 (65.47) 
   11.49 
  0.0007
# 




Major   
Allele Model Genotype      Case (%)   Control (%)   χ2     P 
         
rs10767664     A    T Full genotype AA  135 (21.95)       103 (18.43) 
   12.17 0.0021* 
        TA     325 (52.84)  263 (47.05) 
        TT   155 (25.21)       193 (34.52) 
                  
      Dominant AA+TA   460 (74.80) 366 (65.47) 
   11.49 
 0.0005
# 












Table 5:  Association of haplotypes in the BDNF gene to AR 
 
















H1 (rs11030101 and rs12273539) 
AA 0.163 0.163 0.163 0.00 0.988 
CC     0.255 0.248 0.262 0.84 0.360 
AC 0.582 0.589 0.574 0.68 0.410 
H2 (rs12273539 and rs10767664) 
CC 0.450 0.481 0.420 9.30 0.002* 
AA 0.170 0.164 0.175 0.58 0.446 
CA 0.380 0.355 0.405 6.47 0.011* 
H3 (rs10767664 and rs962369) 
AC 0.045 0.040 0.051 1.92 0.166 
CA 0.453 0.486 0.420 10.82 0.001* 
AA 0.502 0.475 0.529 7.31 0.007* 
H1 (rs11030101 and rs12273539) 
AA 0.15635 0.1496 0.1631 0.9745 0.323 
CC 0.25545 0.2482 0.2627 0.7793 0.377 
AC 0.58815 0.6021 0.5742 2.283 0.130 
H2 (rs12273539 and rs10767664) 
CC 0.4511 0.4825 0.4197 9.193 0.002* 
AA 0.1654 0.1554 0.1754 1.684 0.194 
CA 0.3835 0.3621 0.4049 4.471 0.034* 
H3 (rs10767664 and rs962369) 
AC 0.04719 0.0433 0.05108 0.7876 0.374 
CA 0.4524 0.4845 0.4203 9.715 0.002* 
AA 0.50045 0.4722 0.5287 7.441 0.006* 
Haplotypes are constructed using the sliding window method and haplotype frequencies estimated 






Our study has identified significant association of a BDNF SNP to AR. To the best of our 
knowledge this is the first evidence of genetic association of BDNF to AR. Similar 
association has also been observed for allergic asthma in our population suggesting an 
important role of BDNF variations in asthma susceptibility. The same tagSNP rs10767664 
had a significant PDominant = 0.0007 and OR = 1.3 for AR and PDominant = 0.0005 and OR = 1.3 
for allergic asthma. Further the association of single SNP analysis was confirmed by 
significant association of two-SNP haplotypes to both AR and asthma. Hence these results 
confirm that BDNF gene variants do contribute to disease predisposition and progression in 
allergic diseases. The SNP identified to be associated rs10767664 is one of the tagSNPs used 
in the study and hence we need to take a look at the other SNPs linked to rs10767664 to 
understand which of them might be causal.  The SNP rs6265 is in very significant LD of r
2 
= 
0.95 with the associated SNP (Supplementary Figure 1). The polymorphism rs6265 
commonly referred to as the ―Val66Met‖ is a missense mutation which alters the amino acid 
at position 66 in the protein from valine to methionine and is in a recombination hotspot 
(recombination rate of 0.8). The recombination rate was estimated using the NextBio web-
based analysis portal using the Hapmap CHB population as the reference. Petryshen et al., 
have recently reported that the region containing this functional variant might be different in 
various populations and hence estimated recombination rates with correction using the 
Hapmap population data [49]. This functional polymorphism affects intracellular trafficking 
and regulates the secretion of BDNF based on activity although it doesn‘t affect severity in 
neurodegenerative diseases [41, 50]. The SNP rs10767664 has been previously reported to be 
significant for association to serotonin reporter availability [51]. Notably, the authors have 
suggested that the association could be observed due to the strong linkage between 





haplotype block containing both these SNPs. In an animal model for anxiety and stress 
related disorders, a transgenic mouse engineered to code for methionine resulted in defective 
secretion of BDNF from neurons [52]. Deficits in BDNF release from neurons were observed 
but the expression remained unaltered. Non-neuronal cells such as eosinophils, macrophages 
and mast cells constitutively express BDNF which suggests a possible bidirectional link 
between the neurosensory system and their influence on activation and/or initiation of the 
immune response and that neurotrophins such as BDNF could play a critical role in the 
coordinating this interaction [15, 21]. Further evidence linking the role of neurotrophins to 
inflammation and in particular allergic diseases is the increasing literature published 
associating increased levels of BDNF, NGF and other neurotrophins such a NT-3 in allergic 
patients [11, 53]. In a study on allergic rhinitis, the increased nasal expression of BDNF 
positively correlated with the AR score in patients, while there was no difference in 
expression for controls [54].  
Hence a common, single point mutation identified through a genetic association study 
has been shown to produce a phenotype in transgenic mice similar to that seen in the humans. 
There are other intronic SNPs linked to the associated SNP, and the effect of these SNPs 
cannot be neglected as well. Hence further functional studies involving in vitro studies 
analyzing the effect of polymorphisms on BDNF expression and thereby elucidate its role 
and significance in allergic diseases and/or its severity. Thus BDNF could serve as a potential 
biomarker for allergic phenotypes such as asthma and allergic rhinitis and also could provide 









Several studies have suggested that BDNF has great therapeutic potential to treat a wide 
variety of neurodegenerative diseases [55, 56]. A recent paper by Xu et al., has demonstrated 
that combined effects of genetic variants in BDNF do influence the response to therapy with 
risperidone in a Chinese Han population [57]. In allergic diseases such as asthma, allergic 
rhinitis and atopic dermatitis altered expression of BDNF has been positively correlated to 
the increased symptomology or severity of the disease [54, 58] [59]. In our study we 
identified a tagSNP rs10767664 which is strong linkage with another functional variant 
rs6265 (Val66Met) which has been shown to alter the expression of BDNF. Taken together 
these results and current literature suggests that the study of genetic variants in BDNF and 
other neurotrophins warrants further research to elucidate its role in airway pathophysiology 
and thereby providing new therapeutic options in the future. 
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7. Variation in Uteroglobin-Related Protein 1 (UGRP1) gene is associated with Allergic 
Rhinitis in Singapore Chinese 
 
7.1 Background  
Allergic diseases such as asthma, allergic rhinitis and atopic dermatitis are global health 
problems affecting 10-25% of the world‘s population. Allergic rhinitis (AR) is an IgE-
mediated inflammatory disease of the nasal mucosa which is caused by exposure to allergens. 
AR is characterized by hyper-responsiveness, high levels of Th2 cells [1] and manifestation 
of symptoms such as rhinorrhea, sneezing, nasal congestion and rhino-conjunctivitis. AR 
affects approximately 500 million people worldwide [2, 3]. In Singapore, the prevalence of 
AR was reported to be 13.1% [4]. AR is not a life threatening disease; however its impact on 
the quality of life and productivity is significant [3, 5]. In addition, AR is known to be 
associated with other conditions such as asthma, sinusitis, anosmia, otitis media, nasal 
polyps, lower airway infections and dental malocclusion [2, 6-8]. 
Many reports support a genetic basis for atopy and allergy [9, 10]. The underlying 
pathogenic mechanism of allergic diseases is not fully elucidated and may be the result of 
complex interactions between genetic and environmental factors [2, 6]. Studies looking at 
twins have provided convincing evidence for a genetic influence, as observed by the greater 
concordance of allergic manifestations in monozygotic compared to dizygotic twins [11-14]. 
Non-genetic factors such as an increase in exposure to irritants and allergens, changes in 
lifestyle, nutrition, pollution and stress, may also influence the onset and development of 
atopic diseases [7, 15-17]. Individuals with a strong family history of allergic disease are 
more likely to develop allergic symptoms, irrespective of the varying environmental risk 





The gene coding for secretoglobulin (SCGB3A2), also known as UGRP1, is located 
within chromosome 5q31-33. This region of the human chromosome 5 also contains many 
other candidate genes for allergic diseases such as interleukins - IL-3, IL-4, IL-5, IL-9, IL-13; 
macrophage colony stimulating factor (CSF) and β2-adrenergic receptor (ADRB2) [19]. 
Genetic variations in UGRP1 have been associated with autoimmune diseases such as 
Hashimoto thyroiditis (HT) and Graves‘ disease (GD) [20], and allergic diseases such as 
asthma [21]. A promoter polymorphism in the gene (G-112A) was found to increase the risk 
of asthma in a Japanese population [19]. However, the association was not replicated in 
studies involving Indians [22] and German Caucasians [23]. There has not been any 
association study evaluating the role of these polymorphisms in AR to date. In Singapore a 
family based linkage study had previously identified the 5q31-33 region to be significantly 
linked to atopy and asthma in the local ethnic Chinese population [24]. As part of a larger 
study to fine-map candidate genes for atopy and asthma in this chromosome region, 
resequencing of the UGRP1 gene was performed, with the aim of identifying novel 




7.2.1 Ethics Statement 
This study has been performed with the approval of the Institutional Review Board (IRB, 
Reference - NUS07-023 and NUS10-343) of the National University of Singapore and is in 








7.2.2 Study Population 
Ethnic Chinese subjects were recruited at the National University of Singapore, KK 
Women‘s and Children Hospital and the National University Hospital as a part of an on-
going epidemiological collection for the study of allergic diseases and through multiple 
recruitment drives in Singapore (Table 1). Those not born in Singapore and did not reside 
locally in the past 10 years were excluded. Volunteers were then classified as individuals 
with AR, asthma and healthy controls according to their status as determined by an 
interviewer-administered questionnaire based on the Allergic Rhinitis Impact on Asthma 
(ARIA) and International Study of Asthma and Allergies in Childhood (ISAAC) guidelines 
[2, 6], and a doctor‘s diagnosis. The validity and use of ARIA- and ISAAC-based 
questionnaires has been discussed by others groups [25, 26] and ours as well [27]. In 
addition, all volunteers were subjected to a skin prick test (SPT) using a panel consisting of 
common allergens in Singapore such as Dermatophagoides pteronyssinus (house dust mite), 
Blomia tropicalis (dust mite), Elaeis guineensis (pollen) and Curvularia lunata (fungi). A 
SPT response is considered positive when the wheal diameter is 3 mm or greater, when 
compared to positive (histamine) and negative (saline) controls. The selection of these 
allergens was based on previous studies in the region which clearly demonstrated that 
sensitization of the major indoor allergen – the house dust mite (HDM), was considered an 
important risk factor for the development of asthma and allergic diseases, especially in South 
East Asian populations, such as those from Singapore, Malaysia and Thailand [28-30].  Based 
on our previous epidemiological studies [31, 32], the majority of AR and atopic asthma 
individuals would be sensitized to one or both of the major dust mites evaluated 
(Dermatophagoides pteronyssinus, and/or Blomia tropicalis) and up to 30% would be poly-
sensitized (to dust mites and pollen and/or fungal allergens). Atopy was defined as a positive 





Table 1: Demographic and clinical characteristics of the samples used in the study 
 
# 
an asthma case was classified based on doctor diagnosis of the disease with a positive skin 
prick test reaction to one of the allergens tested (based on WHO and GINA guidelines for 
asthma). 
$ 
Allergic Rhinitis (AR) was classified based on 2 or more major symptoms which include 
(nasal congestion, rhinorrhea, nasal itching, sneezing) and a positive skin prick test reaction 
to one of the allergens tested (based on 2008 guidelines set by Allergic Rhinitis Impact on 
Asthma (ARIA) consortium). 
^ 
Healthy controls are individuals classified based on no symptoms or history of allergic 
disease and are non- atopic (Negative skin prick test reaction to ALL of the allergens). 















Subjects  718 795 717 
Age, mean  20.24 21.06 22 
Gender    
Male 377 (52.5%) 385 (48.4%) 196 (27.3%) 





allergens. AR was diagnosed based on the presence of the atopic status and typical AR 
symptoms as defined by the ARIA 2008 guidelines [2, 6], i.e., two or more AR symptoms 
(nasal congestion, rhinorrhea, nasal itching, sneezing) persisting for four or more days a week 
during the past year. Asthma was classified based on a positive doctor-diagnosed asthma with 
wheezing symptoms and positive skin prick responses to common allergens. A subset of the 
asthmatic individuals would have complete ACT (Asthma Control Test) scores, lung function 
and peak flow reversibility data. (This is however currently on-going, and thus not reported in 
this study). Conversely, healthy control individuals were defined as those with no atopy (i.e., 
skin prick negative) and with no history of allergic conditions, diagnosis, or symptoms. 
 
7.2.3 Resequencing 
Genomic DNA was extracted from buccal cells obtained from 15ml of mouthwash in 0.9% 
saline solution as previously described [33]. DNA was then quantified using Nanodrop and 
by flourimetric analysis using Pico-Green (Molecular Probes, Invitrogen, OR, USA). DNA 
from a subset of 40 randomly selected individuals was used for sequencing and the 
identification of genetic polymorphisms [34]. The 3 exons and exon-intron boundaries of 
UGRP1 were sequenced (Additional File 1). Information on primer sequences and the 
regions covered by resequencing have been described below in Additional File 2. 
 
7.2.4 Genotyping 
Genotyping was performed on the Illumina BeadXpress platform (Illumina Inc., San Diego, 
CA, USA) at the University of Utah Genomics Core Facility (Salt Lake City, UT, USA) 







7.2.5 Statistical Analysis 
Linkage Disequilibrium (LD) blocks were generated with the SNPs identified using 
Haploview v4.2 [26]. Hardy-Weinberg equilibrium (HWE) was assessed in the control 
population as a quality control measure. Tests for association were performed at the allelic, 
genotypic and haplotypic levels and odds ratio with 95% confidence intervals were estimated 
by PLINK v1.06. A P-value less than 0.05 were considered statistically significant (with 
Bonferroni corrections for multiple testing where necessary). 
 
7.2.6 In silico analysis using bioinformatics tools 
In silico analysis was performed using bioinformatics tools such as TRANSFAC, 
(http://www.gene-regulation.com/cgi-bin/pub/databases/transfac/search.cgi) and TFSEARCH 
(http://www.cbrc.jp/research/db/TFSEARCH.html) to predict potential transcription factor 
binding site (TFBS) and possible effects of the polymorphisms on the binding of transcription 
factors. The results were cross compared using another transcription factor prediction server, 




Of the 27 polymorphisms identified through resequencing of the UGRP1 gene [23 SNPs and 
4 INDELs (INsertion/DELetion)], 11 were novel (Additional File 3). Of the 16 
polymorphisms previously reported in NCBI, only 4 SNPs were present in the HapMap 
database for the Han Chinese (CHB) population. LD blocks were constructed using r
2 
values 
estimated for all SNPs identified through the resequencing of the UGRP1 gene (Figure 1). 
Tagging was performed using an LD threshold of r
2 
=0.8 resulting in a total of 11 tagSNPs 





Figure 1: LD block of the Singapore Chinese population for the UGRP1 gene 
Linkage disequilibrium block generated using SNPs identified in the UGRP1 gene. Figure generated using Haploview 4.1 and the values 





7.3.2 Single SNP marker association analysis 
A total of 10 out of the 11 tag SNPs in UGRP1, targeted for genotyping, passed the 
BeadXpress assay design quality control and were successfully genotyped in 1893 samples 
(with a genotyping success rate of 99.6%). Allele based association analyzed using the 
Cochran Armitage trend test for the AR phenotype revealed that rs7726552 is significantly 
associated (Ptrend=0.032, OR=0.81) (Table 2). Association at the genotype level appeared 
stronger with Pgenotype=0.00085 and OR=0.79 (PBonferroni=0.0085) (Table 3). No significant 
association was detected for the asthma phenotype (Additional File 5). 
 
7.3.4 Haplotype based association analysis 
Haplotypes within UGRP1 were tested for significant associations with the atopic conditions 
using PLINK. The haplotype H2 (ATGGTGC), covering a region of 4.13 kb, encompassing 
the promoter and the first intron, and consisted of the SNPs rs7726552, rs7727031, UGRP1-
G-1351A, rs6882292, rs17107353, rs17703574 and UGRP1-C1360A, was found to be the 
most common with a frequency of 69.6% in controls and 65.5% in cases (P=0.017)              
(Table 4). These results are consistent with the single SNP association of rs7726552 with 
AR, and where the allele frequencies were 14% in cases and 17% in controls (P=0.039). 
 
7.3.5 In silico prediction of putative function 
TRANSFAC was used to predict possible TFBS which might be affected due to the SNP. The 
in silico prediction tool revealed that the region containing SNP rs7726552 has potential 
consensus binding sites for transcription factors Oct-1, NF-1 and GATA-1. The A to T 
polymorphism was predicted to result in a new binding site for GATA-1, the loss of binding 
site for Oct-1 and no change in transcription factor binding for NF-1. Similar results were 






Table 2: Allele based association test for Allergic Rhinitis (AR) phenotype 
 
Ptrend is calculated by the Cochran Armitage trend test using the PLINK v 1.06 software. 
*  Ptrend < 0.05 for the association test for AR. 




















rs7726552 147235795 T 0.14 0.17 A 0.039* 0.81 0.66 0.98 
rs7727031 147236113 C 0.06 0.06 T 0.544 0.91 0.67 1.23 
UGRP1-G-1351A 147237116 A 0.07 0.07 G 0.641 1.07 0.81 1.41 
rs6882292 147237749 A 0.06 0.06 G 0.739 0.95 0.70 1.28 
rs17107353 147239022 A 0.11 0.12 T 0.154 0.85 0.67 1.06 
rs17703574 147239339 T 0.05 0.06 G 0.141 0.79 0.56 1.08 
UGRP1-C1360A 147239920 A 0.07 0.07 C 0.81 1.04 0.78 1.36 
UGRP1-A1846G 147240405 G 0.06 0.06 A 0.687 0.94 0.69 1.27 
rs3910207 147241677 T 0.11 0.13 C 0.202 0.87 0.69 1.08 


















* P value calculated using χ2 test of association for all the three genotypes. 
# P value calculated using χ2 test of association for a dominant model. 
 




Major   
Allele Model Genotype      Case (%)   Control (%)   χ2     P 
         
rs7726552     T    A Full genotype TT     16 (2.02)  6  (0.84) 
   7.95 0.00085* 
        TA    190 (23.93) 227 (31.70) 
        AA   588 (74.06)       483 (67.46) 
                  
      Dominant TT+TA   206 (25.94) 233 (32.54) 
   14.13   0.0048
# 





Table 4:  Association of AR associated haplotypes in UGRP1 gene  
 















H1 A C G A A G C 0.053 0.059 0.536 
H2 A T G G T G C 0.696 0.655 0.017 
H3 A T A G T G A 0.071 0.066 0.637 
H4 T T G G T G C 0.135 0.162 0.036 
H5 A T G G A T C 0.046 0.058 0.120 







UGRP1 was originally suggested to have an anti-inflammatory function due to its 
similarity to uteroglobin/Clara cell secretory protein [21]. UGRP1 is localized in the 
chromosome 5q31-32 region where asthma susceptibility locus has been assigned 
[35] and the high expression of this protein in epithelial cells of the airway [21] 
suggests a possible role in allergic airway inflammation. Further evidence of the role 
of UGRP1 is seen in its regulation by various T-regulatory cytokines such as IL-10 
[36], IL-5 and IL-9 [37, 38], suggesting its involvement in allergic response. Claire et 
al., have shown that there is an increase in UGRP1 in the induced sputum of patients 
with asthma and rhinitis, further suggesting a possible role in inflammatory diseases 
[39]. 
The SNP rs7726552 showed significant association with AR in our 
population. Haplotype analysis revealed a single haplotype block which, when tested 
for association, was significantly different in cases as compared to controls. This 
haplotype block, a 4.13 kb region, includes the 5‘ upstream, promoter and the first 
intron. The SNP rs7726552 is present in the 5‘ upstream region and hence could 
affect the regulation of gene expression levels. Previous reports have shown that such 
polymorphisms in the UGRP1 gene could predispose an individual to allergic 
inflammation by reducing the levels of UGRP1 in the airway epithelial cells [19]. 
Interestingly, the promoter polymorphism G-122A, which was previously associated 
with asthma in Japanese people [19] was also identified in our population and was 
designated as UGRP1-G-1351A. However, similar to studies on Indians and German 
Caucasians, the association to asthma for this SNP was not replicated in the Singapore 
Chinese population. This could be attributed to underlying differences in the genetic 





UGRP1 expression and regulation would be helpful in identifying the role it may play 
in allergy. Much is known as to how a gene is regulated and this may involve multiple 
potential mechanisms such as differential gene splicing or binding of transcription 
factors to regulatory elements. The presence of SNPs in these regulatory regions 
might then predispose an individual to disease [40, 41]. The in silico analysis revealed 
potential binding sites for Oct-1, NF-1 and GATA-1 at the 5‘ upstream locus where 
rs7726552 was identified. Oct-1 has been previously shown to be important in 
regulating the expression of IL13 which is a key regulator of Th2-mediated 
inflammation in allergic diseases. Kiesler et al., demonstrated that a polymorphism in 
the regulatory element affects the transcription of the IL13 gene by creating a binding 
site for Oct-1 [42]. Similarly, Hasegawa et al., demonstrated that the T allele on the 
Fc epsilon RI alpha-chain promoter introduced an additional binding motif for 
GATA-1 compared to the C allele and hence the transcription activity of the T allele 
was enhanced because of the higher affinity for the transcription factor [43]. In a 
similar fashion, the A to T change in rs7726552 is predicted to result in the loss of the 
binding site for Oct-1 and conversely introduce an additional binding site for GATA-
1. This prediction suggests why the T allele confers protection (OR 0.81) with a 
higher proportion of the controls (17%) having the allele as compared to the cases 
(14%). The genotyping results showed more evidence for a dominant model of 
association producing a Pdominant = 0.0048 and OR=0.79. The functional significance 
and the mechanism of the causal variant in UGRP1 leading to the onset of allergic 
rhinitis needs to be confirmed and validated with further studies. 
Haplotype association analysis revealed a common haplotype on UGRP1 to 
have significant different frequencies between cases and controls. This haplotype 





the UGRP1 gene have also confirmed the functionality of haplotype to be associated 
with the promoter region [36] and the regulation of UGRP1 expression in asthmatic 
patients [19]. Srisodsai et al., have shown that in a mouse model, administration of 
IL10 increased constitutive UGRP1 mRNA expression and suggested UGRP1 as a 
potential target for IL-10 anti-inflammatory activities in the lung [36]. Chiba et al., 
demonstrated that UGRP1 can suppress inflammation in a mouse model for allergic 
airway inflammation and also proposed UGRP1 as a therapeutic candidate for treating 
lung inflammation [35]. These reports highlight a potential role for UGRP1 in 
treatment of allergic airway diseases. 
 
7.5 Conclusion 
In summary, our study reveals the association of UGRP1 polymorphisms, specifically 
rs7726552, with allergic rhinitis in the Singapore Chinese population. Haplotype 
analysis suggests that multiple polymorphisms in the gene could be contributing 
collectively to the pathogenesis of AR. Further functional characterization of these 
variants would be important in determining if these variants could be used as risk 
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8. GENE-GENE INTERACTION IN ALLERGIC RHINTIS AND ASTHMA 
8.1 Introduction 
Current technologies have enabled genome wide association studies (GWAS) that use 
a single DNA chip containing millions of SNPs to survey the entire genome at a 
considerable cost and time. However the results from GWAS for majority of complex 
disease phenotypes have yielded results consisting of novel genes, but the entire 
heritability of the disease has not been elucidated. This heritability unaccounted for 
has been termed as ‗missing heritability‘. There has been considerable debate on why 
we couldn‘t identify this heritable component with well-powered GWAS studies. This 
lack of understanding needs to be dealt with as it is extremely important to find this 
genetic variation contribution to the disease so as to design and implement further 
studies to help in disease prognosis, diagnosis, prevention and better treatment of 
management of these diseases. Researchers have suggested that this missing 
heritability could be due to a variety of factors [35,36], which include but not 
restricted to (i) rare variants which are inadequately assayed using current genome-
wide DNA chips which focus on common variants with MAF> 5%; (ii) a larger 
number of common variants with smaller effects which results in disease in a 
combinatorial manner; (iii) structural and copy number variants (CNV) which are not 
assayed/ poorly covered by the current DNA chips; (iv) and most importantly 
eliminating the influence of environment which is almost indispensable for the 
genetic predisposition to result in symptoms.  
Complex diseases result from great network interactions among genes and the 
environments that regulate the predisposition of an individual to develop disease. This 





involve dynamic interactions that might also be influenced by the genetic 
polymorphisms present in the gene. Understanding this dynamic regulation and the 
genetic loci influencing disease predisposition might be most essential in deciphering 
the pathogenesis of complex diseases [28, 29, 30, and 31]. There has been great 
interest in such interaction studies in the recent years with better and faster 
genotyping and sequencing technologies that are economically viable as well. In 
addition, the potential to provide customized genomics or personal medicine based in 
the genetic architecture of the individual has raised the interest of researchers to focus 
on understanding epistatic interactions in complex diseases [33,34]. Although there 
are a great number of algorithms, software and tools developed using theoretical 
understanding of epistasis [38,39,40,41,42,43], studying gene-gene interactions in real 
genetic studies of complex diseases has been a tall order and the available literature 
usually reflect that these studies focus mostly on lower order interactions (mainly pair 
wise SNP-SNP interactions) and studying hypothesis driven candidate gene based 
interaction [35,38,44].  
8.1.1 Gene-gene interaction in allergy 
Gene-gene interaction studies for allergic diseases such as asthma and allergic rhinitis 
have not been extensively studied. However we have previous reports of reported 
gene-gene interactions for allergic phenotypes [1]. However these studies are few and 
far between and have not been replicated by other research groups and also following 
them up functionally have not been easy. There have also been pathway based 
interactions among SNPs present in genes [4] or in a group of genes that control a 
particular cell function as shown by Bottema et al., for genes in involved in regulatory 
T-cell function [2]. In some cases these interaction among genes have shown to 





Some studies have also highlighted that many orders of interaction (2-SNP, 3-SNP 
and 4-SNP) to be governing the genetic predisposition to development of atopy [11] 
and also more severe phenotypes such as aspirin induced asthma, acetyl salicylic acid-
intolerant asthma, chronic rhinosinusitis, aspirin exacerbated respiratory disease 
[6,7,8,9,10].  In a recent study by Baye et al., the set of interacting genes 
discriminating asthmatic to non-allergic children was different among the Caucasian 
and African-American children [5]. In summary these studies highlight the 
importance of gene-gene interaction studies in allergic rhinitis, asthma and other 
allergic phenotypes and also the significance of using samples of a single ethnicity to 
avoid population stratification issues.  
8.1.2 Study Design for interaction studies for atopy and allergic phenotype such 
as allergic rhinitis and asthma in Singapore Chinese 
The gene-gene interaction study design for allergic phenotype consisted of two main 
strategies: 
8.1.2.1 Candidate gene based interaction 
Using a pair of known candidate genes to evaluate any possible epistatic interaction 
among SNPs present in these genes. The SNPs for these epistasis candidate genes 
were identified using the tagSNP approach similar that of individual candidate gene 
based studies. This approach would thus enable to represent the entire genetic 
variation (SNPs in particular) in a particular gene and thus enable discovery of any 
possible interaction among SNPs between the two genes, if any. However this is a 
hypothesis driven study, considering that we select the genes that we consider as 






8.1.2.2 Hypothesis-free whole genome search for interacting candidates 
The whole genome data for atopy and allergic rhinitis published for our Singapore 
Chinese population highlights that no single SNP reached genome–wide threshold of 
10
-8 
. This is not surprising, given the fact that complex diseases are indeed caused by 
a network of interacting genes, which regulate predisposition to disease. Hence we 
used this dataset to evaluate novel SNP-SNP epistatic interactions that might control 
risk to disease. Such interactions could probably account for the combinatorial 
influence of small effect variants that act in unison to lead to disease onset and 
progression.  
These two approaches, methodologies and results have been discussed in detail in the 
following sections. 
8.2 CANDIDATE GENE BASED INTERACTION STUDY OF PHF11 WITH IFNG IN 
CONTROLLING RISK FOR ALLERGIC RHINITIS AND ALLERGIC ASTHMA 
8.2.1 Background 
Allergic diseases are commonly characterized by an imbalance between Th1 and Th2 
cells, with a bias to Th2 cells leading to allergic disorders[12]. Atopic individuals 
have been shown to have increased apoptosis of Th1 cells[13], leading to the 
suggestion that defects in Th1 cells could lead to the observed Th2 bias in allergic 
individuals.Th1 and Th2 cells differ in the production of cytokines, with Th1 
producing mainly IFNG and IL-2 while Th2 cells secrete mainly IL-4, IL-5, IL-9 and 
IL-13[14]. Th1 cytokines stimulate macrophages for cell-mediated immunity while 
Th2 cytokines stimulate synthesis of IgE for antibody-mediated immunity. Many 





effector T-cells. Hence, polymorphisms in genes involved in T-cell development are 
therefore likely to be contributing to the disease susceptibility.  
Plant homeodomain finger protein 11 gene (PHF11) was originally identified 
through positional cloning association as chromosome 13q14 region showed linkage 
to atopy and serum IgE level[15]. PHF11 gene product contains two plant 
homeodomain (PHD) zinc finger and is functionally characterized by E Clarke et al. 
as a positive regulator of Th1 type cytokines IL-2 and IFNG[16]. Study also showed 
that there is a higher expression of PHF11 in Th1 type cells as compared to Th2 cells. 
Besides, PHF11 are suggested to be playing a part in T cell viability and 
activation[17]. Meanwhile, in the downstream pathway of PHF11, Th1 type cytokine 
interferon gamma (IFNG) plays an important anti-inflammatory role. IFNG 
suppresses the development of Th2 cells and inhibits IgE synthesis while promoting 
Th1 response, thus suppressing the development of allergic diseases[18]. Activation 
of an intracellular signaling pathway through the binding of IFNG leads to the 
induction of IFNG regulatory factor 1, which functions as a determinant for Th1 
response[19]. Hence, polymorphisms of PHF11 or IFNG that alter functions or reduce 
expression of the proteins could contribute to Th2 bias leading to allergic diseases.  
Various genetic studies on different population have reported single locus 
association of PHF11 and IFNG SNPs to allergic diseases. Polymorphisms in PHF11 
were found significantly associated with asthma and peripheral blood eosinophils in a 
Chinese population[20] as well as childhood atopic dermatitis in an Australian 
population[21]. However, the same result was not replicated in another study on 2 
independent Western Australian populations [22]. PHF11 was also found not 
associated with asthma and eczema in Hong Kong Chinese children[23]. For studies 





population, with individuals of AA homozygous showing significant decrease in 
IFNG level[24]. A CA repeats polymorphism in linkage disequilibrium with +874T/A 
was also found to be associated with asthma in Japanese and Indian 
population[19,25,26]. IFNG rs1861494 A/G polymorphism has also been found 
associated with asthma in Indian population[27]. However, to our knowledge, no 
statistical interactions between PHF11 and IFNG have been reported. 
Given the important roles of both PHF11 and IFNG in allergy as well as the 
biological interaction of the two genes where PHF11 regulates IFNG expression, we 
hypothesized that polymorphisms in these genes would be associated with allergic 
diseases through effect of the single gene or gene-gene interactions. Thus, we 
performed a case control study to identify polymorphisms of PHF11 and IFNG in 
Singapore Chinese population and to evaluate their association to allergic rhinitis and 
asthma. We also performed statistical analysis to identify interaction of SNPs in 
PHF11 and IFNG. 
8.2.2 Methods 
This study has been performed with the approval of the Institutional Review 
Board (IRB, Reference - NUS07-023) of National University of Singapore and is also 
in compliance with the Helsinki declaration. DNA samples used in this study were 
collected from ethnic Chinese participants following standard protocols of informed 
consent.  
8.2.2.1 Study Population 
Study subjects were recruited from the Singapore Chinese population through 





atopy cases, AR cases and healthy controls according to their disease status as 
determined by ARIA document and ISAAC-derived questionnaires. Diagnosis 
included personal interview of medical history using a standardized questionnaire and 
skin prick test (SPT) using a panel consisted of common allergens in Singapore such 
as Dermatophagoides pteronyssinus, Blomia tropicalis, Elaeis guineensis and 
Curvularia lunata. A positive control containing histamine and a negative control of 
saline were always used. SPT was performed on the volunteers only if they had not 
taken any anti-allergic drugs especially antihistamines for at least 3 days prior to the 
test. A wheal diameter of 3 mm or greater is considered as a positive SPT response. 
Atopy is defined by a positive SPT reaction to either one of the dust mite allergens. 
AR is then diagnosed based on the presence of atopic status and typical AR symptoms 
as defined by the ARIA 2008 guidelines [1] i.e., two or more AR symptoms (nasal 
congestion, rhinorrhea, nasal itching, sneezing) persisting for four or more days a 
week during the past year. Subjects are identified as controls if they have no atopy 
and no history of allergy. A total of 2880 Singapore Chinese were genotyped. 
Demographic and clinical characteristics of the samples are shown in Table 1. 
8.2.2.2 Genotyping 
Genomic DNA of all samples used in the study was extracted from buccal 
cells obtained from 15ml of mouthwash solution containing 0.9% saline following a 
standardized procedure [31,32]. The DNA is then quantified using Nanodrop and by 
flourimetric using Pico- Green (Molecular Probes, Invitrogen, OR, USA) and stored 
appropriately. Genotyping was performed on purified DNA samples using the 
Illumina BeadXpress Assay (Illumina Inc., San Diego, CA, USA) at the University of 






Table 1: Demographic and clinical characteristics of the samples used in study 
* Atopy was characterized by a positive skin prick test reaction to one of the allergens 
tested. (Based on 2008 guidelines set by Allergic Rhinitis Impact on Asthma (ARIA) 
consortium) 
# 
Asthma case was classified based on doctor diagnosis of the disease with a positive 
skin prick test reaction to one of the allergens tested. (Based on WHO and GINA 
guidelines for asthma) 
$
Allergic Rhinitis (AR) was classified based on 2 or more major symptoms which 
include (nasal congestion, rhinorrhea, nasal itching, sneezing) and a positive skin 
prick test reaction to one of the allergens tested.  
^ 
Healthy controls are individuals classified based on no symptoms and history of 











Subjects, n 2163 795 718 717 
Median age, years 21.43 20.24 21.06 22 
Gender, %Female
 50.3 51.6 47.5 72.6 
Skin Prick Test positive reaction 
(Allergen tested) 
    
Dermatophagoides pteronyssinus 91.4% 92% 90.2% N.A 
Blomia tropicalis 78.6% 85% 81.5% N.A 
Smoking Status     
Current 1.2% 0.9% 1.5% N.A 
Ex-smoker 1.196% 0.4% 0.2% N.A 





8.2.2.3 Statistical Analysis 
Linkage Disequilibrium (LD) blocks were generated with the SNPs identified using 
the Haploview software version 4.2. Genotypes of the tagSNPs were then tested for 
Hardy-Weinberg equilibrium (HWE) in control subjects by χ2 test. However it should 
be noted that a deviation from HWE need not necessarily mean a genotype error, 
rather it might reflect a potential effect of association. Tests for association were 
performed at the allele and genotype level and Odds ratio and 95% confidence 
intervals were estimated using the PLINK program version 1.06. For identification of 
SNP-SNP interaction, an epistasis test was performed using PLINK program. SNP 
pairs with a P value of less than 0.05 were considered significant. These SNP pairs 
were furthered tested for epistatic interaction using Synergy Factor as provided by 
Cortina-Borja et al..[33] A P value less than 0.05 was considered significant for all 
tests. In analysis for allergic rhinitis, there are 795 cases and 527 controls. These give 
a 80-100% power to detect SF of 2.0 [33]. 
 
8.2.2.4 Power calculation 
This cohort with 2163 atopic cases (795 AR cases and 718 asthma cases) and 717 no 
allergy controls has more than 95% power to detect an association at P<0.05 and OR 
=1.5. The two-locus tests are also well-powered to detect an epistatic interaction with 
synergy factor SF >=2 at above 80%. However for lower SF, the sample sizes are not 
adequate with power ranging between 40% - 70% for SF=1.5. Power was estimated 






8.2.2.5 In silico prediction using bioinformatics tools 
Bioinformatics tools TRANSFAC [34] and FASTSNP [35]  were used for predicting 
the putative effect of the SNP on the transcription factor binding site (TFBS) and also 
the regulatory potential of the region containing the SNPs. 
8.3 Results 
8.3.1 Single locus test of association 
Of the 12 PHF11 SNPs attempted for SNP design using the Beadxpress 
platform two SNPs failed assay design and thus 10 SNPs were successfully genotyped 
in 2880 Singapore Chinese samples. 3 SNPs in IFNG were also successfully 
genotyped. The total genotyping success rate was 99.46%. Minor allele frequency of 
all SNPs tested was greater than 0.05 in our population. Hence we had a power of 
greater than 80% to detect any association at P < 0.05 with effect size of 1.5 or 
greater. The allele based association test reveals no significant association of any of 
the SNPs tested to atopy, AR and allergic asthma in our population even at a nominal 
P value threshold of 0.05 (Table 2). Gender-specific association of the SNPs was 
performed and revealed no significant associations (data not shown).  
8.3.2 SNP- SNP two locus tests of association  
 We then performed two-locus tests of association using PLINK v1.07 program 
to detect any interactions between pairs of SNPs. The ―--epistasis‖ command was 
used to find any significant interaction between SNPs present in PHF11 and IFNG 
gene. For the atopy phenotype, 2 pairs of SNPs were detected at P < 0.05 for epistasis 
(Table 6). The SNP pairs were detected rs2069728 (IFNG) with rs3794381 (PHF11) 





Table 2: Single locus association of SNPs in PHF11 and IFNG 
Gene SNPs A1 A2 Controls Atopics P OR (95% CI) 
AR  
Cases P OR (95% CI) 
Asthma 
Cases P OR (95% CI) 
IFNG rs2069728 A G 0.104 0.093 0.21 0.88(0.72-1.07) 0.099 0.628 0.94(0.74-1.12) 0.106 0.911 1.01(0.80-1.29) 
  rs2069718 T C 0.164 0.168 0.688 1.03(0.88-1.22) 0.163 0.98 1.0(0.82-1.2) 0.17 0.651 1.046(0.86-1.27) 
  rs1861493 G A 0.299 0.292 0.59 0.97(0.85-1.1) 0.302 0.871 1.01(0.87-1.18) 0.279 0.227 0.91(0.77-1.06) 
PHF11 rs3794381 G C 0.285 0.281 0.734 0.98(0.86-1.17) 0.287 0.928 1.01(0.86-1.18) 0.298 0.45 1.06(0.91-1.25) 
  rs9568227 A G 0.202 0.216 0.278 1.09(0.94-1.26) 0.218 0.294 1.1(0.92-1.31) 0.221 0.236 1.12(0.93-1.34) 
  rs7998996 G T 0.144 0.156 0.275 1.10(0.93-1.3) 0.156 0.39 1.09(0.9-1.33) 0.148 0.763 1.03(0.84-1.27) 
  rs7994710 T C 0.066 0.065 0.968 1.0(0.78-1.27) 0.063 0.772 0.98(0.72-1.282) 0.066 0.992 1.00(0.75-1.35) 
  rs9568232 T C 0.238 0.226 0.374 0.94(0.81-1.08) 0.215 0.138 0.88(0.74-1.04) 0.229 0.561 0.95(0.80-1.13) 
  rs8000149 C T 0.136 0.148 0.252 1.11(0.94-1.32) 0.155 0.131 1.17(0.95-1.43) 0.155 0.146 1.17(0.95-1.44) 
  rs2274276 C G 0.371 0.372 0.974 1.0(0.89-1.13) 0.366 0.762 0.98(0.84-1.13) 0.38 0.643 1.04(0.90-1.21) 
  rs7332573 T G 0.207 0.226 0.146 1.12(0.96-1.29) 0.228 0.169 1.13(0.95-1.34) 0.206 0.935 0.99(0.83-1.19) 
  rs7139494 C T 0.481 0.471 0.513 0.96(0.85-1.08) 0.472 0.625 0.97(0.84-1.11) 0.476 0.788 0.98(0.85-1.14) 





rs9526569 (PHF11) with an odds ratio for interaction ORint =1.571 (P =0.017). 
Interestingly, for the AR phenotype the same SNP pair, rs2069728 (IFNG) with 
rs9526569 (PHF11) was significantly interacting (ORint =1.586; P =0.036). Another 
pair, rs1076025 (IFNG) with rs3794381 (PHF11) was also found to be significant 
(ORint =1.331; P =0.047) (Table 6). For the asthma phenotype however more number 
of significant SNP pairs (7) was detected. Two SNP pairs were detected at a P < 0.01; 
rs2069728 (IFNG) was significantly interacting with rs9526569 (PHF11) at a P 
=0.005 and ORint =1.881 and rs1861493 (IFNG) with rs2274276 (PHF11) at P =0.005 
and ORint =0.669. For the allergic asthma phenotype, 3 SNPs from PHF11 
(rs9568232, rs2274276, rs7139494) were found to be interacting with the same IFNG 
SNP rs1861493 and 3 other SNPs (rs3794381, rs8000149, rs9526569) from PHF11 
with rs2069728 from IFNG (Table 6). It is important to note that the SNP pair of 
rs2069728 (IFNG) and rs9526569 (PHF11) was consistently associated (P =0.017, 
0.036 and 0.005) with all 3 phenotypes atopy, AR and allergic asthma. Also the ORint 
=1.571 for atopy, ORint =1.586 for AR and ORint =1.881 for allergic asthma indicate 
an increase in risk for the same SNP pair from atopy to allergic asthma.  
8.3.3 Synergy factor Analysis  
SNP pairs detected to be interacting using the PLINK program were then 
analyzed using the synergy factor (SF) analysis. The advantage of using SF analysis is 
to calculate a synergy factor or index for the interaction. It also confirms the 
association if the P value calculated is less than alpha = 0.05. The basic principle is 
that the observed OR for the interaction must be greater than the expected combined 






All SNP pairs identified by PLINK epistasis remained significant when analyzed 
using the SF analysis. For the atopy phenotype, rs2069728 (T) and rs3794381 (G) had 
a synergy factor = 1.81(95% CI-1.15 -2.86) with P = 0.01 and rs2069728 (T) and 
rs9526569 (G) had a synergy factor = 1.78(95% CI-1.0 -3.8) with P = 0.01 (Table 3). 
Similarly for AR phenotype, rs2069728 (T) and rs9526569 (G) had a synergy factor = 
1.92(95% CI-1.12 -3.27) with P = 0.017 and rs1076025 (T) and rs3794381 (G) had a 
synergy factor = 1.66 (95% CI-1.09 -2.53) with P = 0.01 (Table 4). For the asthma 
phenotype, rs2069728 (T) and rs9526569 (G) had a SF = 2.224 (95% CI - 1.299-
3.805) with P = 0.0035 (Table 5). Three other SNPs pairs also had SF close to 2; 
rs2069728 (T) and rs3794381 (G) with SF=1.999 (95% CI: 1.163-3.440) and P= 0.01, 
rs1861493 (AA) and rs7139494 (CT+TT) with SF=1.916 (95% CI: 1.166-3.148) and 
P= 0.01, rs2069728 (AG+AA) with rs8000149 (CT+CC) SF=1.9 (95% CI: 1.06-3.41) 
and P= 0.03. The entire SF analysis for the asthma phenotype has been summarized in 
Table 5. 
4 pairs of IFNG and PHF11 SNPs were found significant (p<0.05) to be in 
SNP-SNP epistasis interaction to risk of allergic rhinitis through PLINK program 
(rs1861493-rs3794381, p=0.041; rs1861493-rs9526569, p=0.036; rs2274276-
rs9568227, p=0.015; rs2274276-rs7332573, p=0.046). None of these SNPs were 
significantly associated with the disease in the single locus model of association as 
shown in Table 2. Synergy factor analyses were then performed for the 4 SNP pairs 
and results are as shown in Table 3. With the presence of rs1861493GG (IFNG) or 
rs3794381CC (PHF11), both genotypes alone are shown to have a protective 
association (OR= 0.4973, 0.7663 respectively). Based on the multiplicative model, 





Table 3: Synergy Factor Analysis of Potential Interactions in the Risk of Atopy 
















   alpha 
         
rs2069728(T) rs3794381(G)        
- - 349 1100 1.00 SF= 
1.81                     
(1.15 -2.86) 
 0.05 
+ - 221 667 0.958 
se(ln(SF
))= 
0.232   
- + 99 215 0.689 ln(SF)= 0.594   
+ + 43 162 
1.26  
(0.84 -1.71) 
Z= 2.558   
     P = 0.011   
rs2069728(T) rs9526569(G)        




+ - 235 727 0.994 
se(ln(SF
))= 
0.228   
- + 94 200 0.683 ln(SF)= 0.577   
+ + 47 177 1.2 (0.86 -1.71) Z= 2.529   





Table 4: Synergy factor analysis of potential interactions in the risk of AR 
SNP 1 (Allele 1) SNP 2 (Allele 1) Controls count Cases count Odds ratio(OR)    Alpha 
rs2069728(T) rs9526569(G)        
- - 334 383 1.00 SF= 
1.92                     
(1.12 -3.27) 
 0.05 
+ - 235 262 0.972 se(ln(SF))= 0.272   
- + 94 73 0.677 ln(SF)= 0.650   
+ + 47 68 1.26 (0.85-1.9) Z= 2.391   
     P = 0.017*   
rs1076025(T) rs3794381(G)        




+ - 147 143 0.840 se(ln(SF))= 0.214   
- + 233 231 0.857 ln(SF)= 0.508   
+ + 117 162 1.2 (0.89-1.6) Z= 2.374   





Table 5. Synergy Factor Analysis of Potential Interactions in the Risk of Asthma 
SNP Pairs SNP1 SNP2 Cases Controls Odds Ratio Synergy Factor (95% CI, p) 
rs2069728(AG+AA) - - 349 351 Reference  
Vs + - 99 77 0.7734  
rs3794381(GG+GC) - + 221 216 0.9718  
 + + 43 65 1.5 (1-2.27) SF=1.999 (1.163-3.440, 0.0123) 
rs2069728(AG+AA) - - 421 418 Reference  
Vs + - 110 91 0.8332  
rs8000149(CT+CC) - + 149 150 1.0139  
 + + 32 51 1.6(1.01-2.55) SF=1.900 (1.059-3.411, 0.0315) 
rs2069728(AG+AA) - - 334 344 Reference  
Vs + - 94 69 0.7127  
rs9526569(CT+CC) - + 235 224 0.9255  
 + + 47 71 1.46(1-2.2) SF=2.224 (1.299-3.805, 0.0035) 
rs1861493AA - - 197 212 Reference  
Vs + - 216 215 0.9249  
rs9568232(CT+CC) - + 162 124 0.7113  
 + + 138 157 1.05(0.78-1.43) SF=1.607 (1.051-2.457, 0.0286) 
rs1861493AA - - 125 136 Reference  
Vs + - 145 126 0.7987  
rs2274276(CG+CC) - + 235 202 0.7901  
 + + 209 247 1.08(0.8 -1.47) SF= 1.721 (1.119-2.647, 0.0134) 
rs1861493AA - - 77 85 Reference  
Vs + - 94 71 0.6842  
rs7139494(CT+TT) - + 282 250 0.8031  
 + + 259 301 1.05(0.74-1.49) SF= 1.916 (1.166-3.148, 0.0103) 
rs1076025(T) - - 263 260 Reference  
Vs + - 100 89 0.900  
rs8000149(G) - + 269 248 0.933  
 + + 81 114 1.4(1.02 -1.98) SF= 1.70 (1.06-2.72, 0.028) 
 
SNP1 and SNP2 refer to the first and second SNP in the SNP pairs‘ column 
respectively;     CI= confidence interval; ‗-‘ indicates the absence of the genotype; ‗+‘ 










Table 6: SNP-SNP epistasis using PLINK software 
 
is 0.38 (0.4973x0.7663). However, the observed combined odd ratio was found to be 
1.3098, resulting in a SF of 3.4367 (95% CI: 1.5434 – 7.6527; p=0.0025). This 
suggests that the presence of both genotypes interacts and changes the protective 
association of both rs1861493GG and rs3794381CC to being a risk factor. Similarly, 
the pairings of rs1861493GG-rs9526569TT (SF=2.8524, 95%CI: 1.3046 – 6.2363, 
p=0.0086); rs2274276GG-rs9568227A+ (SF= 2.0684, 95%CI: 1.2478-3.4287, 
p=0.0048); rs2274276GG-rs7332573T+ (SF= 1.9465, 95%CI: 1.2169 – 3.1136, 
         
Atopy 
12 IFNG rs2069728 13 rs3794381 PHF11 1.592 5.915 0.015 
12 IFNG rs2069728 13 rs9526569 PHF11 1.571 5.721 0.017 
Allergic Rhinitis 
12 IFNG rs2069728 13 rs9526569 PHF11 1.586 4.418 0.036 
12 IFNG rs1076025 13 rs3794381 PHF11 1.331 3.947 0.047 
Asthma 
12 IFNG rs2069728 13 rs3794381 PHF11 1.742 6.123 0.013 
12 IFNG rs2069728 13 rs8000149 PHF11 1.705 4.849 0.028 
12 IFNG rs2069728 13 rs9526569 PHF11 1.881 7.981 0.005 
12 IFNG rs1861493 13 rs9568232 PHF11 0.7467 4.301 0.038 
12 IFNG rs1861493 13 rs2274276 PHF11 0.699 7.882 0.005 
12 IFNG rs1861493 13 rs7139494 PHF11 1.326 5.763 0.016 





p=0.0055) are found to be in epistatic interactions associated with risk of developing 
AR. 
We then further stratified cases and controls of our population based on a third 
SNP to identify possible three locus epistatic interaction and results of the analysis are 
shown in Table 7 and 8 for AR and asthma respectively. As we stratified rs1861493-
rs3794381 and rs1861493-rs9526569 to subsets of a second IFNG SNP, empty cells 
appeared due to small sample size after stratifications (results not shown). When 
rs7332573 and rs2274276 are stratified based on the subset of rs1861493 GG and 
rs1861493 A+, the odds ratio increases from 1.49 in rs1861493 A+ subset to 1.90 in 
rs1861493GG subset. However, the odds ratio of the rs1861493 GG subset was not 
statistically significant. Similarly, stratification of rs9568227 and rs2274276 does not 
improve the odds ratio or significance of association.  
However, with regards to asthma, stratification of the 3 SNP pairs by IFNG 
rs1861493AA resulted in an improved odds ratio (Table 8). rs2069728 A+/ 
rs3794381C+, rs2069728A+/ rs8000149C+ and rs2069718/ rs9526569C+ were all 
significantly associated with asthma only in the presence of rs1861493AA genotype. 





Table 7. Odds Ratio for AR for two PHF11 SNPs, stratified by a IFNG SNP 
Odds ratio of AR for: Subset of: Controls Cases Odds Ratio for AR (95%CI, p) 
PHF11 IFNG T+/GG: 5 T+/GG: 14  
rs7332573/rs2274276 rs1861493 GG GG/C+: 17 GG/C+: 25 1.90 (0.58-6.27, 0.286) 
T+/GG vs GG/C+ IFNG T+/GG: 60 T+/GG: 133  
 rs1861493 A+ GG/C+: 179 GG/C+: 266 1.49 (1.04-2.14, 0.029) 
PHF11 IFNG A+/GG: 48 A+/GG: 119  
rs9568227/rs2274276 rs2069728 GG GG/C+: 196 GG/C+: 318 1.53 (1.05-2.23, 0.028) 
A+/GG vs GG/C+ IFNG A+/GG: 18 A+/GG: 19  
 rs2069728 A+ GG/C+: 50 GG/C+: 62 0.85 (0.40-1.79, 0.670) 
       
Table 8. Odds ratio of Asthma for SNP pairs stratified by a third SNP 
Odds ratio of Asthma for: Subset of: Controls Cases Odds Ratio for AR (95%CI, p) 
rs2069728/rs3794381 IFNG A+/G+: 15 A+/G+ 14  
A+/G+ vs GG/CC rs1861493 G+ GG/CC: 186 GG/CC: 189 0.92(0.43-1.96, 0.826) 
 IFNG A+/G+: 28 A+/G+: 51  
 rs1861493 AA GG/CC: 163 GG/CC: 162 1.83(1.10-3.05, 0.019) 
rs2069728/rs8000149 IFNG A+/C+: 13 A+/C+ 9  
A+/C+ vs GG/TT rs1861493 G+ GG/TT 229 GG/TT: 222 0.71(0.30-1.70, 0.446) 
 IFNG A+/C+: 19 A+/C+: 41  
 rs1861493 AA GG/TT: 192 GG/TT: 196 2.11(1.18-3.77, 0.010) 
rs2069728/rs9526569 IFNG A+/C+: 16 A+/C+: 15  
A+/C+ vs GG/TT rs1861493 G+ GG/TT: 174 GG/TT: 178 0.92(0.44-1.91, 0.816) 
 IFNG A+/C+: 31 A+/C+: 55  
 rs1861493 AA GG/TT: 160 GG/TT: 166 1.71(1.05-2.79, 0.031) 





better in distinguishing cases from control (rs2069728A+/ rs3794381C+/ 
rs1861493AA, OR=1.83, p=0.019; rs2069728A+/ rs8000149C+/ rs1861493AA, 
OR=2.11, p=0.010; and rs2069718A+/ rs9526569C+/ rs1861493AA, OR=1.71, 
p=0.031). 
8.3.4 In silico prediction of putative function 
The in silico prediction of the intronic SNP rs8000149 of PHF11 associated 
with allergic rhinitis, suggests that the base change from C to A results in a loss of 
TFBS for the transcription factor sp-1.  We then predict possible function for the 
coding-synonymous SNP rs2031532 which is in linkage with rs8000149. The G to A 
polymorphism in SNP rs2031532 was predicted to result in the loss of binding site for 
transcription factor c-Ets-1. In addition, this SNP is present in a region of regulatory 
potential region as predicted from seven species alignment using the FASTSNP 
program. SNP rs2031532 is also predicted to be in putative exon splicing 
enhancer/silencer region. 
8.4 Discussion 
 Chromosome 13q14 was identified as a QTL (quantitative trait loci) for serum 
immunoglobulin E levels and severe asthma. Positional cloning of this region 
identified PHF11 as a potential asthma candidate gene in 2003. Since then multiple 
studies have reported association of PHF11 SNPs to atopy, asthma and atopic 
dermatitis in different cohorts. However there have been studies with negative 
association of PHF11 SNPs to asthma and asthma related phenotypes. Chromosome 
12 was identified as a candidate locus for mite-sensitive childhood asthma through a 
genome-wide linkage study in a Japanese population. Fine mapping of this region 





association of IFNG polymorphisms to asthma, other studies have reported negative 
results for association to asthma and related phenotypes. However,  various groups 
have suggested that the negative association of candidate gene based association 
studies may not suggest no role in asthma and or related phenotypes, but would have 
been a result of poor study design. This could be due to insufficient power, replication 
at the SNP level which doesn‘t consider population based differences, publication 
bias known as the ―winners curse‖ and probably due to the heterogeneous/complex 
nature of asthma and allergy. In addition these studies also do not account for epistatic 
interaction with other loci and with other environmental factors which might 
influence the disease outcome.  
 In our study we have accounted for the design issues by having the following 
study design: (1) considerably large sample size of well-characterized cases and 
controls (2) homogenous population (all Singapore Chinese) with no population 
stratification issues (3) age matched with majority of the cohort between 20-24 years 
of age. In addition, we have also explored epistatic interactions between SNPs in 
genes which are biologically interacting as well. Although the epistatic interaction 
analyzed is not exhaustive, it does shed light on the fact that epistatic interaction do 
indeed mask the association of certain SNPs and in turn genes to disease phenotypes.  
For complex diseases such as allergy, identifications of gene-gene interactions 
are important in understanding the genetics basis. It is believed that the frequent 
failure of replication of single polymorphism association studies across independent 
studies could be partly due to epistasis[10]. Marginal effects of a gene could be 
masked by another and therefore, important epistasis effects could be missed out 
when studying on a single gene association only, thereby underlying the importance 





to produce the disease phenotype is not clearly understood. In our study, we showed 
evidence of gene-gene interaction in terms of SNPs between PHF11 and IFNG in the 
Singapore Chinese population. 
None of the SNPs of PHF11 or IFNG were associated with atopy, asthma or 
allergic rhinitis phenotypes. Synergy Factor analysis was also performed to identify 
epistatic interactions between IFNG and PHF11 for both AR and asthma. As shown 
in Table 3, rs1861493 (IFNG) and rs3794381 (PHF11) were found to be interacting. 
Considering the effect of rs1861493GG (IFNG) and rs3794381CC (PHF11) 
genotypes individually, an odds ratio of 0.4973 and 0.7663 was obtained. However, 
collectively, rs1861493GG and rs3794381CC results in an odds ratio of 1.3098, 
showing significant synergistic effects measured by a Synergy Factor (SF) of 3.4367 
(p=0.0025). It is to be noted that in the single locus model, both SNPs were not 
significantly associated with the disease. Only through the introduction of a second 
locus, odds ratio as well as the statistical significance improved. Similarly, IFNG SNP 
rs1861493 is also found to be interacting with rs9526569 of PHF11 where 
rs1861493GG and rs9526569TT have a combined odds ratio of 1.267 (SF=2.8524, 
p=0.0086). For rs2274276 and rs9568227 as well as rs2274276 and rs7332573 
interaction for AR phenotype, since the SNPs are all present on the same gene 
(PHF11), it will only be biologically meaningful as a gene-gene interaction if a third 
SNP of IFNG is included. However, as shown in Table 5, when further stratifying the 
subjects into subsets based on a IFNG SNP, both the odds ratio and p-value did not 
improve from the two locus model. 
For asthma phenotypes, rs2069728A+ of IFNG is in synergy with 3 PHF11 SNPs 
(rs3794381C+, rs8000149C+ and rs9526569C+) with odds ratio of 1.50, 1.61 and 





rs9568232C+, rs2274276C+ and rs7139494T+. However, although statistically 
significantly found to be synergistic, the odds ratios of these 3 pairs are very close to 
1.0, unable to distinguish between cases and controls. We therefore omit them from 
further analysis where we further stratified the population with a third SNP to identify 
higher order interactions. In the case of asthma phenotypes, rs2069728A+ / 
rs3794381C+, rs2069728A+ / rs8000149C+ and rs2069728A+ / rs9526569C+ are 
found significantly associated with the disease only in the presence of rs1861493AA 
genotype (Table 6), with an odds ratio of 1.83, 2.11 and 1.71 respectively, improving 
from the two locus model. This suggests the presence of interaction between 
rs1861493AA and the SNP pairs. In summary, we identify interactions between 
rs1861493GG/ rs3794381CC and rs1861493GG/ rs9526569TT in AR cases and also 
that the 3 locus interactions of rs2069728A+/ rs3794381C+/ rs1961493AA, 
rs2069728A+/ rs8000149C+/ rs1961493AA and rs2069728A+/ rs9526569C+/ 
rs1961493AA play a role in the genetic disposition and susceptibility of developing 
asthma. 
These results are consistent to the suggestion that due to epistasis, SNPs with 
marginal effects or SNPs being masked by other SNPs may lead to it being missed out 
in single locus analysis. However when interactions are included in analysis, these 
SNPs synergize to exert greater effect that can be detected statistically. This 
statistically significant interaction of PHF11 and IFNG is also supported by studies 
showing biological interactions between the two gene products where PHF11 
regulates expression of IFNG by binding to the IFNG promoter as well as recruiting 







In conclusion, we showed the genetic interactions between PHF11 and IFNG SNPs 
and its association to the susceptibility of allergic diseases in Singapore Chinese 
population. This is supported by a possible biological interpretation where PHF11 is 
the regulator of IFNG in the T cell development pathway. However, it is important to 
take note that statistical interactions does not necessarily imply biological mechanism 
of interactions[36]. The tag SNPs that were used for analysis may not be the actual 
disease causing SNP. Significant association signals could be due to SNPs in high 
linkage disequilibrium with the tag SNPs. Therefore, further functional studies would 
be required for a clearer understanding of the interaction as well as correlate the 
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The dataset used for evaluating the SNP-SNP pair wise interactions has been 
described previously in Andiappan et al [8] and also in Chapter 3. The discovery 
dataset consisted of 515 individuals who were atopic (skin prick test positive to any of 
the house dust mite allergens tested) and 486 non-atopic non-allergic rhinitis (NANR) 
controls that had no medical history of allergy. In the total of 515 atopic individuals 
used in the study, 456 volunteers had allergic rhinitis (skin prick test positive and 
defined symptoms of allergic rhinitis as defined by ARIA guidelines). The top SNP 
pairs were then replicated in a validation cohort of 2323 atopic individuals and 511 
non-atopic and non-allergic rhinitis (NANR) controls. In the total 2323 atopic cases, 
676 individuals had allergic rhinitis. Thus the combined population for this interaction  
study had 2838 atopic cases (with 1132 individuals having allergic rhinitis) and 997 
NANR controls with no medical history of allergy. 
8.3.1.2 Statistical Analysis 
The SNPs in the dataset were first subjected to quality control to ensure high 
genotyping rates for the SNPs proceeding into the interaction analysis. The samples 
that had lesser genotyping success were removed from the dataset. The PLINK whole 
genome analysis toolset (pngu.mgh.harvard.edu/~purcell/plink) was used to evaluate 
pair wise SNP-SNP interactions. A total of 460183 SNPs were used in the initial 





between genes on different chromosomes. This interaction analysis across the whole 
genome was time consuming with the entire analysis taking a little over three months 
to complete on an Intel Core2duo processor with 2GB RAM. 
8.3.2 Results 
Table 1: Frequency of interacting SNP pairs over various P value thresholds  
The interaction analysis as expected identified as large number of interacting SNP 
pairs, which were influencing the risk to both atopy and allergic rhinitis as observed 
from their Odds Ratios (OR). A table of the interacting pair of SNPs is given below.  
* The P value range indicates the P value of the interacting SNP pair 
 
 
P value range for SNP/SNP interaction*  Frequency  
10 
—12
  3 
10 
—11
  8 
10 
—10
  64 
10 
—9
  587 
10 
—8
  5398 
10 
—7
  55058 
10 
—6





8.3.2.1 Bonferroni correction for multiple testing 
The P value thresholds for GWAS are usually set at (0.05/ Number of tests 
performed). In our case close to 10
11 
epistatic tests were performed, which leads to a 
bonferroni P value threshold of 0.05/10
11
, which is around 5*10-
13 
. However this 
threshold is too conservative and not realistic as numbers of tests are extremely large 
and the P values are too small to reach [1,2,3,and 26]. The assumption of 
independence for the multiple testing is also violated in a sense as epistasis is testing 
for dependence; where the effect of one SNP ‗masks‘ the effect of the other SNP. 
Hence assuming total independence might not correct, in light of research that has 
clearly shown initial evidence of the contrary that there are multiple regulatory 
network of genes possibly controlled by SNPs which influence an individual‘s 
predisposition to disease and its progression [4,5,6,7].    
8.3.2.2 Prioritizing of ‘top’ SNP pairs from interaction analysis 
Although Bonferroni correction might be too stringent for whole genome SNP-SNP 
pair wise epistasis, we need to have identified criteria to prioritize interacting 
candidates. We thus used 3 main criteria: 
8.3.2.2.1 Linkage Disequilibrium 
In population genetics, linkage disequilibrium is defined as a non-random association 
of alleles at two or more loci, usually (not always) on different chromosomes 
(http://en.wikipedia.org/wiki/Linkage_disequilibrium). This natural phenomenon has 
been used in genetic association studies to evaluate the genetic recombination in 
various populations and also has been widely used in the past decade in disease 





information or to identify ancestry informative markers in certain ethnic populations 
[12,13,14,and 15].  In addition, this linkage equilibrium information was 
instrumental in designing whole genome genotyping chips, which have been used for 
genome wide association studies (GWAS)  [16,17,and 18]. We thus decided to use 
this as a criterion to prioritize candidate SNP pairs that were interacting. The main 
hypothesis is that these genome wide chips generally must have SNPs in linkage 
disequilibrium with other SNPs (usually considered over a 200kb span on a 
chromosomal locus). Hence if there is a particular SNP identified to be interacting, 
there must be other SNP(s) in the same locus around about the 200kb region that 
should also interact. If yes, then we consider the locus to be a true interacting locus 
represented by a panel or haplotype of SNPs rather than just 1 interacting SNP, which 
might suggest random chance. Hence we use this strategy to study both SNPs of an 
interacting pair and thus could be considered as two regions interacting rather than 
individual SNPs. A similar framework based on linkage disequilibrium has been 
proposed by Fang et al.,  to analyze genetic interaction in humans [19]. 
8.3.2.2.2 P value threshold 
We also used an arbitrary P-value threshold of 10
-6 
for a SNP pair to be considered for 
the interaction test. This would also help to filter out the noise at the lower P value 
thresholds but still allow for meaningful interactions, which could be tested, in an 
independent validation set.  
8.3.2.2.3 Gene deserts 
Gene deserts are regions in the human genome that are long stretches of no (known) 
protein coding genes and also no recorded biological function [21,22]. Research 





21]. There has been mixed views on whether these regions are indeed essential to 
function of the genome [23,24,and 25]. However the focus of this study we try to 
eliminate those SNPs that occur in regions where the 200kb span surrounding the 
SNP has no protein coding gene or any phenotypic effect reported. The inadequate 
characterization of the biology of such a locus would further impair the study of the 
interactive effects in relation to the locus.  
8.3.2.3 Top SNP pairs identified for replication in the validation cohort 
Thus in summary a description of the top 20 SNP pairs selected using the above 
mentioned criteria have been tabulated below (Table 2). An example of multiple 
SNPs in the LD block interacting with the same/multiple SNPs on another locus is 
given in supplementary table 1. This table describes multiple SNPs in the locus on 
chromosome 3 near the LPP (LIM domain containing preferred translocation partner 
in lipoma) gene interacting with the same SNP from IMMP2L (IMP2 inner 
mitochondrial membrane peptidase-like (S. cerevisiae)) gene.   
8.3.2.4 Genotyping and statistical analysis in the validation cohort 
These top SNP pairs identified were attempted to be genotyped using the Sequenom 
platform. The SNP assays were then designed and the genotyping was performed in 
the validation cohort of 2323 atopic cases with 676 AR cases and a NANR control 
batch of 511 individuals. Quality control was performed on the SNPs to ensure high 
genotyping call rate. SNPs that had low call rate were exempted from further analysis. 
In addition, samples quality was also assessed to remove any sample that had low 
genotyping success. Hardy Weinberg Equilibrium (HWE) testing was performed to 





Table 2: Top 20 SNP pairs identified using the 3 main criteria (i) LD blocks 
based interaction (ii) P value threshold of 10
-6
 (iii) not in a gene desert. 
SNP1 Gene 1 SNP2 Gene 2 Interaction p-value*  
rs669775 RAB38 rs7689179 GYPA 2.446E-12 
rs3765087 ADAM15 rs4355720 SEMA3A 4.62E-10 
rs1463243 A2BP1 rs11879029 SIRT2 5.273E-10 
rs6799581 TDGF1 rs2639889 CDH8 5.509E-10 
rs12475141 FLJ34870 rs674747 MEF2C 7.662E-10 
rs2256748 RAD54B rs927544 HTR2A 7.75E-10 
rs12135959 CACNA1E rs2616591 CNTN4 9.056E-10 
rs4953081 SLC3A1 rs2083567 ING1 1.81E-09 
rs282876 KCNMB2 rs7072004 SH3PXD2A 3.37E-09 
rs1679256 ZNF659 rs10216531 CSMD1 6.31E-09 
rs1496770 MAGI2 rs7337720 GPC6 6.39E-09 
rs6685801 ARHGEF16 rs1014329 LRRTM3 9.84E-09 
rs7613818 CAST1 rs700925 NPR3 1.22E-08 
rs857826 OR6N1 rs12527698 GMDS 1.65E-08 
rs1204891 PADI4 rs2302415 TTC19 3.27E-08 
rs688136 VIP rs884904 EGFR  4.52E-08 
rs1001484 CUTL2  rs9584410 HS6ST3  9.29E-08 
rs3856921 LPP rs7801774 LRRN3 1.43E-07 
rs2243290 IL4 rs639434 CYP39A1 1.85E-07 
rs4675374 ICOS  rs695002 ANK2 9.86E-07 







8.3.2.5 Results of validation of the top 20 SNP pairs selected for replication in 
another Singapore Chinese population 
We used a strategy similar to the GWAS single SNP association study design where 
an initial discovery in one population is validated in a larger cohort of the same 
population to identify if the observed interacting SNP pairs stay interacting in the 
second cohort. Table 3 provides the statistics for the SNPs pairs which still remained 
interacting at a P value <0.05. For the atopy phenotype, three SNP pairs were 
interacting in both the discovery and validation cohorts (Table 3a). The SNP 
rs3856921 from LPP gene and rs7801774 from LRRN3 gene were interacting in both 
cohorts with a combined interacting P value of 9.86 x 10
-09
 and with an odds ratio of 
0.55. The ORs were comparable in both the discovery and validation cohorts at 0.39 
and 0.6 respectively. The second pair interacting was rs1463243 from A2BP1 gene 
and rs11879029 from SIRT2 gene with a combined P = 2.68 x 10
-08
 with a significant 
odds ratio of 1.544. The last significant pair of interacting SNPs was rs1496770 from 
MAGI2 gene and rs7337720from GPC6 gene.  
Considering the AR phenotype, two of the above mentioned interacting pair of SNPs 
for the Atopy phenotype was also significant (Table 3b). The SNP pair of rs1463243 
from A2BP1 gene and rs11879029 from SIRT2 gene were significantly interacting 
with a combined P = 9.49 x 10
-10
 with a significant odds ratio of 1.758. The other 
SNPpair of rs3856921 from LPP gene and rs7801774 from LRRN3 gene were 
interacting in both cohorts with a combined interacting P value of 3.48 x 10
-09
 and 
with an odds ratio of 0.48. It is indeed interesting to note that two of the SNP pairs are 
interacting in both cohorts for both phenotypes although the sample sizes are indeed 
different for the two phenotypes. However there is a slight increase in the effect size 





of 0.55 for the Atopy phenotype which increases in size for the AR phenotype to 0.48. 
Similarly for the A2BP1-SIRT2 SNP pair, the OR which is at 1.54 for the Atopy 
phenotype significantly improves for the AR phenotype to 1.76. This might reflect the 
disease condition or severity where Atopy indicates a positive sensitivity towards an 
allergen which may or may not develop to an allergic state, whereas AR documents 
manifested symptoms of nasal conditions such as runny nose, sneezing, blocked nose 
and nasal itching. Similar results have also been observed in our single SNP 
association for GWAS [8] where the OR for the AR phenotype was generally higher 
than that for the Atopy phenotype.  
Summary 
This whole genome pairwise interaction analysis has several limitations. The first is 
the sample size used for the interaction analysis with 515 cases and 486 controls. 
Although it provided more than 80% power for individual SNP analysis at an 
OR>=1.5 detected at around 10-20% MAF and a disease prevalence of around 25%, 
there is minimum power for the interaction analysis accounting for the massive 
multiple testing performed. Hence we used a two-stage design to validate our SNP 
pairs found to be interacting in the discovery cohort in a validation cohort. However 
the second limitation of the study is that when choosing SNPs for validation we used 
the three criteria (i) Linkage Disequilibrium (ii) moderate P value threshold (iii) gene 
desserts, which could potentially bias the SNPs chosen for replication. Having 
mentioned this, our strategy of using the two stage design in our Singapore Chinese 
population consisting of 4461 individuals does have some strengths in (i) no clear 
population stratification issues (ii) similar environmental conditions as all samples 





Table 3b: Validation results of the interacting SNP pairs which were significant (Pval<0.05 in the validation) for AR 
























ORval , ORGWAS are the Odds Ratio in the GWAS cohort (discovery) and the validation cohort (val) respectively for the atopy phenotype. 
Pval , PGWAS are the P values in the GWAS cohort (discovery) and the validation cohort (val) respectively for the atopy phenotype. 
Table 3a: Validation results of the interacting SNP pairs which were significant (Pval<0.05 in the validation) for Atopy 




































Supplementary Table 1: Interacting loci from chromosome 3 and chromosome 7 
Chr1 SNP1 Position Gene 1 Chr2 SNP2 Position Gene 2 Chi-sq p-value 
3 rs3856921 190033273 LPP 7 rs7801774 110457787 IMMP2L 27.68 1.43E-07 
3 rs4686998 190038576 LPP 7 rs7801774 110457787 IMMP2L 27.3 1.75E-07 
3 rs9985234 190029520 LPP 7 rs7801774 110457787 IMMP2L 26.76 2.31E-07 
3 rs10937369 190015503 LPP 7 rs7801774 110457787 IMMP2L 26.04 3.34E-07 
3 rs1513181 190057690 LPP 7 rs7801774 110457787 IMMP2L 25.58 4.26E-07 
3 rs3914270 190043711 LPP 7 rs7801774 110457787 IMMP2L 24.48 7.54E-07 
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9. REPLICATION IN OTHER INDEPENDENT POPULATIONS  
 
9.1 Background 
Genetic association studies for allergic phenotypes over the past two decades have 
yielded mixed results. We have discovered new genetic susceptibility markers, which 
identify new ‗candidate genes‘ which were not reported earlier. However multiple 
groups started studying these candidate genes, many of them were not associated 
across multiple populations as reported by various studies. Thus standards for 
publishing ‗novel‘ genes for diseases were made more stringent. Thus we had the 
two-stage genetic association study design where the novel candidate genes identified 
in one population must be replicated in another independent population to validate as 
a ‗novel candidate gene‘. Taking a closer look at these genes published as potential 
allergy susceptibility genes, only a handful are published in more than 5 studies at 
least [1]. Majority of these genes were negative in association studies. However the 
failure to a find association in another ethnically different population need not 
necessarily suggest that the initial finding was false [2, 3]. Lack of replication might 
be due to underlying population structure variations that are not considered in the 
analysis [4,5]. Some studies attempted replicating candidate SNPs rather than using 
the gene as the unit of replication and hence the lack of association is probably 
because the wrong marker was typed [6,7]. In other cases, the negative result might be 
due to different disease annotations, lack of statistical power, disease heterogeneity 
and in some cases insufficient sequence coverage [3,4]. In some cases the association 
is observed in terms of P values of association but the effect is reversed. This 
phenomenon is observed in about 20% as reported by Lohmueller et al., and could 





haplotype blocks between populations. Another possible confounder might be 
underlying interactions, gene-gene or gene-environment, which are not considered in 
study design. For example, genetic variation in the CD14 gene has shown to vary 
effects in different ethnicities and in some cases the effect is actually reversed [9,10]. 
In this chapter, we compile different studies that evaluated the relevance of the same 
set of allergy candidate genes in two ethnically different populations: Singapore 
Chinese and Swedish. 
 
9.2 Rationale 
We used two different approaches summarized in the following studies to evaluate the 
replication of allergy candidate genes in the two independent populations.  
 
o Study 1: Toll-like receptor gene polymorphisms are associated with 
allergic rhinitis in both Swedish and Singapore Chinese populations. 
 
o Study 2: Investigating association of highly replicated asthma 
candidate genes to allergic rhinitis in an ethnic Chinese population in 
Singapore and a Swedish population 
 
Many of the genetic association studies for allergic phenotypes have been performed 
in European populations including the recent genome-wide association studies 
published. The relevance of these genes in Asian populations has not been studied 
extensively. Also replication was attempted at the SNP levels for significant 
candidates that are not ideal, as this doesn‘t account for the population differences 





significantly different in terms of linkage and hence tagSNPs have to be chosen based 
on the population under study and not the original population identified in. Some 
reviews on genetic association studies suggest that this might be one of the reasons 
why some genes are not significant in other populations investigated as the tagSNPs 
might be different or even absent in some cases [11]. In some other instances the SNP 
is present at the same allele frequencies in two different populations, but associated 
with disease predisposition in one and not significant in another as reported for 
systemic lupus erythematosus [13]. Hence in our study we validated SNPs associated 
with allergic rhinitis in TLR genes for the Swedish population in a Singapore Chinese 
population (Study 1). For study 2 and 3 we used independent datasets from the two 
populations to evaluate the relevance of SNPs in these candidate genes and then 
compared the association results to identify common genes/SNPs relevant in both 
populations which might be key in revealing mechanisms associated with the 
pathophysiology of allergic diseases such allergic rhinitis and asthma. 
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9.2 TOLL-LIKE RECEPTOR GENE POLYMORPHISMS ARE ASSOCIATED WITH 
ALLERGIC RHINITIS IN SINGAPORE CHINESE AND A SWEDISH POPULATION 
 
9.2.1 Background 
The human Toll-like receptor (TLR) proteins are pattern recognition proteins 
important in early detection of pathogens and subsequent triggering of the innate 
immune response [1]. All TLRs share the same basic organization with an extra-
cellular domain containing a variable number of leucine-rich repeats, a single 
transmembrane spanning domain and an intracellular Toll-Interleukin-1 receptor 
(TIR) domain. TLRs are expressed on various cells of the immune system, including 
dendritic cells, macrophages and B- and T-cells. Some of the TLRs are located on the 
surface of the cell (TLR1, TLR2, TLR4, TLR5 and TLR6) while others are located 
intra-cellular (TLR3, TLR7, TLR8 and TLR9). The different TLRs recognize 
different microbial products including: LPS (TLR4), viral dsRNA (TLR3), viral 
ssRNA (TLR7 and TLR8) and CpG DNA (TLR9) and some of the TLRs can even 
recognize several unrelated ligands. Homo- and hetero-dimerization of TLRs or 
association with other receptors such as CD14 increase the diversity of molecules that 
can be recognized by TLRs. Following encounter with a pathogen, TLRs trigger 
signalling cascades and the production of cytokines and chemokine but also interact 
with the adaptive immune response [1]. 
The 10 TLR genes are located on chromosomes 3, 4, 9 and X in a total of 6 
chromosome regions. They are highly polymorphic with a large number of non-
synonymous polymorphisms, some present at high frequencies [2]. Many studies have 
reported that genetic variation in the TLR genes modifies cellular immune response 





and TLR4, but also polymorphisms in TLR1, TLR5, TLR6, TLR9 and TLR10 have 
been associated with susceptibility to different infections. Although there is 
convincing evidence for a number of these findings, many studies rely on small 
sample sizes and have not been convincingly replicated [3]. A number of studies have 
searched for associations between genetic variation in the TLR genes and allergic 
disorders such as asthma, atopic eczema and allergic rhinitis (AR). Genetic variation 
in TLR2 [4], TLR4 [5], TLR10 [6] and TLR1, TLR6 and TLR10 [7] have been 
associated with the development of asthma, and in TLR9 a promoter polymorphism 
has been associated with atopic eczema [8]. Other studies, however, have failed to 
find associations with genetic variants in TLR2 and TLR4 in atopic eczema [9] and in 
AR [10]. Linkage analysis identified a susceptibility locus on chromosome Xp for 
various atopic phenotypes including AR [11]. Since this chromosome region harbours 
the TLR7 and TLR8 genes, a later study investigated the possible role of these genes 
in the development of atopic disease [12]. SNPs in both genes showed significant 
associations with asthma, atopic dermatitis and AR. Since TLRs are so centrally 
involved in the recognition of microbes and the initiation of the innate and adaptive 
immune responses, genetic changes in the TLR molecules may have profound effects 
on the development and severity of allergy. In addition, since a number of studies 
have reported significant associations between polymorphisms in the TLR genes and 
different atopic phenotypes we decided to search for associations with AR in these 
genes. The aim of this study is to search for genetic variation associated with allergic 






Note: The data presented in this study is currently under review in the journal 
“Clinical and Experimental Allergy” under the title,‘ Toll-like receptor gene 
polymorphisms are associated with allergic rhinitis‘. 
9.2.2 Results 
9.2.2.1 Association testing TLR1-TLR10 in the Swedish population 
In a first exploratory step, tagSNPs were selected from HapMap data for each of the 
10 TLR genes (TLR1-TLR10) and non-synonymous SNPs with reported frequencies 
in dbSNP or HapMap were added to this selection. A total of 73 SNPs were 
successfully genotyped in a subset of the Swedish population and subsequently tested 
for association with AR in 182 cases and 378 controls. Five of the analyzed genes 
contained no significant SNPs in the association analysis, whereas the genes TLR1, 
TLR6 and TLR7 each showed one SNP, and TLR8 had three SNPs with uncorrected P-
values below 0.05 (Table S3). In none of these cases the q-values were below 0.1 
giving only weak support for an association to allergy. However, the TLR7 and TLR8 
genes were a priori implicated [12]. Given this fact, it is noteworthy that: 1) the three 
lowest P-values (0.02-0.04) and the three highest odds ratios (1.4-1.6) were found for 
SNPs in TLR8, 2) one additional SNP with a P-value below 0.05 was found in TLR7, 
and 3) the TLR7 and TLR8 genes are located in the same chromosome region. We 
therefore decided to extend the analysis of the TLR7-TLR8 gene region. TLR1 and 
TLR6 which each showed a single marginally significant SNP and had no prior 








9.2.2.2 Association testing the TLR7-TLR8 region in the extended Swedish 
population 
The TLR7-TLR8 gene region was further investigated using a set of 24 SNPs. This set 
included the two SNPs previously associated with AR (rs179008 and rs2407992) by 
Møller-Larsen et al. [12]. All SNPs were genotyped in the complete Swedish 
population and subsequently tested for association with AR in 352 cases and 709 
controls. The association analysis detected a total of 7 SNPs with P-values <0.05 at 
the genotype level. Three of these also showed P-values <0.05 in the allele test in 
females and in males - females combined (Table 1). In all cases the major allele was 
6-7 % more common in cases compared with controls (Table S4). The genotype tests 
gave q-values equal to 0.06 for all 7 SNPs. Two SNPs gave slightly lower q-values 
(0.04) for the allele test in females. None of the seven SNPs showed a deviation from 
the Hardy-Weinberg equilibrium (Table 1). Using Haploview on HapMap CEU data 
to analyze the haploblock structure of the TLR7-TLR8 region identifies 3 haploblocks; 
one encompassing the promoter region and a major part of the TLR7 gene, one 
covering the last part of TLR8 and one encompassing the region in between those two 
blocks (Figure S1). The 7 indicated SNPs are all located in the latter haploblock. 
Haplotypes were constructed from the 3 SNPs that were associated both at the allele 
and genotype levels (rs3788935, rs3761624 and rs4830805) and had the highest odds 
ratios (Table S4). When analyzing males and females together, the most common 
haplotype (AAG) showed a higher frequency in cases than in controls, 0.81 versus 
0.75. This difference was significant (P = 0.0045, uncorrected P-value) and 
compatible with the notion of this haplotype being a risk-haplotype (Table 2). This 
was true also when analyzing females separately (P = 0.0061), but when analyzing 





Table 1. Association of SNPs in the TLR7-TLR8 region with AR phenotype in the Swedish population 
      Association test Skin prick test 




 HW Allele M+F Allele M Allele F Genotype Birch Timothy grass 
TLR7 rs179021 12889763 T/G 0.22 0.25 0.60 0.54 0.82 0.50 0.64 0.061 
TLR7 rs179020 12889857 G/A 0.24 0.32 0.40 0.71 0.16 0.36 0.17 0.49 
TLR7 rs179019 12889969 C/A 0.24 0.32 0.41 0.69 0.16 0.36 0.17 0.49 
TLR7 rs179016 12894442 G/C 0.36 0.52 0.34 0.31 0.69 0.61 0.90 0.14 
TLR7 rs179014 12899765 G/A 0.24 0.13 0.58 0.65 0.25 0.45 0.19 0.43 
TLR7 rs179013 12901471 G/A 0.22 0.44 0.42 0.50 0.56 0.63 0.42 0.095 
TLR7 rs179012 12901562 G/A 0.29 0.98 0.67 0.68 0.84 0.83 0.32 0.28 
TLR7 rs179011 12901960 G/T 0.23 0.20 0.41 0.63 0.44 0.57 0.46 0.093 
TLR7 rs179010 12902885 C/T 0.31 0.012 0.47 0.95 0.26 0.55 0.97 0.90 
TLR7 rs179008 12903659 A/T 0.22 0.16 0.29 0.38 0.47 0.44 0.39 0.11 





TLR7 rs179007 12910322 A/G 0.23 0.81 0.53 0.50 0.90 0.87 0.20 0.21 
TLR7 rs179006 12910521 G/A 0.20 0.61 0.17 0.46 0.30 0.43 0.42 0.22 
TLR7 rs2269809 12910619 G/T 0.50 0.057 0.58 0.91 0.40 0.028 (0.064) 0.81 0.054 
TLR7 rs5935438 12913022 G/C 0.45 0.21 0.28 0.99 0.22 0.0059 (0.064) 0.81 0.019 (0.051) 
TLR8 rs178998 12917787 C/T 0.34 0.045 0.19 0.86 0.080 0.15 0.10 0.23 
TLR8 rs3788935 12922659 A/G 0.23 0.53 0.0036 (0.076) 0.36 0.0037 (0.046) 0.012 (0.064) 0.44 0.23 
TLR8 rs3761624 12923681 A/G 0.22 0.62 0.0080 (0.076) 0.49 0.0056 (0.046) 0.016 (0.064) 0.40 0.16 
TLR8 rs5741883 12924221 C/T 0.25 0.96 0.28 0.96 0.17 0.068 0.67 0.038 (0.054) 
TLR8 rs17256081 12926045 T/C 0.49 0.11 0.80 0.64 0.98 0.021 (0.064) 0.76 0.0066 (0.035) 
TLR8 rs4830805 12927759 G/A 0.21 0.92 0.0069 (0.076) 0.25 0.013 (0.071) 0.042 (0.064) 0.34 0.080 
TLR8 rs1548731 12927947 C/T 0.27 0.93 0.50 0.89 0.48 0.046 (0.064) 0.94 0.49 
TLR8 rs4830808 12932334 C/T 0.16 0.44 0.70 0.53 0.38 0.55 0.24 0.22 
TLR8 rs2407992 12939112 G/C 0.38 0.068 0.63 0.75 0.40 0.67 0.42 0.040 (0.054) 
The Hardy-Weinberg (HW) test uses both cases and controls. Male (M) and Female (F) individuals were used separately and combined in the allele tests. The Kruskal-Wallis 
test is used on skin prick data. P-values are given for the HW and the association tests. Q-values are given in parenthesis.
*
Position according to NCBI build 37.1. 
†
Allele 





Bonferroni correction for nine tests is the most conservative approach. This gives a P-
value limit at 0.0055, rendering the haplotype test for all individuals still significant 
(P = 0.0045). 
To test for genotype effects on the level of AR among the cases the Kruskal-
Wallis test was used. The SPT scores for birch and timothy grass were tested against 
all 24 SNPs in the TLR7-TLR8 region. A total of 4 SNPs  had P-values <0.05when 
analyzing timothy grass SPT data (Table 1), including the rs2407992 SNP previously 
associated with AR by Møller-Larsen et al. [12]. The strongest association was found 
for rs17256081 (P = 0.0066 and q = 0.03). The remaining three indicated SNPs had q-
values equal to 0.05. If the effect of genotype on SPT scores is investigated in detail 
for this SNP, it is seen that the heterozygotes have a lower average score than the 
homo- and hemizygotes. The same general effect is seen in rs5935438 and rs2407992. 
No SNPs were detected as significant when birch SPT data were analyzed. 




frequency Association test 




M+F M F 
H1 A A G 0.75 0.81 0.0045 0.32 0.0061 
H2 G G A 0.22 0.17 0.0092 0.31 0.014 
H3 G G G 0.025 0.019 0.48 0.80 0.26 
Male (M) and female (F) individuals were used separately and combined in the 
association tests.  
Haplotype frequencies are given as the combined frequencies for males and females. 





9.2.2.3 Association testing the TLR7-TLR8 region in the Chinese population  
The same set of SNPs was also genotyped and 23 SNPs were subsequently analyzed 
for association with AR in a Chinese population containing 948 cases and 580 
controls. The association analysis detected a total of 5 SNPs with P-values below 0.05 
when males were analyzed separately; the q-values for these five SNPs were 0.07. All 
but one of the indicated SNPs had genotype distributions that were in Hardy-
Weinberg equilibrium (Table 3). The rs2407992 SNP showed the strongest 
association in the Chinese population (P = 0.0054) with the major allele 10% more 
common among male cases than male controls (Table S5). The LD pattern for the 
TLR7-TLR8 region in the Chinese population was investigated using Haploview and 
HapMap CHB data. The analysis revealed one haploblock spanning the major part of 
TLR7 and one haploblock spanning the last part of TLR7, the intergenic region and the 
complete TLR8 gene (Figure S1B). Haplotypes were constructed from the 5 SNPs that 
were indicated to be associated with AR (i.e. rs178998, rs3788935, rs17256081, 
rs4830805 and rs2407992; Table4). These SNPs are all located in the haploblock 
covering the TLR8 gene. The most common haplotype (TGTAC) showed a higher 
frequency in cases than in controls, 0.76 versus 0.73, which was only marginally 
significant (P = 0.044). When analyzing females separately, the frequencies of this 
haplotype did not differ between cases and controls (P = 0.53), but when comparing 
frequencies among male cases and controls, 0.80 versus 0.66, the difference is 
significant (P = 0.0016). Given the data in Table 4, a Bonferroni correction for 20 
tests is the most conservative approach. This gives a P-value limit at 0.0025, 
rendering the haplotype test for males still significant. Of the five SNPs listed above, 
two were also included in the haplotype analysis in the Swedish population 





Table 3. Association of SNPs in the TLR7-TLR8 region with AR phenotype in the Chinese population. 
      Association test Skin prick test 









TLR7 rs179021 12889763 T/G 0.01 1.0 0.72 0.42 0.62 0.62 0.70 0.12 
TLR7 rs179020 12889857 G/A 0.25 0.26 0.65 0.38 0.36 0.56 0.021 (0.32) 0.010 (0.025) 
TLR7 rs179019 12889969 C/A 0.25 0.34 0.78 0.36 0.44 0.70 0.022 (0.32) 0.0090 (0.025) 
TLR7 rs179016 12894442 G/C 0.12 1.0 0.61 0.62 0.81 0.85 0.094 0.013 (0.025) 
TLR7 rs179014 12899765 G/A 0.00 1.0 0.80 - 0.91 0.91 0.091 0.24 
TLR7 rs179013 12901471 G/A 0.01 1.0 0.85 0.42 0.76 0.76 0.72 0.14 
TLR7 rs179012 12901562 G/A 0.06 1.0 0.66 0.92 0.75 0.95 0.67 0.011 (0.025) 
TLR7 rs179011 12901960 G/T 0.01 1.0 0.65 0.42 0.58 0.58 0.73 0.13 
TLR7 rs179010 12902885 C/T 0.35 0.18 0.86 0.45 0.52 0.59 0.078 0.0046 (0.025) 
TLR7 rs179008 12903659 A/T 0.00 1.0 0.37 - 0.47 0.47 0.76 0.43 





TLR7 rs179007 12910322 A/G 0.00 0.0044 0.17 - 0.25 0.55 0.76 0.43 
TLR7 rs179006 12910521 G/A 0.00 0.0036 0.17 - 0.25 0.55 0.76 0.43 
TLR7 rs2269809 12910619 T/G 0.16 0.20 0.38 0.061 0.97 0.27 0.59 0.18 
TLR7 rs5935438 12913022 G/C 0.15 0.017 0.34 0.056 0.92 0.27 0.77 0.26 
TLR8 rs178998 12917787 T/C 0.16 0.053 0.18 0.024 (0.072) 0.74 0.34 0.43 0.56 
TLR8 rs3788935 12922659 G/A 0.17 0.10 0.27 0.025 (0.072) 0.85 0.80 0.45 0.14 
TLR8 rs5741883 12924221 C/T 0.02 0.35 0.66 0.84 0.64 0.39 0.27 0.53 
TLR8 rs17256081 12926045 T/C 0.15 0.018 0.20 0.010 (0.072) 0.86 0.54 0.84 0.19 
TLR8 rs4830805 12927759 A/G 0.19 0.29 0.42 0.016 (0.072) 0.84 0.74 0.40 0.053 
TLR8 rs1548731 12927947 C/T 0.02 0.68 0.33 0.93 0.38 0.26 0.16 0.25 
TLR8 rs4830808 12932334 T/C 0.23 0.41 0.16 0.054 0.58 0.85 0.091 0.057 
TLR8 rs2407992 12939112 C/G 0.19 0.18 0.023 (0.33) 0.0054 (0.072) 0.30 0.59 0.12 0.45 
The Hardy-Weinberg (HW) test uses both cases and controls. Male (M) and female (F) individuals were used separately and combined in the 
allele tests.  The Kruskal-Wallis test is used on skin prick data. P-values are given for the HW and association tests. 
*
Position according to NCBI build 37.1  
†










alleles in both populations. Since the allele frequencies of the two populations are 
highly different the opposite alleles are associated with AR in the two populations. 
This is illustrated for rs3788935 where the two alleles, A and G, have frequencies 
0.77 and 0.23 in the Swedish population (Table 1) and 0.17 and 0.83 in the Chinese 
population (Table 3). Since LD is relatively strong in this region the same scenario is 
seen for a number of SNPs in the region. The Kruskal-Wallis test was used to 
determine the effect of genotype on the level of allergy of Dermatophagoides 
pteronyssinus and Blomia tropicalis that are the two major allergens in Singapore. 
Five SNPs located in the TLR7 gene showed uncorrected P-values below 0.05 and q-
values equal to 0.025 for an SPT response for D. pteronyssinus between genotypes.  
Two of those (rs179020 and rs179019) had P-values <0.05 when testing the response 
for B. tropicalis, however both of these had high q-values and are thus not indicated. 




frequency Association test 




M+F M F 
H1 T G T A C 0.73 0.76 0.044 0.0016 0.53 
H2 C A C G G 0.12 0.11 0.34 0.070 0.82 
H3 T G T A G 0.064 0.047 0.065 0.30 0.19 
H4 C A C G C 0.025 0.021 0.45 0.37 0.73 
H5 T A T G C 0.017 0.021 0.48 0.70 0.41 
H6 T G T G C 0.012 0.014 0.69 0.80 0.58 
H7 C G T A G 0.012 0.010 0.55 - 0.72 
Male (M) and female (F) individuals were used separately and combined in the association test. 
Haplotype frequencies are given as the combined frequencies for males and females. Disease-






9.2.3 Discussion  
A number of observations indicate that genetic variation in the TLR7-TLR8 gene 
region influences the risk for and the degree of AR: 1) the a priori indicated TLR7 
and TLR8 genes gave the strongest signals among the tested TLR genes. 2) 
Association tests in both the Swedish and the Chinese populations yielded several 
uncorrected p-values <0.05 with their corresponding q-values <0.1 and in some cases 
<0.05. When haplotype associations were tested using the Bonferroni correction, 
significant differences were still observed. 3) Comparing the results from the Swedish 
and Danish populations, a similar pattern of association was seen. In the Danish 
population [12], two SNPs were associated with AR, rs179008 in TLR7 and 
rs2407992 in TLR8. The A-allele of the rs179008 SNP was over-transmitted in 
Danish cases (P = 0.0039). This pattern was seen also in the Swedish population, 
albeit at a non-significant level (P = 0.38). In the same way, the G-allele of the 
rs2407992 SNP was over-transmitted in Danish cases (P = 0.037) with the same 
pattern observed in Swedish cases, but again at a non-significant level (P = 0.40). 
Thus, the congruence of the allelic associations detected in the Swedish and Danish 
populations may simply reflect the fact that they have the same major allele. 4) When 
the effect of genotype on the severity of phenotype among the cases were tested, 
several p-values yielded uncorrected p-values <0.05 and corresponding q-values < 0.1 
and in some cases < 0.05. This is particularly important since the phenotype test relies 
on cases only and furthermore do not depend on the exact genotype numbers among 
the cases. Thus, the phenotype test is independent from the case-control association 
test.   
Although a number of results indicate an association between genetic variation 





have been made. The first is that, for many of the SNPs in the region, the major allele 
in the Swedish population is the minor allele in the Chinese population and vice versa. 
However, in both populations it is the most common haplotype that is associated with 
AR. A situation where different major alleles of the same locus are risk-associated in 
different populations is compatible with a scenario where the risk is contributed by 
many different rare alleles that each has a relatively limited life span. Under these 
conditions, the major haplotypes will on average be more associated with risk. There 
are good reasons to believe that multiple rare variants, both within and across genes, 
collectively affect the expression and function of genes. This hypothesis can be tested 
by simply re-sequencing large numbers of cases and controls and evaluate the patterns 
of rare alleles in the two groups.  Many reports on the association of rare variants with 
specific disease phenotypes exist (reviewed in Bansal et al. [27]). 
The second discordant observation is that, in the Swedish population the AR 
association is seen primarily in females, whereas in the Chinese population the 
association is observed among males only. However, the Swedish population is most 
likely underpowered when analyzing X-chromosomes in males and a contribution to 
disease from males can therefore not be ruled out. In fact, when analyzing both males 
and females together, the P-values of the significant SNPs (rs3788935, rs3761624, 
rs4830805) are almost the same compared to when analyzing females separately. 
Also, when analyzing males, a tendency for association among these SNPs (P-values 
from 0.25 to 0.49) can be observed. In the Chinese population, however, the observed 
association is restricted to males with no tendency of association among females. Also 







A number of studies have reported associations between various diseases and 
variants in the TLR7 or TLR8 genes. For example, systemic lupus erythematosus was 
found to be associated with variation in TLR7 [28] and Crohn‘s disease and ulcerative 
colitis with variation in TLR8 [29]. In particular, the only high frequency missense 
polymorphism in the TLR8 gene (rs3764880) has been implicated in a number of 
diseases, such as tuberculosis [30] and progression of HIV infection [31]. This SNP is 
in perfect LD with rs3761624, indicating that these SNPs may serve as proxies for 
each other. The common allele of rs3761624 (A-allele in the CEU population) is 
present on the risk haplotype detected in the Swedish population, being compatible 
with the reported disease associations for rs3764880 where the common allele is the 
disease-associated allele. The pleiotropic effect seen for this allele also supports the 
disease association in the present study. Just as in the case of AR in the present study, 
several of the studies cited above reveal sex-specific disease associations for the 
TLR7-TLR8 gene region. In the association study of Crohn‘s disease and ulcerative 
colitis one risk- and one protective haplotype was detected among females, and the 
study of systemic lupus erythematosus detected an association to this region with a 
stronger effect in males compared to females (OR, male/female = 2.3, 95% CI = 1.64-
3.30).  
Association analysis based on case-control populations is a very popular 
method to search for genes that influence specific phenotypes. However, many studies 
suffer from limited population sizes, where the obvious drawback is the risk of false 
positives. This emphasizes the importance of large population sizes and the 
replication of positive findings but also of meta-studies where the combined efforts of 
many studies are evaluated. In the present study, genetic variation in the TLR7-TLR8 





Since this region has earlier been associated with asthma and AR in a Danish linkage 
study this speaks strongly in favour of this region being truly involved in the 
development of AR. 
 
9.2.4 Methods 
9.2.4.1 Ethics Statement 
This study was approved by the Ethics Committee of the Medical Faculty, Lund 
University and the Institutional Review Board of National University of Singapore 
and written informed consent was obtained from all subjects. This study is also in 
compliance with the Helsinki declaration. 
 
9.2.4.2 Subjects and phenotypes 
The Swedish study population was recruited at Malmö University hospital (Malmö, 
Sweden) between the years 2003 and 2009 and consists of unrelated subjects from the 
general population. It is comprised of 360 AR cases (169 females, 191 males, mean 
age 33 years). All cases were patients at the allergy clinic and were diagnosed with 
symptomatic birch and/or timothy grass pollen induced intermittent AR and 720 
controls (294 females, 426 males, mean age 43 years) with no atopy and allergic 
symptomology. Both cases and controls were of Caucasian origin, with both parents 
born in Sweden. In the Swedish population skin prick tests (SPT) [13] were 
performed with a standard panel of 11 common airborne allergens (ALK-Abelló, 
Hørsholm, Denmark).  This study population has previously been analyzed in several 
AR studies [14, 15]. The Singapore Chinese population was collected in Singapore 
over multiple volunteer recruitment drives and consists of unrelated subjects. In the 





in Singapore such as Dermatophagoides pteronyssinus and Blomia tropicalis. The 
population used in this study consists of 1024 AR cases (549 females, 475 males, 
mean age 22 years) with symptomatic dust mite induced AR and 605 controls (449 
females, 156 males, mean age 22 years) with no atopy and allergic symptomology. 
This study population has previously been analyzed in several AR studies [16-19]. 
Diagnostic procedures for the study populations included personal interview of 
medical history and skin prick test (SPT) [13] or Phadiatop test and were performed 
using standard panels of common airborne allergens. SPT were performed on the 
volar side of the forearm with saline buffer as negative and histamine chloride (10 
mg/ml) as positive controls. A wheal reaction diameter of ≥3 mm was considered a 
positive SPT response. SPT was only performed if the AR cases had not taken any 
anti-allergic drugs for at least 3 days prior to the test. Atopy is defined as a positive 
SPT reaction to either one of allergens tested. AR is thus diagnosed based on the 
presence of atopic status and typical AR symptoms as defined by the Allergic Rhinitis 
Impact on Asthma (ARIA) guidelines i.e., two or more AR symptoms (nasal 
congestion, rhinorrhea, nasal itching, sneezing) persisting for four or more days per 
week during the past year [20, 21]. Conversely, the non-allergic controls are defined 
by having no atopy and no typical AR symptoms.  
 
9.2.4.3 Genotyping  
Genomic DNA was extracted from blood collected in EDTA using QIAamp DNA 
Blood Maxi or Mini kits (Qiagen, Hilden, Germany) and DNA concentrations 
determined by fluorometry using PicoGreen (Molecular Probes, Invitrogen, Eugene, 
OR, USA). Genotypes were determined using the Sequenom MassARRAY MALDI-





software (Sequenom Inc, San Diego, CA, USA) and primers were obtained from 
Metabion GmbH (Martinsried, Germany). HapMap (release 24) data were used (r
2
 cut 
off = 0.8, and minor allele frequency cut off = 0.2) to identify haplotype-tagging 
SNPs for each of the 10 TLR genes (TLR1-TLR10). In addition, non-synonymous 
SNPs reported in dbSNP or HapMap with minor allele frequencies above 5% were 
added to this selection. Based on the results obtained in the first experiment, 
additional SNPs covering the TLR7-TLR8 region were selected together with two 
SNPs reported in the literature as being associated with AR (rs179008 and rs2407992) 
[12]. All SNPs attempted and successfully genotyped are summarized and described 
in Tables S1 and S2. A detailed description of genotyping and association testing in 
the two populations is given in the Supporting information (Text S1). 
 
9.2.4.4 Statistical analysis 
Statistical analyses were made using R statistical software [22] and the genetics 
package [23]. Genotype frequencies were calculated and tested for Hardy-Weinberg 
equilibrium in both cases and controls. Allele and genotype frequencies were then 
investigated for association with AR using a χ2-homogeneity test. The Kruskal-Wallis 
rank sum test was used for analysis of association between genotype and SPT-score. 
The score is defined as the size of the wheel reaction in relation to histamine. 
Haplotypes, haplotype blocks and linkage disequilibrium plots were constructed using 
Haploview 4.2 [24] and the default algorithm proposed by Gabriel et al. [25]. In order 
to compensate for the effect of multiple testing, the q-value introduced by Storey [26] 
was calculated using the software QVALUE (ver.1.0). The q-value is not just a 
modified P-value, as in the case of the Bonferroni correction, but is a conservative 





are reported if the corresponding uncorrected P-values are <0.05. Since the 
calculation of q-values is based on the distribution of P-values, it is not suited for 
significance testing of haplotypes. Instead the Bonferroni correction was used.  
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Appendix for Chapter 9.2 
Table S1. Investigated genes and number of attempted and genotyped SNPs   
Chromosome position data from NCBI database, GRCh 37.       










Swedish population, first screen           
TLR1 Chr 4 (38,797,876-38,806,412) 8.5 11   8   
TLR2 Chr 4 (154,605,441-154,627,243) 21.8 8   8   
TLR3 Chr 4 (186,990,309-187,006,252) 15.9 10   8   
TLR4 Chr 9 (120,466,460-120,479,768) 13.3 12   7   
TLR5 Chr 1 (223,283,584-223,316,624) 33 13   0   
TLR6 Chr 4 (38,828,408-38,831,160) 2.8 10   7   
TLR7 Chr X (12,885,202-12,908,480) 23.3 13   13   
TLR8 Chr X (12,924,758-12,941,288) 16.5 15   10   
TLR9 Chr 3 (52,255,098-52,260,179) 5.1 4   4   
TLR10 Chr 4 (38,774,234-38,784,589) 10.4 11   8   
              
Swedish population, second screen           
TLR7-TLR8 Chr X (12,885,202-12,941,288) 56.1 30   24   
              
Chinese population           










Table S2. Description of genotyped SNPs         
 
   
Exp.* SNP ID Chromosome 
position 
Gene location 
Primer sequences     
Forward Reverse Extension 
1 rs352140 3 52256697 TLR9 exon 2 ACGTTGGATGATAAGCTGGACCTCTACCAC ACGTTGGATGTGGCTGTTGTAGCTGAGGTC CACTCATTCACGGAGCTACC 
1 rs352139 3 52258372 TLR9 intron  ACGTTGGATGGAAGATGCTAGAAGATGCCC ACGTTGGATGTGGGAGGGCTGTGTGAGTG GTGGAGTGGGTGGAGGT 
1 rs5743836 3 52260782 TLR9 near-gene-5 ACGTTGGATGTTGGGATGTGCTGTTCCCTC ACGTTGGATGAGCAGAGACATAATGGAGGC CTGTTCCCTCTGCCTG 
1 rs187084 3 52261031 TLR9 near-gene-5 ACGTTGGATGTATTCCCCTGCTGGAATGTC ACGTTGGATGTGCTGGGCACTGTACTGGAT CCCCTGCTGGAATGTCAGCTTCTT 
1 rs10776483 4 38775040 TLR10 exon 4 ACGTTGGATGATGGAATGGGTTCCAGTAAG ACGTTGGATGTGAATTCTACTTTGCCCACC GGTTCCAGTAAGATAAGAATTAT 
1 rs11096955 4 38776107 TLR10 exon 4 ACGTTGGATGTGAGAGTTTTCAAGTGAGGC ACGTTGGATGCCAATAATATCTTAACAGACG AAGTGAGGCAGTTGGA 
1 rs11096956 4 38776180 TLR10 exon 4 ACGTTGGATGCCTGACAATATCAAATGCAC ACGTTGGATGAATATTGGAATTTCGTAGG CCACACATGCTTTTCCC 
1 rs11096957 4 38776491 TLR10 exon 4 ACGTTGGATGTAAGCAATAGAACCGATGTC ACGTTGGATGGGCAAAAGCCAATTTGTAAG AAGCAATAGAACCGATGTCTTAGCAT 
1 rs10856839 4 38777236 TLR10 exon 4 ACGTTGGATGGTTTCTGATGAGTCTCATTG ACGTTGGATGGGGTTTTGAGCTCATCTTC TCCAAGGATTTTACCACT 
1 rs4274855 4 38777471 TLR10 exon 3 ACGTTGGATGTCCTCTCTGAGAATCCTGAC ACGTTGGATGTTGGCTGAGAAGTCTCCAAG AATCCTGACTTACCTCAACAAC 
1 rs7694115 4 38779094 TLR10 intron  ACGTTGGATGCTATAGGTTGCCTCAAACAG ACGTTGGATGCAGCAGAAGATTTAGAGTCC AAATGTATGTCAGAACCTG 
1 rs7698870 4 38781459 TLR10 intron  ACGTTGGATGTACCACGGGAATGAACAGAG ACGTTGGATGGATCTCTTCTGAATGACCTC GAACAGAGAAGGGACAGGTGA 
1 rs4833095 4 38799710 TLR1 exon 4 ACGTTGGATGCTGGAGGATCCTAATGAAAG ACGTTGGATGCCTAAGTATTCTGGCGAAAC GTTTCAATGTTGTTTAAGGTAAGA 
1 rs5743596 4 38802528 TLR1 exon 3 ACGTTGGATGTGCTCAGGGTCTTCATGAAC ACGTTGGATGGGTGCCCAATATGCCTTTGT ACCAGGCCCTCTTCCT 
1 rs5743595 4 38802644 TLR1 intron  ACGTTGGATGGGAAATTTCCGGGTCTTTCA ACGTTGGATGGCAAGGAAGATGATGCAGAC CGGGTCTTTCAGCCAAA 
1 rs5743594 4 38802751 TLR1 intron  ACGTTGGATGGCTACTCACACAAGGAGCAA ACGTTGGATGGGGTTAGGATTTCAACATAAG GGATGTTATAGCTTGAATGTTT 
1 rs5743580 4 38804405 TLR1 intron  ACGTTGGATGAACATCCAGAGTGACTCAGC ACGTTGGATGTGGCTATGGTAAGCTTCTC AGTGACTCAGCGAGTTTAGAG 
1 rs5743566 4 38805942 TLR1 exon 2 ACGTTGGATGAAGGACTAGCTAGTGGGAAG ACGTTGGATGAGTTACTCCCGGAGGCAATG ACAAACCTGGCCACAAAAACA 
1 rs5743565 4 38805983 TLR1 exon 2 ACGTTGGATGAGCTGAACAGCAGCATTGCC ACGTTGGATGTTCTCTTCACCTAATCCCGC CCGGGAGTAACTGACT 





1 rs5743818 4 38829163 TLR6 exon 1 ACGTTGGATGCATACCCTTAGAAGAACTCC ACGTTGGATGCCAGGCAGAATCATGTTCAC ACCTCCAGTTTCATGC 
1 rs3821985 4 38830012 TLR6 exon 1 ACGTTGGATGAAAATACTATCTGTGAAAAC ACGTTGGATGATGCTGTGTCCTCATGCACC ACTATCTGTGAAAACGTTCTG 
1 rs5743810 4 38830350 TLR6 exon 1 ACGTTGGATGATTTTTATCAGAACTCACC ACGTTGGATGAGGCATTTCCAAGTCGTTTC AGAACTCACCAGAGGT 
1 rs5743808 4 38830736 TLR6 exon 1 ACGTTGGATGGTTGCAAAAGATATCCTGCC ACGTTGGATGGCAGGGCCTTGAAATCATTG AAGATATCCTGCCATCCTA 
1 rs1039559 4 38831596 TLR6 near-gene-5 ACGTTGGATGGCAAGCAGCAGACACATCAA ACGTTGGATGCTCAGCCTTTTTTCTCCCAC GGAAATATGCAAAGATATATGGA 
1 rs5743805 4 38832059 TLR6 near-gene-5 ACGTTGGATGCCCCAAGTTCTGGGACTATA ACGTTGGATGCAAGAAGCAACAATACACCC GGCTTAAGCCACTGTGC 
1 rs5743788 4 38833207 TLR6 near-gene-5 ACGTTGGATGGACACTGCAAGAGAGTGAAA ACGTTGGATGCAAGTCCCTATCATATATGG TGAAAAAGACAAACCACAGACT 
1 rs893629 4 154604968 TLR2 near-gene-5 ACGTTGGATGACATCACCTGAAACACACCG ACGTTGGATGGATTCATGAGCCTGAGTTCG TCCACTCCTGATGCTT 
1 rs4696480 4 154607126 TLR2 intron  ACGTTGGATGCTCACCATGTGATGCTTTCC ACGTTGGATGGGGAAGTCCAAGATTGAAGG TGTAGCCAGATGACCCTC 
1 rs1898830 4 154608453 TLR2 intron  ACGTTGGATGGATCCCCTATTTTCTAGCAC ACGTTGGATGAAAACTGGAAAAGGAATAG CTTATATTATTATTTCCCCTGTTC 
1 rs1816702 4 154609523 TLR2 intron  ACGTTGGATGGTGTGAGCCTTACTAAAGGT ACGTTGGATGCTTTGATTCCTCTAGCGCTG GTAACTTAGAATTACAATGGACTGC 
1 rs4235232 4 154618084 TLR2 intron  ACGTTGGATGGCTGTTCTTACCCAAAACAC ACGTTGGATGTGTGGTACTAGAATTACCAG AAAACACATCTTACCTTCTTTTC 
1 rs3804099 4 154624656 TLR2 exon 3 ACGTTGGATGCTGCTTCATATGAAGGATCAG ACGTTGGATGGATCTACAGAGCTATGAGCC CTTCATATGAAGGATCAGATGACTTAC 
1 rs3804100 4 154625409 TLR2 exon 3 ACGTTGGATGTTGAACTTATCCAGCACACG ACGTTGGATGTTCCAGTGTCTTGGGAATGC AACTTATCCAGCACACGAATACACAG 
1 rs5743704 4 154625951 TLR2 exon 3 ACGTTGGATGTGCATCATAGCAGATGTTCC ACGTTGGATGTGAAAATGATGTGGGCCTG cGCTGGGAGCTTTCCTG 
1 rs5743303 4 186988853 TLR3 near-gene-5 ACGTTGGATGGGGATAGGTATGAAGGATTG ACGTTGGATGATTGGAATGGTGTCATATGC gAGGATTGTTGAGATGATGTGTTTT 
1 rs5743305 4 186989333 TLR3 near-gene-5 ACGTTGGATGATCAGAGACATGTAGCCCTG ACGTTGGATGAAAGTGCCCTCTTGTGGGCT TGAGCCCAGTAACTATAAAGCGG 
1 rs7657186 4 186994039 TLR3 intron ACGTTGGATGCTTCTCACTAGAATGTGAAGC ACGTTGGATGTCTTGTTCTAGGCACAGAC TAGAGGACATAGTTCTTATTCCATA 
1 rs3775296 4 186997767 TLR3 exon 2 ACGTTGGATGGCCATCTGCTATTAATGTTGC ACGTTGGATGTACAAGGCAAAGTCTGTCTC ACTTTTTAATGTTTCTTTTCTACAG 
1 rs5743312 4 187000256 TLR3 intron ACGTTGGATGGTGGATAGTCCCTATCTGTG ACGTTGGATGGGAAGGATTGCTGGAAGACA TAGTCCCTATCTGTGTCACATACA 
1 rs5743314 4 187000375 TLR3 intron ACGTTGGATGTTCCACCCAGTGCTGCAGG ACGTTGGATGTGGTGTCATCCTCCTGAGAG TGCAGGGCGGCAGAGTCC 
1 rs3775292 4 187003025 TLR3 intron ACGTTGGATGGGAACCGAGTAAGGAAGGAC ACGTTGGATGCACCCTTCACCACATCCCAT GGAAGGACTCGTGCATTA 
1 rs3775291 4 187004074 TLR3 exon 4 ACGTTGGATGTATCACTTGCTCATTCTCCC ACGTTGGATGGAGAAAGCATCACTCTCTAT TGCTCATTCTCCCTTACACATA 
1 rs2770150 9 120463139 TLR4 near-gene-5 ACGTTGGATGCACTCAATCATTTACTGACC ACGTTGGATGACACATGGTCTGCCTTCTGG ATCAAAGACATCTAGGTTCTATG 





1 rs1927911 9 120470054 TLR4 intron ACGTTGGATGAGACCTTCCTTAGTCATGGC ACGTTGGATGCATCACTTTGCTCAAGGGTC CCAGATTTTGACAACTGCATTCTTTT 
1 rs10759933 9 120470372 TLR4 intron ACGTTGGATGGGTAATAAAATATCCAATATCG ACGTTGGATGTGCTCATCTTCTCTGTATCC AAAATATCCAATATCGTGCTTGC 
1 rs1927907 9 120472764 TLR4 intron ACGTTGGATGTTTTTCAAACAAGAAGTAG ACGTTGGATGGGGTATCCAGTGGATTGAAG TCAAACAAGAAGTAGTTTTTCA 
1 rs7869402 9 120478032 TLR4 exon 3 ACGTTGGATGTTTAGGGAGACACAGATGGC ACGTTGGATGACCTTCACACGTAGTTCTCC TGGCTGGGATCCCTCCCCTGTACC 
1 rs7873784 9 120478936 TLR4 exon 4 ACGTTGGATGGCTCTAAAGATCAGCTGTAT ACGTTGGATGGGTACCCTCTTAACAAAATG AAGATCAGCTGTATAGCAGAGTTC 
1 rs2302267 X 12885578 TLR7 intron ACGTTGGATGAGCTACAGTATTGTGCTGTC ACGTTGGATGATGGGCCCAATAGCATCAAC TTGTGCTGTCTTTGAAATGTAAACTT 
1 rs5741880 X 12887416 TLR7 intron ACGTTGGATGGTGTAATCTCTAGATCAAAG ACGTTGGATGAAAGGCAAAAAAGCACAGGG TCTCTAGATCAAAGGATCTG 
1 rs179022 X 12888567 TLR7 intron ACGTTGGATGTAGGAAATTTCTTTATGGC ACGTTGGATGCCAAATTTTTAAATAATCAG GGCTAAAAAAAGGTTATTAAGTAATC 
1,2,3 rs179021 X 12889763 TLR7 intron ACGTTGGATGGGCTCAAGCAACTCTTTGTC ACGTTGGATGCAGAAAAAAGCCAAGTTGCC CAGATCCCAACATTTCCTTT 
1,2,3 rs179020 X 12889857 TLR7 intron ACGTTGGATGATGGGGCTGTTGTCCTCTC ACGTTGGATGCTAACCAACCAGTCAGAAAG GGCTGTTGTCCTCTCAGGGCT 
1,2,3 rs179019 X 12889969 TLR7 intron ACGTTGGATGGAGATGAGACTATTTGAGGC ACGTTGGATGAGTCAGGAGAGCAGGAAATC TGAGGCCTGGGGAACGCTT 
1,2,3 rs179017 X 12893793 TLR7 intron ACGTTGGATGGTCTCACAAGATCTGATGG ACGTTGGATGATTACGTCTTACATGGCGTC ACAAGATCTGATGGTTTCATAAACGGC 
1,2,3 rs179016 X 12894442 TLR7 intron ACGTTGGATGAACCAATTTCTCTATGCCCC ACGTTGGATGGTTCAAGTATTCTTGGTACTC ATTTCTCTATGCCCCAAAACC 
1 rs1634321 X 12895325 TLR7 intron ACGTTGGATGACTTTCTCTTTAAATAACAG ACGTTGGATGAGGCTGTGTTAAACTTGTG CTTTCTCTTTAAATAACAGATTTAGA 
2,3 rs179014 X 12899765 TLR7 intron ACGTTGGATGAATAACTATTGAGGCCTGGG ACGTTGGATGAGAGTGGACAATCCTATATG TTCCATAATCAAACACACAAAATTTC 
2,3 rs179013 X 12901471 TLR7 intron ACGTTGGATGAAGTAGAAATCTGGTGGGTG ACGTTGGATGACCCAAGTTCCCTGACTTGC aagaTGGTGGGTGAAAATGGTAG 
2,3 rs179012 X 12901562 TLR7 intron ACGTTGGATGCATGGCATCCAAAGTCTTCC ACGTTGGATGGTGAGGCTAGTAGAGGAATT gtcATTTGTACCCTGTCTACTTGTC 
1,2,3 rs179011 X 12901960 TLR7 intron ACGTTGGATGGAGGTACAAAATTGTCTCTTC ACGTTGGATGCAGCTGGACTCTCAATGTTT AATTGTCTCTTCTTCTTGTCACC 
2,3 rs179010 X 12902885 TLR7 intron ACGTTGGATGTGGATCAGTTATACGGTTCC ACGTTGGATGTGGAGAGGAGATAGTAGTAG ggTCCTCTGATTATGTATCACC 
1,2,3 rs179008 X 12903659 TLR7 exon 3 ACGTTGGATGATCTAGCCCCAAGGAGTTTG ACGTTGGATGGTTTCCAATGTGGACACTGA GGATTATGTTAAAAAGGATAAGAATT 
1,2,3 rs864058 X 12906030 TLR7 exon 3 ACGTTGGATGCACACAAGTCACATCTGTGG ACGTTGGATGGTGATGCTGTGTGGTTTGTC GTGGCCAGGTAAGGAATAGTCACCTC 
1 rs3853839 X 12907658 TLR7 exon 3 ACGTTGGATGCTTTCTTTCTTACTGTTTCCC ACGTTGGATGGGTTGCTGCTTCAGTGCTTC CAGAAGCAGGCCCAAG 
2,3 rs179007 X 12910322 TLR7 near-gene-3 ACGTTGGATGTTTCTTCTTTTGCCTCCCCC ACGTTGGATGTTGCTTGACACTTGCTGTGG ctgaCTCCCCCTCCCTCTC 
2,3 rs179006 X 12910521 TLR7 near-gene-3 ACGTTGGATGTGAATGTGTCAGAGTCCAGC ACGTTGGATGCTTCAGTGAGCATGATCTTC gaacGTGTCACCTAGGGAAGATTCCA 





2,3 rs5935438 X 12913022 TLR7 near-gene-3 ACGTTGGATGTGACTTAATTAACGGGCGTG ACGTTGGATGGCCTACTTGACTGTCAGTTC GCATCATGCCTGTTCA 
2,3 rs178998 X 12917787 TLR8 near-gene-5 ACGTTGGATGCCTAAACTGTATGCATTGCC ACGTTGGATGTGGGCCTTCCTGTAGAAGAC gggtGGGGAAGCAACCTAGT 
2,3 rs3788935 X 12922659 TLR8 near-gene-5 ACGTTGGATGGTCTAGTATCTATGTCAAGC ACGTTGGATGGTGTGGAGAAAACTGAAGGC AACTCATAAAAATGAGTTACTTACTTA 
1,2,3 rs3761624 X 12923681 TLR8 near-gene-5 ACGTTGGATGTTGGTTTTCTCCCACTCCTG ACGTTGGATGCCCTGGCCACAAGAATAAAG GTAAGGCAAGATGAAACAT 
2,3 rs5741883 X 12924221 TLR8 near-gene-5 ACGTTGGATGAAGCGAGCATCTTTCTCCTG ACGTTGGATGACAATGAACACTCATTGAGC gaaaATGCCTCCTCCAGCACCTGGC 
1 rs3764880 X 12924826 TLR8 exon 1 ACGTTGGATGGCTAAAGAAATAGAAGTGGC ACGTTGGATGCTGCTGCAAGTTACGGAATG GAAATAGAAGTGGCTTACCA 
2,3 rs17256081 X 12926045 TLR8 intron ACGTTGGATGGCACTAAAATTTTACAATGC ACGTTGGATGATGTGTCATTGGCCCAGTTG GCTTTACAAAATGACTGTAGG 
1 rs2109134 X 12927186 TLR8 intron ACGTTGGATGCCCAGATGAACTCAGAGATG ACGTTGGATGAAGTGCATCATAGTGTCGCC cATGACGTTCCCCTCAATGGA 
1,2,3 rs4830805 X 12927759 TLR8 intron ACGTTGGATGAAGGGAACGTGGAAAATCCG ACGTTGGATGATCAGCAGAGACCTGATAGC ACCAGCATTTGAGTCTTGGA 
1,2,3 rs1548731 X 12927947 TLR8 intron ACGTTGGATGACCCAAAGAAGTCCATGAGG ACGTTGGATGGAGTGACCTTGAAAACATTC TCCATGAGGCCCCTGCTTT 
1,2,3 rs4830808 X 12932334 TLR8 intron ACGTTGGATGGGTAAATGGGTCTCCATTTAG ACGTTGGATGTCCCACTGGAATTGTTTAGG TAGAAAAAAATAATGTGGGTCTA 
1 rs1013150 X 12932441 TLR8 intron ACGTTGGATGATCACTCAGGGCAGTGTAAG ACGTTGGATGTTACTAGGAAAAAGATGAG CAGGGCAGTGTAAGGCATAAAGGAT 
1 rs5744068 X 12935058 TLR8 intron ACGTTGGATGTCATTTCCTTGCTAGCTGCC ACGTTGGATGCCCACAACAAGGAATGCAAG CCTGCAGAGAGCCACTCTCAGCTTCCA 
1 rs5744080 X 12937804 TLR8 exon 2 ACGTTGGATGGCTGACAAATTTGGAGTTGC ACGTTGGATGGTAGGGAGCTTGGCAGTTTG TATCTTTCAATTCTCTTTCACA 
2,3 rs2407992 X 12939112 TLR8 exon 2 ACGTTGGATGGACTCGCTGGCAAATTAAGG ACGTTGGATGGACACGTCTGGATTTATCCC GCTTCATTTGGGATGTGCTT 
1 rs3747414 X 12939412 TLR8 exon 2 ACGTTGGATGGGTCTTAGTTTCAAGTGCGG ACGTTGGATGAGTCAGTAGTCTGAAGCACC TCAAGTGCGGATTTGTT 
*1, Swedish population, first screen; 2, Swedish population, second screen; 3, Chinese population.         
 
Chromosome positions are given as chromosome number followed by chromosome positions according to NCBI database, GRCh 37. Base 
changes are given as major/minor alleles from HapMap data, release 24. Minor allele frequencies are given for the HapMap CEU population, 
whereas the allele frequencies reported for the HapMap CHB population are given for the minor allele in the CEU population. Primer sequences 






Table S3. Complete first experiment association test results in the Swedish population 
P-values are given for the Hardy-Weinberg (HW) and association tests. 
HW test  uses cases and controls. Q-values for the FDR-test are given in parenthesis. 









TLR9 rs352140 3 52256697 0.45 0.92 0.59 0.73 
TLR9 rs352139 3 52258372 0.43 0.76 0.48 0.70 
TLR9 rs5743836 3 52260782 0.13 0.28 0.74 0.87 
TLR9 rs187084 3 52261031 0.44 0.93 0.68 0.28 
TLR10 rs10776483 4 38775040 0.27 0.75 0.44 0.54 
TLR10 rs11096955 4 38776107 0.42 1.0 0.32 0.46 
TLR10 rs11096956 4 38776180 0.26 0.57 0.47 0.56 
TLR10 rs11096957 4 38776491 0.42 0.97 0.35 0.49 
TLR10 rs10856839 4 38777236 0.19 0.11 0.71 0.82 
TLR10 rs4274855 4 38777471 0.22 0.62 0.55 0.22 
TLR10 rs7694115 4 38779094 0.41 0.62 0.39 0.64 
TLR10 rs7698870 4 38781459 0.04 0.30 0.70  - 
TLR1 rs4833095 4 38799710 0.30 0.83 0.046 (0.29) 0.056 
TLR1 rs5743596 4 38802528 0.20 0.89 0.85 0.50 
TLR1 rs5743595 4 38802644 0.22 0.68 0.41 0.38 
TLR1 rs5743594 4 38802751 0.17 0.35 0.096 0.26 
TLR1 rs5743580 4 38804405 0.22 0.68 0.36 0.33 
TLR1 rs5743566 4 38805942 0.22 0.63 0.51 0.51 
TLR1 rs5743565 4 38805983 0.22 0.65 0.42 0.40 
TLR1 rs5743557 4 38806827 0.23 0.76 0.44 0.41 
TLR6 rs5743818 4 38829163 0.26 0.81 0.39 0.27 
TLR6 rs3821985 4 38830012 0.34 0.57 0.76 0.45 
TLR6 rs5743810 4 38830350 0.37 0.38 0.29 0.18 
TLR6 rs5743808 4 38830736 0.00 0.95 0.23  - 
TLR6 rs1039559 4 38831596 0.43 0.036 0.30 0.16 
TLR6 rs5743805 4 38832059 0.03 0.23 0.046 (0.29) 0.15 
TLR6 rs5743788 4 38833207 0.48 0.055 0.35 0.30 
TLR2 rs893629 4 154604968 0.01 0.90 0.40  - 
TLR2 rs4696480 4 154607126 0.46 0.96 0.19 0.43 
TLR2 rs1898830 4 154608453 0.31 0.31 0.79 0.39 
TLR2 rs1816702 4 154609523 0.10 0.16 0.072 0.18 
TLR2 rs4235232 4 154618084 0.01 0.90 0.41  - 
TLR2 rs3804099 4 154624656 0.43 0.43 0.35 0.28 
TLR2 rs3804100 4 154625409 0.08 0.20 0.72 0.93 





TLR3 rs5743303 4 186988853 0.19 0.76 0.58 0.86 
TLR3 rs5743305 4 186989333 0.34 0.66 0.095 0.081 
TLR3 rs7657186 4 186994039 0.18 0.86 0.30 0.49 
TLR3 rs3775296 4 186997767 0.20 0.92 0.67 0.90 
TLR3 rs5743312 4 187000256 0.16 0.79 0.76 0.90 
TLR3 rs5743314 4 187000375 0.19 0.47 0.37 0.60 
TLR3 rs3775292 4 187003025 0.18 0.19 0.23 0.29 
TLR3 rs3775291 4 187004074 0.29 0.19 0.16 0.32 
TLR4 rs2770150 9 120463139 0.25 0.85 0.55 0.84 
TLR4 rs1927914 9 120464725 0.34 0.99 0.27 0.50 
TLR4 rs1927911 9 120470054 0.28 0.26 0.76 0.57 
TLR4 rs10759933 9 120470372 0.04 0.88 0.29 0.28 
TLR4 rs1927907 9 120472764 0.15 0.24 0.72 0.73 
TLR4 rs7869402 9 120478032 0.03 0.65 0.81 0.70 
TLR4 rs7873784 9 120478936 0.17 0.58 0.88 0.95 
TLR7 rs2302267 X 12885578 0.03 0.76 0.62 0.35 
TLR7 rs5741880 X 12887416 0.07 0.80 0.097 0.41 
TLR7 rs179022 X 12888567 0.40 0.81 0.83 0.025 (0.47) 
TLR7 rs179021 X 12889763 0.20 0.78 0.16 0.31 
TLR7 rs179020 X 12889857 0.25 0.59 0.13 0.37 
TLR7 rs179019 X 12889969 0.25 0.56 0.18 0.45 
TLR7 rs179017 X 12893793 0.09 0.60 0.92 0.50 
TLR7 rs179016 X 12894442 0.33 0.48 0.19 0.46 
TLR7 rs1634321 X 12895325 0.07 0.82 0.68 0.56 
TLR7 rs179011 X 12901960 0.20 0.59 0.31 0.56 
TLR7 rs179008 X 12903659 0.20 0.90 0.23 0.32 
TLR7 rs864058 X 12906030 0.06 0.34 0.30  - 
TLR7 rs3853839 X 12907658 0.16 0.96 0.90 0.40 
TLR8 rs3761624 X 12923681 0.21 0.97 0.043 (0.29) 0.13 
TLR8 rs3764880 X 12924826 0.21 0.98 0.034 (0.29) 0.12 
TLR8 rs2109134 X 12927186 0.07 0.24 0.40  - 
TLR8 rs4830805 X 12927759 0.19 0.48 0.017 (0.29) 0.12 
TLR8 rs1548731 X 12927947 0.25 0.70 0.49 0.058 
TLR8 rs4830808 X 12932334 0.16 0.67 0.93 0.69 
TLR8 rs1013150 X 12932441 0.20 0.76 0.21 0.65 
TLR8 rs5744068 X 12935058 0.16 0.44 0.27 0.78 
TLR8 rs5744080 X 12937804 0.37 0.026 0.73 0.69 








Table S4. Allele and genotype frequencies for all significant SNPs in the Swedish 
population 
Odds ratios (OR) and 95% confidence intervals (CI) are calculated for the risk allele.  
SNP ID Allele/Genotype 
Allele/Genotype 
frequency OR  95% CI 
Controls Cases Lower Upper 
rs2269809 
G 0.49 0.52 1.10 0.89 1.36 
T 0.51 0.48  - - - 
GG 0.22 0.32 1.19 0.68 2.08 
GT 0.59 0.46 0.66 0.40 1.09 
TT 0.19 0.22  - - - 
rs5935438 
C 0.44 0.48 1.16 0.94 1.44 
G 0.56 0.52  - - - 
CC 0.16 0.28 1.66 0.96 2.90 
GC 0.58 0.45 0.75 0.47 1.20 
GG 0.26 0.27  - - - 
rs3788935 
A 0.75 0.82 1.48 1.14 1.93 
G 0.25 0.18  - - - 
AA 0.59 0.70 4.35 1.44 19.54 
AG 0.34 0.28 3.02 0.97 13.88 
GG 0.07 0.02  - - - 
rs3761624 
A 0.76 0.82 1.56 1.20 2.04 
G 0.24 0.18  - - - 
AA 0.59 0.69 9.31 3.08 41.85 
AG 0.34 0.29 3.02 0.97 13.88 
GG 0.07 0.02  - - - 
rs17256081 
C 0.47 0.52 1.18 0.95 1.46 
T 0.53 0.48  - - - 
CC 0.18 0.29 1.57 0.90 2.73 
CT 0.58 0.47 0.80 0.50 1.30 
TT 0.24 0.24  - - - 
rs4830805 
G 0.77 0.83 1.45 1.11 1.92 
A 0.23 0.17  - - - 
GG 0.61 0.71 3.22 1.02 14.76 
GA 0.34 0.27 2.23 0.68 10.43 
AA 0.05 0.02  - - - 
rs1548731 
T 0.27 0.28 1.08 0.85 1.37 
C 0.74 0.72  - - - 
TT 0.05 0.11 1.98 0.97 4.12 
CT 0.43 0.35 0.80 0.53 1.20 






Table S5. Allele frequencies in Chinese males for all significant SNPs  
Odds ratios (OR) and 95% confidence intervals (CI) are calculated for the risk allele.  




Controls Cases Lower Upper 
rs178998 
T 0.79 0.87 1.77 1.06 2.89 
C 0.21 0.13  - - - 
rs3788935 
G 0.77 0.85 1.71 1.05 2.75 
A 0.23 0.15  - - - 
rs17256081 
T 0.79 0.88 1.92 1.15 3.16 
C 0.21 0.12  - - - 
rs4830805 
A 0.74 0.83 1.74 1.09 2.74 
G 0.26 0.17  - - - 
rs2407992 
C 0.75 0.85 1.92 1.20 3.05 



























9.3 ASSOCIATION OF HIGHLY REPLICATED ASTHMA CANDIDATE GENES TO 
ALLERGIC RHINITIS IN TWO INDEPENDENT POPULATIONS 
 
9.3.1 Background 
It has long been recognized that the development of allergic diseases like asthma, 
allergic rhinitis and atopic eczema is dependent on interactions between different 
genetic and environmental factors 
1
. Several studies have shown that the genetic 
factors play a major role and the heritability for allergic rhinitis has been estimated to 
be as high as 70% 
2, 3
. Allergic rhinitis is a common inflammatory disease, affecting 
about 25% of the Swedish population 
4-6
. Although allergic rhinitis is defined as 
allergic inflammation in the nasal mucosa this disorder is not only confined to the 
upper airways, it has effects on the lower airways as well
7
, and it is well known that 
allergic rhinitis is closely related to asthma. Approximately 80% of individuals with 
asthma also present symptoms of allergic rhinitis, and patients with rhinitis have a 5-6 
fold increased risk of developing asthma 
8-10
.  
Asthma genetics has been extensively studied and several genes have 
been pointed out as associated with the development or severity of this disease
11
. In 
contrast, little has been written about the genetic basis of allergic rhinitis. However, 
due to the close relationship between allergic rhinitis and asthma, it is likely that these 
two phenotypes share some common genetic origins. In the beginning of 2006, Ober 
and Hoffjan listed 118 genes that had been reported to be associated with asthma- or 
atopy-related phenotypes
12
. Of the 118 listed genes, 25 had been found to be 
positively associated with asthma/atopy in 6 or more independent studies and these 
genes were considered to be true susceptibility genes for asthma- or atopy-related 





hence not known if they also apply to allergic rhinitis. Researchers have also 
suggested that well-designed replication of candidate genes is a requisite for 
identification and confirmation of allergy candidate genes
13
. The present study was 
thus designed to investigate if highly replicated asthma genes reported in the Ober and 
Hoffjan study, also are associated with the occurrence of allergic rhinitis.  
 
Note: The data present in this study in Chapter 6.2 has been drafted to a paper titled, 
―Investigating highly replicated asthma candidate genes and their association 
with allergic rhinitis‖ and is to be submitted to the journal, ‗American Journal of 







The Swedish study population consists of 246 AR patients (108 female, 138 male) 
and 431 control individuals (185 female, 246 male) and was recruited from southern 
Sweden in 2003-2009. All subjects are unrelated and of western European origin, 
with both parents born in Sweden. The diagnosis of birch and/or grass pollen induced 
AR was based on a positive history of intermittent AR for at least 2 years and a 
positive skin prick test (SPT) or Phadiatop test with at least class 2 to birch and/or 
timothy grass. All patients were classified as having severe symptoms i.e., nasal 
itching, sneezing, rhinorrhea and nasal congestion during pollen season and they had 
all been treated with antihistamines and nasal steroids during pollen seasons previous 
years. Control individuals had no history of AR or any other atopic disease and had a 
negative SPT or Phadiatop test. Genomic DNA was extracted from blood collected in 
EDTA using QIAamp DNA Blood Maxi or Mini kits (Qiagen, Hilden, Germany) and 
DNA concentrations determined by fluorometry using PicoGreen (Molecular Probes, 
Invitrogen, Eugene, OR, USA). 
The Singapore Chinese population consists of 448 AR patients (250 female, 
198 male) and 462 control individuals (337 female and 125 male) and was collected 
in Singapore between 2008 and 2010. The study population is of Chinese origin, 
residence of Singapore and all subjects are unrelated to one another. The diagnosis of 
dust mite induced AR was based on interviews of medical history using a 
standardized questionnaire and SPTs performed using a panel of common allergens in 
Singapore such as the house dust mite Dermatophagoides pteronyssinus and Blomia 
tropicalis. AR is thus diagnosed based on the presence of atopic status and typical AR 





(nasal congestion, rhinorrhea, nasal itching, sneezing) persisting for four or more days 
a week during the past year. Control individuals had no history of AR or any other 
atopic disease and had a negative SPT. More detailed phenotypic characteristics of the 
Singapore Chinese population have been described previously
14
. Genomic DNA was 
extracted from buccal cells obtained from a mouthwash of 0.9% saline solution 
following a standardized protocol
15
. Samples were quantified in triplicate on the 
Nanodrop (ND-1000). 
In both populations, SPT were performed with saline buffer as negative and 
histamine chloride as positive controls. A wheal reaction diameter of more than 3 mm 
was considered a positive SPT response. SPT was only performed if the AR cases had 
not taken any anti-allergic drugs for at least 3 days prior to the test. Atopy is defined 
as a positive SPT reaction to either one of allergens. The study was approved by the 
Ethics Committee of the Medical Faculty, Lund University and the Institutional 
Review Board (IRB, Reference - NUS07-023 and NUS10-343) of National University 
of Singapore and written informed consent was obtained from all subjects. This study 
is also in compliance with the Helsinki declaration. 
  
9.3.2.2 Genotyping 
A total of 21 genes were selected from a compilation of 25 genes reported to be 
associated with asthma/atopy phenotypes in 6 or more unrelated independent 
studies
12
. Polymorphisms of the 21 genes were analyzed for association with allergic 
rhinitis (IL4, IL13, CD14, MS4A2 (FCERB1), IL4R (IL4RA), ADAM33, GSTM1, 
IL10, CTLA4, SPINK5, LTC4S, NPSR1 (GPR154), NOD1 (CARD4), SCGB1A1 
(CC16), GSTP1, STAT6, NOS1, CCL5, TBXA2R, ADRB2 and TGFB1) whereas no 





are situated at the HLA locus. In this study, we consider the gene as the replication 
unit and not the individual SNPs.  
For genotyping in the Swedish study population, HapMap (release 24) data 
were used to identify haplotype-tagging SNPs (r
2
 cut off = 0.8, and minor allele 
frequency cut off = 0.2) for each gene. Non-synonymous SNPs reported in dbSNP or 
HapMap with minor allele frequencies > 5% was added to this selection. Genotypes 
were determined using the Sequenom MassARRAY MALDI-TOF system. Assay 
design was made using the MassARRAY Assay Design ver. 2.0 software (Sequenom 
Inc, San Diego, CA, USA) and primers were obtained from Metabion GmbH 
(Martinsried, Germany). Of the 275 SNPs initially attempted in the 21 genes, 192 
were successfully genotyped; 15 did not produce a working assay, 55 failed the 
genotyping cutoff of 95% and 13 were monomorphic in the study population. The 
total genotyping rate after removal of low-quality SNPs and DNA samples was 98.4 
% in 246 patients and 431 controls. Genotyping in the Singapore Chinese population 
was performed using the Illumina HumanHap 550 k BeadChip version 3 (Illumina, 





9.3.2.3 Statistical analysis 
Statistical analyses were made using R statistical software and the genetics package. 
Golden Helix SNP variation Suite was used to generate the QQ plots for the genome-
wide data. Genotype frequencies were calculated and tested for Hardy-Weinberg 
equilibrium in both cases and controls. Allele and genotype frequencies were then 
investigated for association with AR using a χ2-homogeneity test. Association 





A p-value < 0.05 were considered significant in all tests. Haplotypes, haplotype 
blocks and linkage disequilibrium plots were constructed using Haploview 4.2 using 
the default algorithm proposed by Gabriel et al. As the majority of tests performed 
were not independent, the p-values are in general not corrected for multiple testing. 
Instead we rely on the successful parallel analysis in several population samples as 
evidence for a true effect. 
 
9.3.3 Results 
9.3.3.1 Association testing for highly replicated asthma genes in the Swedish 
population 
For each of the 21 genes reported to be highly replicated in asthma, tagSNPs and non-
synonymous SNPs were selected using HapMap data and dbSNP. A total of 192 
SNPs were successfully genotyped and subsequently analyzed for association with 
AR in 246 patients and 431 controls. A total of 6 genes had 1 or more significant SNP 
and none of these showed any significant deviation from Hardy-Weinberg 
expectations. The results for these genes are presented in more detail in Table 1. The 
highest number of significant SNPs was found in NPSR1 where 5 SNPs out of 36 
were significant at the allele and/or genotype level. These SNPs were located in 
intron- 
2
-value (p=0.01) was detected at the allele level 
for rs17789834 in intron-5. CCL5 had a total of 3 significant SNPs out of 4 and 
showed the overall strongest AR association in this study with rs2107538 (p=0.002) 
and rs3817655 (p=0.003) both with an OR = 1.6. These two SNPs were located in the 
promoter region and in intron 2, and were both significant at the allele- and genotype 
level (Table 1). Two out of 13 SNPs genotyped in NOD1 were detected as significant 





showed their strongest association at the genotype level (p=0.045 and p=0.033 
respectively).  IL10, SCGB1A1 and TBXA2R contained 1 significant SNP each 
(Table1).  
All 192 SNPs for  were also analyzed to investigate the effect of 
genotype on the level of allergy, as scored in SPTs, among the patients, using the 
Kruskal-Wallis (KW) non-parametric test. Since the KW analysis only uses cases, this 
test is independent of the case-control association analysis. Significant differences 
were identified for 2 SNPs in IL10 and 3 SNPs in NPSR1 (Table 2). The lowest p-
value (p=0.009) was detected for rs2071487 in IL10 when analyzing timothy SPT-
data, although, this marker showed a strong deviation from Hardy-Weinberg 
expectations (p=0.0001). All significant observations were detected when analyzing 
timothy SPT-data, except rs323917 in NPSR1, which showed a significant p-value 
when analyzing birch SPT-data.  
 
9.3.3.2 Association testing for highly replicated asthma genes in the Chinese 
population 
Of the 21 genes initially identified to be tested for association to AR, 3 genes 
(LTC4S, NOD1, and GSTM1) had no SNPs in the Illumina Human Hap 550k panel 
while CCL5 gene had a SNP but was filtered out after quality control for SNPs. 
Hence a total of 413 SNPs from 17 unique genes previously identified for association 





TABLE 1: Phase1 results 
 








Allele       Genotype OR (95% CI) 
IL10 rs3021094 1 2.1E+08 0.09 0.159 0.078 0.02 1.55 (1.069 - 2.249) 
NOD1 rs4363092 7 3.1E+07 0.18 0.364 0.045 0.05 1.327 (0.9992 - 1.763) 
NOD1 rs4720003 7 3.1E+07 0.18 0.365 0.033 0.041 1.346 (1.012 - 1.79) 
NPSR1 rs2022142 7 3.5E+07 0.1 1 0.056 0.035 1.473 (1.026 - 2.116) 
NPSR1 rs1379925 7 3.5E+07 0.09 1 0.031 0.021 1.559 (1.066 - 2.28) 
NPSR1 rs1379923 7 3.5E+07 0.25 0.413 0.112 0.045 0.7623 (0.5844 - 0.9945) 
NPSR1 rs17788770 7 3.5E+07 0.1 0.676 0.035 0.083 0.7056 (0.4748 - 1.049) 
NPSR1 rs17789834 7 3.5E+07 0.19 0.318 0.039 0.011 1.435 (1.087 - 1.895) 
SCGB1A1 rs11231085 11 6.2E+07 0.36 0.738 0.005 0.037 1.277 (1.015 - 1.608) 
CCL5 rs1065341 17 3.4E+07 0.04 0.413 0.085 0.027 1.846 (1.065 - 3.202) 
CCL5 rs3817655 17 3.4E+07 0.17 0.124 0.009 0.003 1.557 (1.163 - 2.085) 
CCL5 rs2107538 17 3.4E+07 0.17 0.271 0.007 0.002 1.573 (1.177 - 2.101) 
TBXA2R rs3786989 19 3604004 0.93 0.25 0.086 0.038 0.6045 (0.374 - 0.9771) 
 
MAF – Minor Allele Frequency  
P value of association < 0.05 in bold 










TABLE 2 Kruskal Wallis test for sensitization  





HW test  
KW test 
Birch Timothy 
IL10 rs2071487 1 110233081 0.23 0.000 0.274 0.009 
IL10 rs3024492 1 206944112 0.26 0.921 0.170 0.025 
NPSR1 rs323917 7 34741643 0.06 0.768 0.048 0.355 
NPSR1 rs12534369 7 34804709 0.22 0.252 0.643 0.033 
NPSR1 rs17170017 7 34874209 0.25 0.756 0.542 0.011 
 
 Table 3 shows a total of 48 SNPs in 7 genes (NPSR1, AAA1, CTLA4, NOS1, 
SPINK5, IL4R, ADRB2) significant at P < 0.05 with multiple SNPs significant loci in 
the NPSR1 gene (14 SNPs) and SPINK5 gene (13 SNPs). The most significant 
association was for rs10270663 with Pallele = 6.83E-05 and Pgenotype =3.83E-04 with an 
OR = 0.69. Additionally there were 6 other NPSR1 SNPs (rs324389, rs324957, 
rs324987, rs10278663, rs324396, rs10267134) significant at P<0.001.  Interestingly, 
NPSR1 had the maximum number of significant SNPs in the Swedish population as 
well.  Additionally in the Singapore Chinese population, two SPINK5 SNPs 
(rs231804, rs231735) also had P values less than 0.001. Both SNPs had significant 
effect sizes with causative OR for rs231804 =1.461and OR for rs231735= 1.442. A 


















Pallele Pgenotype OR (95% CI) 
NPSR1 rs10270663 7 34752923 0.4614 1 0.00006825 0.0003828 0.6908(0.5756-0.8289) 
NPSR1 rs324389 7 34744239 0.4636 1 0.0001041 0.0005449 0.6972(0.5809-0.8367) 
NPSR1 rs324957 7 34767897 0.4272 0.773 0.0001088 0.0005238 1.437(1.196-1.726) 
NPSR1 rs324987 7 34787953 0.44 0.5692 0.0002094 0.0004867 1.413(1.177-1.697) 
NPSR1 rs10278663 7 34774996 0.3375 0.9231 0.0003236 0.001227 0.7029(0.5798-0.8521) 
NPSR1 rs324396 7 34756648 0.41965 0.4398 0.0003451 0.001161 1.399(1.164-1.682) 
NPSR1 rs10267134 7 34769628 0.337 0.9227 0.0003857 0.001419 0.706(0.5823-0.8559) 
CTLA4  rs231804 2 204416891 0.2278 1 0.0006004 0.002544 1.461(1.176-1.816) 
CTLA4  rs231735 2 204402121 0.22885 1 0.0009039 0.00375 1.442(1.161-1.791) 





NOS1 rs4657180 12 160514362 0.24735 0.7919 0.005079 0.01903 1.351(1.094-1.667) 
CTLA4  rs926169 2 204430997 0.3488 1 0.005865 0.01553 1.307(1.08-1.581) 
NPSR1 rs10081183 7 34706738 0.45225 0.5239 0.006642 0.02259 0.7771(0.6477-0.9324) 
CTLA4  rs6748358 2 204465150 0.2867 0.9053 0.007711 0.006688 1.314(1.075-1.607) 
CTLA4  rs1024161 2 204429997 0.3413 0.833 0.008759 0.02035 1.292(1.066-1.564) 
NPSR1 rs324374 7 34723121 0.48325 0.232 0.009531 0.01 1.271(1.06-1.524) 
NPSR1 rs1419791 7 34722086 0.4833 0.1992 0.009612 0.009564 1.271(1.06-1.523) 
NOS1 rs6659953 12 160516321 0.03488 0.6146 0.01145 NA 0.5169(0.3073-0.8694) 
NOS1 rs6677052 12 160486363 0.28615 0.5557 0.01154 0.04553 1.295(1.059-1.583) 
NOS1 rs6670958 12 160516339 0.03491 0.6146 0.01175 NA 0.518(0.308-0.8713) 
NPSR1 rs1345267 7 34714584 0.4555 0.3626 0.01176 0.03629 0.7915(0.6597-0.9495) 
CTLA4  rs733618 2 204439189 0.40225 0.6437 0.01223 0.0302 0.7896(0.6562-0.95) 
NOS1 rs4145621 12 160485312 0.2024 0.7945 0.01225 0.03605 0.7487(0.5967-0.9394) 





NPSR1 rs1419868 7 34834082 0.2451 0.234 0.01307 0.05356 1.306(1.057-1.613) 
CTLA4  rs3116504 2 204477299 0.4087 0.7005 0.01453 0.02816 1.258(1.046-1.513) 
CTLA4  rs3096851 2 204472127 0.4087 0.7005 0.01453 0.02816 1.258(1.046-1.513) 
CTLA4  rs231726 2 204449111 0.41025 1 0.01642 0.04087 1.253(1.042-1.506) 
SPINK5 rs4472254 5 147433830 0.1998 0.6944 0.01645 0.04433 0.757(0.6028-0.9507) 
SPINK5 rs10463396 5 147395535 0.20135 0.8956 0.01648 0.05306 0.7577(0.6037-0.9509) 
SPINK5 rs1422982 5 147400217 0.20135 0.8956 0.01648 0.05306 0.7577(0.6037-0.9509) 
SPINK5 rs7725292 5 147368581 0.33035 0.6671 0.01655 0.06066 1.266(1.044-1.535) 
NOS1 rs4431825 12 160477095 0.20235 0.7948 0.0172 0.05164 0.7593(0.6051-0.9527) 
NOS1 rs11584803 12 160480393 0.2017 0.8956 0.01827 0.0548 0.7613(0.6068-0.9552) 
SPINK5 rs7707803 5 147368427 0.3314 0.5925 0.02149 0.07678 1.253(1.034-1.519) 
SPINK5 rs4519913 5 147452004 0.50085 0.8556 0.02392 0.05674 0.8116(0.6771-0.9729) 
SPINK5 rs7724165 5 147445445 0.4975 0.8551 0.02723 0.05393 1.226(1.023-1.47) 





IL4R rs3024585 16 27267345 0.379 0.1858 0.03428 0.08752 0.8173(0.678-0.9853) 
SPINK5 rs17774892 5 147395161 0.11705 0.1089 0.03463 NA 0.736(0.5533-0.9788) 
NPSR1 rs411323 7 34668233 0.15295 0.4352 0.03655 0.09471 1.309(1.016-1.685) 
SPINK5 rs10477360 5 147384474 0.4977 0.7842 0.03705 0.06642 0.8245(0.6876-0.9885) 
SPINK5 rs17107650 5 147396591 0.1162 0.1086 0.03897 NA 0.7412(0.5573-0.9857) 
SPINK5 rs11948836 5 147393693 0.1162 0.1086 0.03897 NA 0.7412(0.5573-0.9857) 
SPINK5 rs11742519 5 148218501 0.4532 0.5155 0.0391 0.05587 1.211(1.01-1.453) 
IL4R rs2074570 16 27282658 0.07117 0.6772 0.03998 NA 1.45(1.015-2.07) 
SPINK5 rs17107673 5 147401681 0.1163 0.1086 0.04062 NA 0.743(0.5587-0.9881) 
NOS1 rs423125 12 160575903 0.17825 0.8656 0.04404 0.1343 1.276(1.006-1.618) 
SPINK5 rs12332673 5 147387572 0.1171 0.1087 0.04525 NA 0.7484(0.5632-0.9946) 





OR >1. Multiple SNPs from NOS1 (9 SNPs) and IL4R (3 SNPs) had significant P values less 
than 0.05.  
All candidate genes were then tested for association to skin prick test allergens 
Dermatophagoides pteronyssinus (Der p) and Blomia tropicalis (Blo t) using the Kruskal-Wallis 
test. Significant associations were observed for SNPs in IL4R, NOS1, NPSR1, AAA1, 
ADAM33, SPINK5, ADRB2 and MS4A2, which were found to influence sensitization to Blo_t 
(Table 4). However only four genes mentioned above – NPSR1, ADAM33, AAA1 and ADRB2, 
had SNPs which significantly influence sensitization to Der_p. Similar to the allelic and 
genotypic association, multiple SNPs in each of the above mentioned genes have been associated 
with SPT results. Interestingly, ADAM33 and MS4A2, which showed no association in the case-
control analysis, had SNPs which influenced the sensitization to house dust mites (Table 4).  
 
9.3.4 Discussion  
Allergic rhinitis is a major chronic respiratory disease and the most common allergic disorder 
with a worldwide prevalence of about 10-25%
16
. ARIA has recommended that AR must be 
considered as a risk factor for asthma and so asthmatic patients need to be evaluated 
appropriately for their rhinitis status
16-18
. As asthma and AR might have similar epidemiological 
and pathological features
19-21
, a combined treatment strategy would be most effective
22-25
. 
Chromosomal locations have been associated with atopy, asthma and allergic rhinitis through 
linkage studies
26-28
.  However the association of these genes to AR has not been 
comprehensively evaluated.  In this study, we investigated the association of well replicated 





TABLE 4 Kruskal Wallis test for sensitization in Singapore Chinese 





Blo t Der p 
        
IL4R rs3024585 16 27267345 0.379 0.1858 0.003642 0.980979 
NOS1AP rs1932933 1 1.6E+08 0.25435 0.4774 0.004532 0.583294 
GPR154 rs2023328 7 34998155 0.1964 0.6545 0.005282 0.595277 
GPR154 rs4723388 7 34909345 0.2009 0.5633 0.005621 0.519321 
GPR154 rs4236340 7 34976719 0.20055 0.5637 0.006078 0.456292 
GPR154 rs328906 7 34990440 0.19775 0.7684 0.008022 0.577187 
IL4R rs4787956 16 27285750 0.4777 0.5841 0.00874 0.173199 
IL4R rs1805011 16 27281373 0.074425 0.06093 0.010831 0.075986 
IL4R rs1805012 16 27281465 0.07339 0.09846 0.010831 0.075986 
NOS1AP rs10753789 1 1.61E+08 0.41675 0.6374 0.016116 0.183569 
ADAM33 rs512625 20 3596378 0.39145 0.8481 0.016522 0.216953 
NOS1AP rs7523798 1 1.6E+08 0.2351 0.7126 0.018182 0.59657 
AAA1 rs6947789 7 34417405 0.1299 0.6904 0.018421 0.831017 
IL4R rs1805015 16 27281681 0.07497 0.06093 0.022238 0.106425 
NOS1AP rs3927639 1 1.6E+08 0.23775 0.8069 0.025854 0.559897 
IL4R rs4787426 16 27292232 0.069705 0.7256 0.025895 0.367718 
SPINK5 rs10477360 5 1.47E+08 0.4977 0.7842 0.026547 0.691354 
ADRB2 rs2163752 5 1.48E+08 0.36905 0.8428 0.027036 0.053546 





MS4A2 rs581133 11 59638882 0.40045 0.2992 0.042794 0.990856 
NOS1AP rs1415259 1 1.6E+08 0.32835 0.1533 0.045064 0.932927 
IL4R rs3024685 16 27284411 0.4968 0.8558 0.045412 0.206295 
ADAM33 rs2853210 20 3606211 0.20275 0.4908 0.046493 0.001005 
NOS1AP rs4657154 1 1.6E+08 0.4903 0.203 0.047155 0.571577 
MS4A2 rs540170 11 59636614 0.4012 0.2587 0.048562 0.976269 
NOS1AP rs7550692 1 1.6E+08 0.495 0.4117 0.048798 0.573907 
ADRB2 rs9285673 5 1.48E+08 0.07016 1 0.048829 0.903773 
GPR154 rs1859409 7 34906409 0.22365 0.7942 0.048988 0.834582 
AAA1 rs2058163 7 34301616 0.41645 0.7081 0.049411 0.025312 
NOS1AP rs1415257 1 1.6E+08 0.3289 0.1526 0.049522 0.863704 
AAA1 rs736295 7 34417742 0.2972 0.8282 0.054244 0.039475 
GPR154 rs1637673 7 34964375 0.13745 1 0.148138 0.008053 
GPR154 rs324978 7 34780857 0.2304 0.5289 0.198337 0.000981 
GPR154 rs1419779 7 34779833 0.2304 0.5289 0.205364 0.001072 
ADRB2 rs30325 5 1.48E+08 0.31335 0.8298 0.26672 0.010121 
ADRB2 rs30328 5 1.48E+08 0.293 0.5041 0.276219 0.024933 
ADRB2 rs30330 5 1.48E+08 0.2928 0.5041 0.31671 0.027395 
GPR154 rs1186717 7 34937434 0.1182 1 0.334046 0.035548 
GPR154 rs328902 7 34987368 0.12 0.6501 0.413759 0.038379 
GPR154 rs329240 7 35024965 0.12055 0.6555 0.413759 0.038379 
AAA1 rs1419842 7 34321625 0.2917 0.1723 0.414154 0.030701 






reported for allergic rhinitis in two independent populations (Swedish and Singapore Chinese). 
Gene was used as the level of replication understanding the inherent difference in genetic 
architecture between populations
29
. We used a conventional candidate gene based strategy to test 
for association in the Swedish population by individual genotyping using the Sequenom Mass 
Array platform. In a Singapore Chinese population, a genome-wide association study (GWAS) 
dataset generated using the Illumina HumanHap 550 chip was used for the analysis. GWAS data 
has traditionally been used to detect novel genes for diseases; but it is also a great resource for 
large scale replication of previously reported candidate genes to verify their true association to 
disease. A significant advantage over the discovery of novel genes is that the significant 
thresholds need not be as conservative as say Bonferroni correction
30-32
. In this study, we thus 
GPR154 rs1379928 7 34667814 0.2004 0.7714 0.512973 0.00983 
NOS1AP rs17459307 1 1.6E+08 0.030395 1 0.51421 0.014532 
ADRB2 rs10075995 5 1.48E+08 0.3636 0.9204 0.529887 0.013889 
NOS1AP rs10800409 1 1.61E+08 0.4173 0.6401 0.550817 0.003783 
NOS1AP rs10919103 1 1.61E+08 0.4562 0.927 0.574572 0.048149 
GPR154 rs2609224 7 34672931 0.2017 0.5618 0.619309 0.010566 
GPR154 rs2609220 7 34676579 0.1956 0.6584 0.679021 0.006729 
GPR154 rs11761197 7 34666914 0.1267 0.4095 0.777659 0.013446 
GPR154 rs2531841 7 34686074 0.2581 0.4818 0.807344 0.01173 
GPR154 rs1419837 7 34692064 0.1279 0.2214 0.877156 0.017875 
NOS1AP rs6677052 1 1.6E+08 0.28615 0.5557 0.909008 0.01909 





performed a comprehensive evaluation of asthma candidate genes for their association to AR in 2 
independent populations.  
 We identified SNPs in IL10 (1), NOD1 (2), NPSR1 (5), SCGB1A1 (1), CCL5 (3) and 
TBXA2R (1) to be associated with AR. A total of five genes: NPSR1 (14), CTLA4 (10), NOS1 
(9), SPINK5 (13), IL4R (3) had significant associations to AR in the Singapore Chinese cohort. 
When further tested for the influence of these SNPs on allergen sensitization using the KW test, 
two genes NPSR1 (3) and IL10 (2) had SNPs with significant association to birch and timothy 
grass sensitization in the Swedish population. In contrast, for the Singapore Chinese population, 
genes such as AAA1 (5), ADAM33 (2), ADRB2 (7), GPR154 (18), IL4R (7), MS4A2 (2), NOS1 
(7), SPINK5 (1) had SNPs which significantly associated with sensitization to house dust mites, 
Dermatophagoides pteronyssinus and Blomia tropicalis. Significant associations of multiple 
SNPs in the NPSR1 gene to allergic rhinitis in both the Swedish and Singapore Chinese 
population validate the finding that the NSPR1 is likely a true allergic rhinitis candidate gene. 
Interestingly association of NPSR1 polymorphisms to allergic rhinitis has not been reported prior 
to this. The significance of identifying association in both populations (Swedish and Chinese) 
indicates the relevance and importance of its role in AR. Multiple significant SNPs with varying 
association P values <0.05 also adds value to it being a candidate gene for AR. Previous studies 
have reported ssignificant associations with asthma, atopy and particularly, for asthma with 
atopy, for a large region of 47 kb in the NPSR1 gene, even after Bonferroni correction for 
multiple comparisons (p<0.001) 
33
. Vergara et al
34
., investigate single nucleotide polymorphisms 
(SNPs) in the GPR154 gene and found associations with asthma and total IgE. Indeed, this gene 
has been replicated in studies of  Caucasian
35-39
 and Chinese subjects
40
, but was not replicated in 
a Mexican cohort of childhood asthmatics
41





designed with significant power of association in both populations. The other genes which have 
been associated in one of the two populations however need to be validated in other 
studies/populations for association to allergic rhinitis.  
 
In this study we have identified multiple genes to be associated with influencing sensitization to 
allergens such as birch and timothy grass in the Swedish population and Dermatophagoides 
pteronyssinus and Blomia tropicalis in the Singapore Chinese population. Sensitization to 
allergens has long been considered as a major risk factor for allergic rhinitis and asthma and 
demonstrated in both Swedish and Chinese populations 
42-45
. Interestingly, sensitization to dust 
mite allergens has been considered as risk factors for both asthma and rhinitis while pollen 
sensitization is more closely associated with rhinitis alone
46, 47
. Hence our results which suggest 
that these AR candidate genes identified might not only be relevant for AR in the Singapore 
Chinese population but also be important for asthma pathogenesis.  
 
9.3.5 Conclusion  
In summary, we have assessed the relevance and association of asthma candidate genes to 
allergic rhinitis in two independent populations.  NPSR1 was identified as a potential AR 
candidate gene with multiple SNPs in both the Singapore Chinese and Swedish population 
shown to be significantly associated. There were other genes such as IL10, NOD1, SCGB1A1, 
CCL5 and TBXA2R significant only in the Swedish population and CTLA4, NOS1, SPINK5, 
IL4R significant only in the Singapore Chinese population. These candidate genes could have 
potential significance in AR owing to their relevance in asthma, but need to be confirmed by 





GWAS data resource to replicate candidate genes previously identified or suggested by other 
research groups
48-50
. However replication of candidate genes in each population is crucial 
because of the underlying difference in genetic architecture between populations
51
 as shown for 
asthma and atopy candidate genes  as well
41, 52, 53
. Hence this study highlights the potential AR 
candidates in the Singapore Chinese and Swedish populations and might also shed light on 
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CHAPTER 10 SUMMARY 
10.1 Rationale 
Allergic Rhinitis is a common condition associated with the inflammation of the nasal airways 
mediated through mechanisms involving the production of immunoglobulin E (IgE) which binds 
to the basophils/mast cells with histamine. Most studies on rhinitis focus primarily on ‗hay fever‘ 
caused by seasonal allergens such as grass pollen and pollen from plants (commonly referred to 
as pollinosis). These studies were performed primarily in the European and the American 
populations where allergy is more seasonal than perennial. However in South East Asia, and 
especially here in Singapore the problem of allergens is more perennial in nature. The house dust 
mites are the major allergens in Singapore with a large proportion of close 90% of allergic 
individuals reacting to a house dust time species if tested for sensitization. The prevalence of 
house dust mite sensitization in Singapore is quite high as presented in Chapter 2. This is quite 
unique to this region where although the allergic sensitization prevalence is high, the prevalence 
of allergic phenotypes are comparable to trends seen in other parts of the world. Hence the need 
for more focused studies on Singapore using the perennial model of allergic rhinitis. 
In addition, most genetic studies on allergic phenotypes such as asthma, allergic rhinitis and 
atopic dermatitis are primarily performed in cohorts of European descent and in some instants 
American descent. Only a small proportion of genetic studies including the most recent GWAS 
have been studying Asian populations and to a much lesser extent populations from South East 
Asia such as Singapore, Malaysia, Thailand, Indonesia, Vietnam, etc. A quick review of genetic 
studies would indicate the issues of population based differences when considering association of 





recent past emphasizing the need to find association in specific populations before pursuing the 
functional characterization of such candidates to understand disease pathogenesis.  
Allergic rhinitis and asthma are complex diseases resulting from an interaction between genetic 
and environmental factors. Decades of research on the genetic variants associated with these 
diseases have suggested that possibly there is a large group genetic variant involved in genetic 
predisposition, many of these could be specific to different populations and others controlling the 
biology of the genes relevant across populations. Also these genetic variants have epistatic 
interactions with other candidates (gene gene interactions) and also with environmental 
conditions (gene environment interactions) controlling disease risk. Taken together these 
information suggest that genetic studies in allergic diseases need (i) a large well characterized 
population cohort preferably of a single ethnicity stratified by age, gender and environment (ii) 
an unbiased interrogation to identify genetic variants associated with disease predisposition (iii) 
considering epistatic interactions among candidate genes to understand synergistic and 
antagonistic mechanisms for disease (iv) possible functional interrogation of candidate variants 
to shed light on mechanisms and pathogenesis 
 
10.2 Approach 
The entire study described in this thesis used three main approaches (Figure 10.1) 
(1) Unbiased whole genome approach to identify novel and known genetic variants for 
allergic phenotypes 
(2) Hypothesis driven candidate gene based approach to validate the relevance of known 
allergy candidates to a Singapore Chinese population 










10.3 Significant Findings 
(1) Genome wide association study 
We had performed a two-stage genome wide association study (GWAS) consisting of a total of 
4461 ethnic Chinese volunteers were recruited in Singapore and classified according to their 
allergic disease status. The GWAS included a discovery stage comparing 515 atopic cases 
(including 456 AR cases) and 486 non-allergic non-rhinitis (NANR) controls. The top SNPs 
were then validated in a replication cohort consisting of a separate 2323 atopic cases (including 
676 AR cases) and 511 NANR controls. Two SNPs showed consistent association in both 
discovery and replication phases; MRPL4 SNP rs8111930 on 19q13.2 (OR = 0.69,                     
PCombined = 4.46×10−05) and BCAP SNP rs505010 on chromosome 10q24.1 (OR = 0.64, 
PCombined = 1.10×10−04). In addition, we also replicated multiple associations within known 
candidates regions such as HLA-DQ and NPSR1 locus in the discovery phase. Our study 
suggests that MRPL4 and BCAP, key components of the HIF-1α and PI3K/Akt signaling 
pathways respectively, are two novel candidate genes for atopy and allergic rhinitis. Further 
study on these molecules and their signaling pathways would help in understanding of the 
pathogenesis of allergic rhinitis and identification of targets for new therapeutic intervention. 
Polymorphisms previously identified through GWAS for asthma and related phenotypes also 
showed suggestive associations in our GWAS samples, including the SNPs within previously 
known candidate regions such the HLA locus on chromosome 6 and the NPSR1 locus. Hence 
these results suggest that genetic susceptibility to complex diseases such as atopy, allergic 
rhinitis and allergic asthma might involve a large number of genetic variations, ranging between 
rare alleles with strong effects to intermediate to common alleles with small to moderate effect 





disease associated variants would help elucidate the complex mechanism underlying the genetic 
predisposition of diseases. 
 
(2) Candidate gene based association studies 
(a) Association of BDNF genetic variants to asthma and allergic rhinitis 
Our study has identified a significant association of a BDNF SNP to AR. To the best of our 
knowledge this is the first evidence for the genetic association of BDNF with AR. A similar 
association was observed for allergic asthma in our population, suggesting an important role for 
BDNF variations in asthma susceptibility. The same tagSNP rs10767664 had a significant 
PDominant = 0.0007 and OR = 1.3 for AR and PDominant = 0.0005 and OR = 1.3 for allergic asthma. 
Furthermore the association of single SNP analysis was confirmed by significant associations of 
two-SNP haplotypes with both AR and asthma. These results therefore confirm that BDNF gene 
variants do contribute to disease predisposition and progression in allergic diseases. The SNP 
identified to be associated, rs10767664, is one of the tagSNPs used in this study. We therefore 
need to investigate other SNPs linked to rs10767664 to understand which of them might be 
causal. This common, single point mutation identified through a genetic association study has 
been shown to produce a phenotype in transgenic mice similar to that seen in humans. There are 
other intronic SNPs linked to the associated SNP and the effect of these SNPs cannot be 
discounted. 
10.3.1 Current Work 
Further functional studies are required, including in vitro studies analyzing the effect of 
polymorphisms on BDNF expression in order to elucidate its role and significance in allergic 





(i) In-vitro study to evaluate the effect of BDNF variant rs6265 (Val66Met) 
The tagSNP identified to be associated with both asthma and AR in this study (rs10767664) is in 
very strong LD with the functional polymorphism rs6265 (r
2
 =0.95) for the Hapmap CHB 
population. This polymorphism has been studied with respect to neurodegenerative disease but 
there is a lack of understanding why and how this neurotrophin functions to result in an increased 
risk for allergic phenotype. Hence currently we are using in-vitro cell line based systems (HaCat 
and HEK293T cell lines) to evaluate the effect of the wild type and mutant forms in parallel. As 
the variation is an exonic non-synonymous variant changing the amino acid form from valine to 
methionine it would be possible that the secretion of BDNF is affected and also the functionality 
and activity of the secreted protein might be variable as well. However we need to confirm this 
using transfected clones containing the protein in the native form and the protein obtained as a 
result of the genetic variation. 
(ii) Ex-vivo studies to evaluate the functional parameters affected by the polymorphism 
A functional cohort recruited based on the genotype of the polymorphism under study, rs6265 is 
currently being designed to evaluate the effect on the different cell types such as T cell subsets,  
B cell subsets and may the dendritic cells as well. Due to complex involvement of these cells in 
the development of allergic phenotypes such as Th1/Th2 balance, IgE+ B cell percentage and 
other mechanisms it would be interesting to observe any of these trends in the individuals with 
the risk genotype coding for the methionine. Effect of genotype of serum levels of BDNF would 
also be evaluated to observe any trends similar to the effect on disease risk. 
Thus BDNF could serve as a potential biomarker for allergic phenotypes such as asthma and 





(b) Genetic association of UGRP1 SNPs to allergic rhinitis 
Uteroglobin-Related Protein 1 (UGRP1) is a secretoglobulin protein which has been suggested to 
play a role in lung inflammation and allergic diseases. UGRP1 has also been shown to be an 
important pneumoprotein, with diagnostic potential as a biomarker of lung damage. Here we 
performed a candidate gene based association study for UGRP1 to allergic rhinitis phenotype.  
We first resequenced the UGRP1 gene was conducted on 40 randomly selected individuals from 
Singapore of ethnic Chinese origin. The polymorphisms identified were then tagged and 
genotyped in a population of 1893 Singapore Chinese individuals. Genetic associations were 
evaluated in this population comparing 795 individuals with allergic rhinitis, 718 with asthma (of 
which 337 had both asthma and allergic rhinitis) and 717 healthy controls with no history of 
allergy or allergic diseases. The SNP rs7726552 showed significant association with AR in our 
population. Haplotype analysis revealed a single Haplotype block which, when tested for 
association, was significantly different in cases as compared to controls. This Haplotype block, a 
4.13 kb region, includes the 5' upstream, promoter and the first intron. The SNP rs7726552 is 
present in the 5' upstream region and hence could affect the regulation of gene expression levels. 
The in silico analysis revealed potential binding sites for Oct-1, NF-1 and GATA-1 at the 5' 
upstream locus where rs7726552 was identified. Oct-1 has been previously shown to be 
important in regulating the expression of IL13 which is a key regulator of Th2-mediated 
inflammation in allergic diseases.  
In summary, this study documents the association between polymorphisms in UGRP1 and 
allergic rhinitis, suggesting an effect in its pathogenesis and also highlights a potential role for 







The functional significance and the mechanism of the causal variant in UGRP1 leading to the 
onset of allergic rhinitis needs to be confirmed and validated with further studies.  
(i) Luciferase based promoter activity for the promoter polymorphism 
The SNP described here is present close to 3kb upstream in the promoter region. A 
previously described polymorphism –G112/A (rs1368408) was identified not to be associated 
with AR in our population. The linkage between these SNPs is almost absent (r
2
 =0.027) for 
the Hapmap CHB and r
2
 =0.027 in our Singapore Chinese population.  However we cannot 
eliminate the functional relevance of the previously reported polymorphism rs1368408 due to 
the lack of association in our population. Hence we designing promoter constructs including 
the various combinations of these risk variants and will evaluate any possible difference in 
the promoter activity. There could be a possible synergistic biological effect when the two 
risk variants are present which might result in an increased risk towards disease.  
 
(ii) Altered Transcription factor binding  
The polymorphism found to be associated with AR has also been predicted to influence 
binding of transcription factors such as Oct-1, NF-1 and GATA-1 through in silico 
predictions. These transcription factors have been shown to have potential to regulate gene 
expression based on the efficiency of binding. Hence we are currently designing EMSA 
(Electrophoretic Mobility Shift Assay) based experiments to attempt at functionally 






(c) Epistatic interactions between PHF11 and IFNG SNPs control risk towards asthma and 
allergic rhinitis 
Various genetic studies on different population have reported single locus association of PHF11 
and IFNG SNPs to allergic diseases. In addition PHF11 has been shown to be functionally 
regulating the expression of IFNG. Given the important roles of both PHF11 and IFNG in allergy 
as well as the biological interaction of the two genes where PHF11 regulates IFNG expression, 
we hypothesized that polymorphisms in these genes would be associated with allergic diseases 
through effect of the single gene or gene-gene interactions. Thus, we performed a case control 
study to identify polymorphisms of PHF11 and IFNG in Singapore Chinese population and to 
evaluate their association to allergic rhinitis and asthma. We also performed statistical analysis to 
identify interaction of SNPs in PHF11 and IFNG. Our results show that none of the PHF11 and 
IFNG SNPs is associated with the susceptibility of allergic diseases in Singapore Chinese 
population. However when interactions are included in analysis, these SNPs synergize to exert 
greater effect that can be detected statistically. This statistically significant interaction of PHF11 
and IFNG is also supported by studies showing biological interactions between the two gene 
products where PHF11 regulates expression of IFNG by binding to the IFNG promoter as well as 
recruiting transcription factor NF-κB. This is supported by a possible biological interpretation 
where PHF11 is the regulator of IFNG in the T cell development pathway. However, it is 
important to take note that statistical interactions do not necessarily imply biological mechanism 
of interactions. The tag SNPs that were used for analysis may not be the actual disease causing 
SNP. Significant association signals could be due to SNPs in high linkage disequilibrium with 
the tag SNPs. Therefore, further functional studies would be required for a clearer understanding 






(i) Effect of risk genotype combination on IFNG expression 
We have shown in the above study that there is observed a genetic epistasis between the 
biologically interacting molecules PHF11 and IFNG. However this could just be associated and 
not causative i.e., the impact the epistasis on the actual biology and function and thereby the 
eventual impact on disease is still debatable. Hence we are currently working to evaluating if this 
potential risk combination actually impacts the expression of IFNG differently compared to the 
non-risk genotype combination. We have selected individuals with the risk genotype 
combinations of PHF11 and IFNG which had an Odds Ratio of 1.6 for asthma in comparison to 
the reference which had neither of the risk variants. Because the PHF11 indeed binds to the 
promoter of the IFNG gene, the alleles present at the locus of biding that are interacting can be 
expected to have a different impact on the expression of IFNG.  
 
(ii) Effect of the risk genotype combinations on the serum IgE levels 
Serum immunoglobulin E (IgE) levels have been shown to be indicative of allergic phenotypes 
such as allergic asthma and AR. Hence it would be interesting to evaluate if the individuals in the 
high risk group have elevated serum IgE levels which might also potentiate that the epistasis 
might actually have an effect on disease predisposition and in some cases may be progression as 
well. Since IFNG is such a key regulator of the immune system and is important for Th1/Th2 
balance this study would be helpful in understanding the role of genetic variants of PHF11 in 







10.3.2 Future Work 
(a) From genotype to gene 
We have identified genetic association through the various approaches as described in                      
Figure 1. However association to disease is correlative and not causative. Hence we need to 
identify the biology of the gene regulated by the SNP and then moving forward how that 
particular biological parameter(s) lead to disease manifestation, progression and in some cases 
severity. We have demonstrated through our ex vivo cohort based functional analysis that 
significant SNPs in ICOS and CTLA4 affect the expression of the respective genes in some 
specific cell types and not in others. So it would be interesting to understand this balance of 
expression levels in different cell sub types and how this is relevant in allergy. Interestingly 
BDNF associated with asthma and AR is a brain derived neurotrophin usually associated with 
cognitive functions, synaptic plasticity, memory and other nervous system related phenotypes. 
However levels of BDNF have been elevated in allergic patients with asthma and AR in 
comparison with normal volunteers indicating that there is correlation to disease. Hence it is 
important to understand the role of neurotrophins such as BDNF, NGF and FGF in allergic 
disease and to design studies carefully to understand the neuroimmune system which refers to the 
interactions of immune and nervous system. This is not totally unrelated given that major 
symptoms of allergic rhinitis such as sneezing and itching are indeed nervous system mediated 
reflexes. Recent research has also identified elevated levels of BDNF and NGF in localized nasal 
mucosa in chronic rhino sinusitis (CRS) which is a severity resulting in a proportion of 
individuals reported to have AR.  In summary we need to identify causation rather than 






(b) Pathways and interactions  
In addition to affecting the genes, genetic variants should also be indicative of key pathways and 
mechanisms which involve a number of players necessary to explain the other observed 
phenotypic manifestations which need to be evaluated. An important aspect for allergic rhinitis 
would be to evaluate the interaction between the immune system and nervous system as 
mentioned above. However we hypothesize that there should be more players involved in the 
disease and hence a pathway based analysis identifying key components regulated in a dependent 
manner which significantly differ in the patient group needs to be employed. In the model of 2q 
region, the four co-stimulatory molecules CTLA4, ICOS, PDCD1 and CD28 regulate each other 
and this regulation is vital in understanding the cause for disease phenotypes to express. 
However the complexity is further increased by considering the genetic variants in these genes 
and hence systems biology approach which incorporates all these data together: genetic, 
functional, clinical would be the best way to understand the disease state better. 
 
10.4 Models of disease 
The genetic variants identified through our association studies and validated in the in vitro and or 
ex vivo studies needs to be studied in disease models. Taking the BDNF gene as an example, the 
variant rs6265 has been studied in a mouse knock out system but evaluating the neuronal 
parameters and in association to psychiatric disorders. However using such a model but focusing 
on parameters relevant for allergic phenotypes such asthma and allergic rhinitis would help 
understand the phenotype of disease better and also to observe other physiological changes 









In conclusion, we have collected a large epidemiological cohort with clinical history of disease 
and special emphasis on allergic diseases such as asthma, allergic rhinitis and atopic dermatitis. 
All volunteers have been tested for house dust mite sensitization using an in vivo skin prick test 
(SPT). DNA samples were extracted and stored appropriately. Genetic association studies 
performed have identified novel candidates and also validated previously known genetic variants 
associated with allergy. Functional analysis performed in the cohort selected based on the risk 
Haplotypes for asthma and AR have identified potential markers or expression levels which 
could act as surrogates to intermediate phenotypes which constitute the disease phenotype in 
general. Possible pathway analysis in future would help integrate all this data using a systems 
biology approach to help segregate the diseased individuals from the healthy non-diseased 
population. Some primer studies on interaction analysis have identified potential epistasis 
between biologically interacting candidates such as PHF11 and IFNG in controlling risk for 
asthma and AR. However this is only correlative at this stage and whether this genetic epistasis 
has an impact on the biological interaction of the candidate genes need to be evaluated through 
well defined functional studies. Gene environment interactions considering multiple factors 
which might serve as confounding factors to dilute the association signals needs to be designed 
and evaluated appropriately. Finally the model of disease pathogenesis, progression and fatality 
needs to be more clearly elucidated which would help identify potential areas of therapeutic 
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